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Abstract 
This thesis examined the effect of single and repeat bouts of prolonged exercise as well 
as an environmental temperature challenge upon left ventricular (LV) function and 
cardiac biomarker release. The primary aims were; (1) does repeated exercise bouts 
mediate a cumulative decrease in LV function and/or increase in cardiac biomarker 
concentrations; and (2) to examine the impact of prolonged exercise in a hyperthermic 
environment upon cardiac function and cardiac biomarker levels. 
 
Study 1 demonstrated evidence of LV systolic and diastolic dysfunction after exercise 
that persisted 22 hours into recovery following 10 days of cycling in amateur cyclists. 
There was however, limited support for a cumulative change in function across days. A 
highly individual, but not cumulative, pattern of cardiac biomarker appearance was 
observed with rapid clearance. This data suggests that the cardiovascular system of the 
amateur cyclists coped well with the accumulated exercise stress imposed by the repeated 
cycling over 10 days. Study 2 revealed that a single bout of prolonged exercise (37 km), 
in a hyperthermic environment, resulted in a decrease in LV systolic and diastolic 
function and an elevation in cardiac biomarkers. There was no evidence of cumulative 
changes in function or biomarker appearance over a further 5 days of exercise in a 
hyperthermic environment. Significant individual variation between participant’s 
responses were again noted.  
 
Study 3 employed a controlled exercise stimulus in a laboratory setting and revealed both 
LV systolic and diastolic function were not significantly altered following 60 minutes of 
running in either a normothermic (13oC) or hyperthermic (30oC) environment. The 
release of cardiac biomarkers was limited, with a tendency for markers to be higher in the 
hyperthemic condition. Participants coped well with the exercise stress, however, the 
V 
 
“low” exercise dose in this study likely negates any meaningful impact upon cardiac 
function and biomarker release. 
 
The final study manipulated core temperature (Tc), through pre-cooling, prior to exercise 
in a hyperthermic environment (32.4 ± 0.9oC and 46.8 ± 6.4% RH). Diastolic, but not 
systolic, function was reduced following 90 minutes of running, with no difference 
apparent between pre-cooling and control conditions. cTnT was evident in all participants 
following both trials, with a limited release of NT-proBNP that was not mediated by pre-
cooling. Pre-cooling appeared to have no beneficial or adverse effect on the 
cardiovascular function and biomarkers that again displayed high inter-individual 
variability. 
 
In conclusion, we observed evidence that acute exercise can result in changes in both 
cardiac function and biomarkers. There was, however; (1) no evidence of an accumulation 
of cardiac function or biomarker data across multiple bouts of exercise across a number 
of days, and (2) limited evidence that either a hyperthermic environment or a pre-cooling 
intervention altered cardiac function and biomarker data after exercise in a controlled 
laboratory design. Changes in cardiac function and biomarkers were transient in nature, 
of relatively small magnitude and subject to high individual variability. It would seem 
that these changes represent an acute physiologic perturbation as opposed to pathology. 
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CHAPTER 1 
Introduction 
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Participation in regular moderate exercise has beneficial effects on the risk factor of 
cardiovascular disease, as well as a variety of other chronic diseases which include 
diabetes mellitus, cancer, obesity, hypertension and depression (Warburton et al., 2006). 
Whilst regular exercise-training can reduce the incidence of coronary heart disease 
(CHD) events, each exercise bout is associated with a transient increase in the risk of 
sudden cardiac death (SCD) and acute myocardial infarction (AMI) in susceptible 
individuals (Thompson et al., 2007). The substantial benefits of exercise greatly outweigh 
the increased risk of a cardiac event, with evidence suggesting the greatest benefit in those 
who exercised in excess of 42 metabolic equivalents (METs) per week (Tanasescu et al., 
2002). Whilst a number of elite athletes are reported to exercise in excess of 20 hours or 
300 METs per week (La Gerche et al., 2008), little is known regarding the upper limit of 
exercise volume for cardiac health (Whyte, 2008). La Gerche and Prior (2007) proposed 
that at extreme levels of endurance training, there may be a decline in the overall benefits 
of exercise when compared to an increased risk of a cardiac event.  
 
Taking part in prolonged exercise, such as training for and participating in endurance and 
ultra-endurance events is becoming increasingly popular. In this thesis, prolonged 
exercise is defined as endurance exercise of 60 minutes or greater. According to Shave et 
al. (2007b), participation in the London marathon has risen from ~8,000 participants in 
1981 to over 30,000 participants in 2006, with many more applying for places. This is 
despite the fact that there is some controversy over the beneficial effect of prolonged 
exercise (Michielsen et al., 2008). This controversy is not limited to scientific debate in 
journal studies but has crossed over to the mass media about the safety of exercise, thus 
having a greater reach and impact (Burfoot, 2008; Parker-Pope, 2009; Yared and Wood, 
2009). Such speculation within the media can act as a deterrent to the physically inactive 
and raises concern with those taking part in recreational endurance events (Shave et al., 
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2007a; Scott et al., 2009).  Endurance athletes are now seeking advice from scientists, 
coaches and clinicians over safety concerns of the exercise they partake (George et al., 
2008).  
 
Moderate steady-state exercise of as little as 10 minutes creates an increased 
hemodynamic and metabolic load, requiring an athlete to maintain a high cardiac 
workload to ensure adequate muscle perfusion (Dawson et al., 2003). As the exercise 
duration becomes prolonged (greater than 60 minutes) the cardiac workload is further 
exuberated due to increased thermal load and blood volume redistribution/reduction, 
placing a substantial strain upon the cardiovascular system (Coyle and González-Alonso, 
2001). A growing evidence-base suggests that the physiological demands of maintaining 
a high cardiac workload for a prolonged period of 60 minutes or greater (Middleton et al., 
2006a) may result in a transient impairment in cardiac function, evidenced by a reduction 
in indices of global LV function such as filling pressures, filling velocities, ejection 
fraction (EF), stroke volume (SV) and systolic and diastolic tissue velocities (e.g. Douglas 
et al., 1990b; George et al., 2004, 2005; Middleton et al., 2007a; Shave et al., 2004a, 
2004c; Vanoverschelde et al., 1991). The release of cardiac biomarkers into the systemic 
circulation such as cardiac troponin (cTn), a biomarker of cardiomyocyte cell insult, 
immediately following acute bouts of prolonged exercise in apparently healthy 
individuals has been documented (Shave et al., 2007a). In addition, there is no consensus 
regarding the prevalence, mechanisms and clinical management of exercise-induced cTn 
release (Shave et al., 2010).  
 
A combination of factors such as exercise duration, intensity and volume, participants 
training experience, as well as environmental factors have been suggested to precipitate 
changes in LV function and biomarker appearance (Gresslien and Agewall, 2016; 
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Oxborough et al., 2010; Sedaghat-Hamedani et al., 2015). However, data interpretation 
is often confounded due to the field-based competitive nature of endurance events, 
particularly in relation to the inability to manipulate environmental conditions. 
Furthermore, whilst single bouts of prolonged exercise provide a substantial 
cardiovascular challenge, these events are typically followed by periods of rest or reduced 
activity allowing the athlete to recover. Many athletes however, engage in repeated bouts 
of exercise either during competition, through the repetitive element of training, or a 
combination of the two. Therefore, the evaluation of single bouts of prolonged exercise 
provides limited information into the practical understanding of cardiac dysfunction and 
biomarker release in different exercise settings. Participation in multi-day endurance 
events, with repeated endurance exercise exposure and limited recovery time, have also 
proved increasingly popular (Knoth et al., 2012), with such events likely representing the 
upper limit of physiological stress placed upon the human heart (George et al., 2011). 
Despite this, there is a lack of evidence examining the cardiovascular consequences of 
these types of events. 
 
To further the current understanding of the impact of single or repeated bouts of 
prolonged exercise, as well as a mediating role for environmental temperature, upon LV 
function and markers of cardiac damage, the aims of this thesis were as follows; to 
examine LV function and markers of cardiac damage in healthy individuals in response 
to (1) 10 days of road cycling, (2) single and multi-day exercise (running) in a field-based 
hyperthermic environment, (3) prolonged running in a lab-based hyperthemic and 
normothermic environment and (4) prolonged running in a lab-based hyperthermic 
environment with and without pre-cooling. 
 
5 
 
The following Chapter of this thesis provides an overview of the existing literature in 
relation to; cardiovascular responses to acute aerobic exercise, the impact of single and 
repeated bouts of endurance exercise upon cardiac function and biomarker release and 
the effect of exercise, thermoregulation and environmental temperature upon 
cardiovascular function. The specific study designs and results from each study are 
presented in Chapters three, four, five and six, respectively. Finally, the overall findings 
are discussed in Chapter seven and the conclusions from the four studies are presented. 
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CHAPTER 2 
Literature Review 
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2.1 Introduction 
The benefits of physical activity are undisputed, with many studies demonstrating that 
physical activity is associated with a reduced risk of cardiovascular disease, cancer, 
diabetes and dementia (Shiroma and Lee, 2010; Warburton et al., 2006). Several 
epidemiological studies have reported an inverse relationship between physical activity 
and cardiovascular disease (Paffenbarger et al., 1978, 1986), with regular exercise 
improving the cardiovascular disease risk profile by lowering blood pressure (Whelton et 
al. 2002), improving endothelial function (Joyner and Green, 2009) and enhancing vagal 
tone (Beere et al., 1992), amongst other adaptations. A dose-response relationship 
between physical activity and cardiovascular outcomes is also well described (Eijsvogels 
and Thompson, 2015), with as little as 15 mins per day of moderate-intensity exercise 
significantly lowering the risk of all-cause mortality and increasing life expectancy (Wen 
et al., 2011). The World Health Organisation (2011) recommends 150 mins of moderate-
intensity or 75 mins of vigorous-intensity aerobic exercise per week, for adults aged 18-
64 years. However, whilst these exercise volumes yield a significant health improvement 
(Powell et al., 2011), with further increasing exercise volumes producing further smaller 
risk reductions (Eijsvogels et al., 2016), a large population do not meet these exercise 
guidelines. In stark contrast, participation in prolonged endurance training and events has 
grown in popularity, particularly in marathons, triathlons and cycling events (Knechtle et 
al., 2011; Shave et al., 2007b; Shoak et al., 2013), whereby participants are frequently 
participating in more than double the recommended daily/weekly exercise guidelines. 
Whilst greater volumes have been found to yield a greater cardiovascular benefit (Sarna 
et al., 1993), the health consequences of participating in extreme volumes of exercise is 
under debate (Eijsvogels et al., 2016; Eijsvogels and Thompson, 2017). Little is known 
regarding the upper limit of exercise volume for cardiovascular health benefits, with some 
authors suggesting no upper limit (Mandsanger et al., 2018), whilst others suggest a 
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plateau or possible increased risk with very high exercise volumes (La Gerche and Prior 
2007; Whyte, 2008). A number of studies have also reported potentially adverse 
cardiovascular responses to prolonged exercise, including post-exercise cardiac 
dysfunction (Oxborough et al., 2010) and exercise-induced elevations in cardiac 
biomarkers (Shave et al., 2007a). Whilst a growing evidence-base suggests that the 
physiological demands of maintaining a high cardiac workload for a prolonged period of 
60 mins or greater (Middleton et al., 2006a) may result in a transient impairment in 
cardiac function, the release of cardiac biomarkers into the systemic circulation may occur 
following as little as 30 mins exercise (Shave et al., 2010). It is also suggested that a 
combination of factors such as exercise duration, intensity and volume, participants 
training experience, as well as environmental factors that precipitate changes in 
ventricular function and biomarker appearance (Gresslien and Agewall, 2016; Oxborough 
et al., 2010; Sedaghat-Hamedani et al., 2015), although more research is required in this 
controversial area (Dawson et al., 2003). Participation in multi-day prolonged endurance 
events, with repeated endurance exercise exposure more than double the World Health 
Organisation (2011) guidelines with limited recovery time is also becoming increasingly 
popular (Knoth et al., 2012). However, limited attention has been given to the effect of 
multi-day exercise upon cardiac function and biomarkers of cardiac damage or stress. 
 
The focus of this literature review, and the empirical studies within this thesis is to 
develop our knowledge of acute cardiovascular consequences of undertaking single and 
repeated bouts of prolonged exercise. Therefore, the following literature review initially 
describes the cardiovascular response to acute aerobic exercise, followed by a review of 
the existing findings in relation to the impact of single and repeated bouts of endurance 
exercise upon cardiac function and biomarker release. Finally, the literature pertinent to 
cardiovascular function during heat stress and strategies to reduce the physiological strain 
9 
 
of exercising in thermally stressful environments is evaluated before the aims and 
hypotheses of this thesis are presented. 
 
2.2 Cardiovascular Responses to Acute Aerobic Exercise 
Prior to reviewing the literature relating to the cardiovascular response to endurance 
exercise, an understanding of the cardiac cycle is important to comprehend before a 
discussion of how the cardiovascular system responds to an acute bout of sub-maximal 
aerobic exercise. The normal cardiac cycle consists of a phase of myocardial contraction 
(systole) and a period of myocardial relaxation (diastole), which results in the ejection 
and filling of blood of the LV. A well-coordinated sequence of pressure and volume shifts 
must occur to maintain the continuous change between filling and ejection from the LV 
(Figure 2.1). 
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Figure 2.1 The normal left ventricular (LV) cardiac cycle. Interaction of the changes in 
pressure, volume and flow in the aorta, LV and left atrium. EDV: end diastolic volume; 
ESV: end systolic volume; SV: stroke volume (From Herring and Paterson, 2018; 
Reprinted with permission from Publisher). 
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LV systole is initiated by a brief period of isovolumetric contraction, whereby a 
shortening of endocardial myofibres and stretch of the epicardial fibres result in an 
increase in intra-ventricular pressure, without a change in LV volume (Herring and 
Paterson, 2018). As the ventricles contract, LV pressure rapidly exceeds left atrial 
pressure creating a pressure gradient, pushing back the leaflets of the mitral valves, 
forcing them to close (Calvert and Lefer, 2012). Further contraction of the LV increases 
LV pressure above that of the diastolic pressure in the aorta. As a result, the aortic valve 
is forced open, ejecting blood into the circulation, reducing the LV volume. The continued 
contraction of the LV increases the pressure in the aorta which peaks approximately half 
way through the systolic ejection period, after which the intra-ventricular pressure starts 
to decline below that in the aorta. This allows for the blood in the aorta to push back on 
the aortic valve, forcing it to close (Calvert and Lefer, 2012). The reduction in LV volume 
at the end of this phase represents the LV end systolic volume (LVESV). The period of 
systole is closely followed by a period of diastole. LV diastole is defined as the period 
from the end of aortic ejection until the onset of ventricular tension of the succeeding beat 
(Gibson and Francis, 2003) and is determined by ventricular relaxation and effective 
chamber compliance (Nishimura and Tajik, 1997). It initiates at the terminal phase of 
systolic activity through the decline in myocardial tension caused by the uptake of 
calcium into the sarcoplasmic reticulum (Gibson and Francis, 2003). The rapid fall in 
intra-ventricular pressure at the end of systole (~80 mmHg to 0-5 mmHg), known as 
isovolumetric relaxation time, allows for the myofibres to relax prior to any change in LV 
volume and begins at the onset on the closure of the aortic valve. The reduction in pressure 
creates a pressure gradient between the left atrium and LV that forces open the mitral 
valve, initiating early LV filling (E). Initially, ventricular pressure falls despite an increase 
in blood volume due to the relaxing ventricle recoiling elastically from its deformed end 
systolic shape. As a result, blood is sucked into the ventricle in early diastole (Herring 
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and Paterson, 2018). Peak E velocity can be measured by pulsed Doppler, with values 
usually ranging 1.0-1.2 m.s-1 in young healthy adults. The rate of filling slows down as 
the ventricle reaches its inherent relaxed volume (diastasis). Venous pressure drives 
further filling, distending the ventricle, causing a gradual increase in ventricular diastolic 
pressure (Calvert and Lefer, 2012). Contraction of the atria propels further blood into the 
ventricle, accounting for 10-20% of ventricular filling at rest (Herring and Paterson, 
2018). This phase of atrial contraction is known as late diastolic filling (A) and produces 
a further increase in left atrial and LV pressures. By the end of the filling phase, the 
volume has increased to represent the LV end diastolic volume (LVEDV), following the 
closure of the mitral valves. The difference between LVEDV and LVESV is known as 
SV and therefore represents the volume of blood ejected from the ventricle with each 
contraction of the heart. During increased cardiovascular demand i.e. during exercise, the 
volumes and durations within the cardiac cycle may all be influenced by three factors: 1) 
preload, 2) afterload and 3) contractility. 
 
A major determinant of preload is venous return, quantified as the amount of blood 
returning to the right atrium each minute (Calvert and Lefer, 2012). Factors that lead to 
an increased venous return/preload include: an increased cardiac output i.e. through 
exercise, increased central blood volume, increased venous tone and rapid ventricular 
relaxation. An enhanced preload leads to further distention of the ventricle during 
diastole, this increased tension of the cardiac myofibres causes a reflex increase in 
myofibre contractility and a greater ejection of blood into the aorta, contributing to an 
increased SV (Calvert and Lefer, 2012). The intrinsic ability of the heart to adapt to 
changes in preload is known as the Frank-Starling mechanism. Preload, therefore, reflects 
the end-point of venous return, LV filling, pressure and stretch on the LV wall, known as 
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LVEDV. It is also important to note that the LV becomes less distensible with greater 
filling (larger fiber lengths) at extreme LVEDV’s. 
 
Afterload (i.e. aortic pressure) reflects the resistance that the LV must overcome to eject 
blood (Calvert and Lefer, 2012). Therefore, an increase in afterload requires a higher peak 
systolic pressure during systole, impacting upon SV. An increase in afterload reduces the 
force production of the LV myofibres due to more energy being used to overcome the 
heightened aortic pressure before blood ejection is possible during isovolumetric 
contraction (Herring and Paterson, 2018). Consequently, a progressive increase in 
afterload can inhibit myofibre shortening during the ejection phase, attenuating a 
reduction in LVESV and subsequently SV. Afterload can be estimated by measuring the 
pressure that the ventricle produces during systolic ejection (systolic blood pressure; 
SBP). 
 
Neural input from the sympathetic and parasympathetic nervous systems influence the 
rate (chronotropic state), force of LV contraction (inotropic effect) and relaxation 
(lusitropic effect), independent of preload (fiber length) and afterload (Calvert and Lefer, 
2012). At rest, the sinoatrial node prompts a calcium ion induced release of calcium ions 
from the sarcoplasmic reticulum. As a consequence, the calcium ions interact with 
troponin C of the troponin-tropomyosin complex, resulting in a cross-bridge formation 
and force generation/myocyte contraction (Takimoto and Kass, 2012). Relaxation 
involves the removal of calcium ions from troponin C and subsequent extrusion from the 
cell via the sodium/calcium exchanger, ATPase pump or intracellular uptake into the 
sarcoplasmic reticulum or mitochondria (Takimoto and Kass, 2012). This process of 
myocyte contraction and relaxation occurs on an average rate of 60 times a minute, 
otherwise known as heart rate (HR). At rest, HR reflects the predominant activity of the 
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parasympathetic nervous system, releasing acetylcholine which slows the intrinsic 
activity of the heart. To produce an increased cardiac output during submaximal exercise, 
an increased HR and SV must occur. A withdrawal of parasympathetic tone and an 
increase in sympathetic activity via the neurotransmitters adrenaline and noradrenaline 
stimulate the β-andrenergic receptors in the myocardium, resulting in an increase in 
chronotropic, inotropic and lusitropic effects (Opie, 2004) from a greater release and 
uptake of calcium into the sarcoplasmic reticulum. An increase in contractility through 
sympathetic stimulation produces a significant change in SV, reflected by an increase in 
EF, calculated as SV expressed as a fraction of LVEDV (Konstam and Abboud, 2017). It 
is important to note that EF is influenced by both preload (diastolic) and afterload 
(systolic) and consequently should not be interpreted as a measure of contractility without 
knowledge of LV loading (Konstam and Abboud, 2017). 
 
The cardiovascular adaptations that occur in response to an acute bout of submaximal 
exercise are well regulated and reflect a rapid adjustment to the increased demands placed 
upon the body. A 30 min bout of submaximal running is tolerated well by most 
individuals, with a rapid recovery post-exercise i.e. rapid decrease in HR when exercise 
ceases. When exercise exposure is significantly increased i.e. increased duration, the 
cardiovascular workload is also elevated. Whether the cardiovascular system copes with 
this higher dose of exercise is under debate and is the focus of this thesis. 
 
2.3 The Impact of Single Bouts of Endurance Exercise on Cardiac Function and 
Biomarker Release 
During prolonged exercise, particularly ultra-endurance exercise, there is a considerable 
amount of cardiac work. Concurrently the heart must also deal with an elevation in Tc, 
increased mechanical work, increased levels of catecholamines, altered pH and an 
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exposure to reactive oxygen species (Dawson et al., 2003; George et al., 2012). Moderate 
exercise (e.g. 50-75% VO2max) of greater than 10 mins is typically associated with a 
progressive rise in HR, despite a maintained workload, commonly known as 
cardiovascular drift. Cardiovascular drift is due to a progressive increase in cutaneous 
blood flow as body temperature rises, increasing cutaneous venous volume. As a result, 
a progressive reduction in ventricular filling pressure, EDV and SV are apparent, with a 
parallel increase in HR observed in order to maintain cardiac output (Coyle and González-
Alonso, 2001). Though the benefits of participating in physical activity are apparent, 
whether the heart can maintain performance alongside such challenges is less clear and 
will be described in the next section. 
 
2.3.1 Alterations in Cardiac Function 
A growing evidence-base suggests that the physiological demands of maintaining a high 
cardiac workload for a prolonged period may result in an immediate depression in systolic 
and/or diastolic function (Douglas et al., 1990b; George et al., 2004, 2005; Middleton et 
al., 2007a; Shave et al., 2004a, 2004c; Vanoverschelde et al., 1991). The transient 
impairment in cardiac function immediately following prolonged exercise in the absence 
of underlying cardiovascular diseases has been termed as exercise-induced cardiac fatigue 
(EICF; Banks et al., 2010; Shave et al., 2004c; Whyte et al., 2000). This area has been 
given a vast amount of attention in recent years, with reviews (Dawson et al., 2003; 
Oxborough et al., 2010; Shave et al., 2008) and a meta-analysis (Middleton et al., 2006a) 
providing more support for the existence of EICF. The majority of previous studies have 
focused upon post-exercise changes in LV function (Shave et al., 2008), therefore, EICF 
has been mainly characterised by an acute post-exercise reduction in LV systolic and/or 
diastolic function (Dawson et al., 2003; Shave et al., 2004c). The mechanisms involved 
in the process are unclear and the exercise parameters that augment cardiac fatigue are 
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poorly described (Oxborough et al., 2010). A wide range of exercise modes, durations 
and intensities within differing environmental conditions have been studied to elucidate 
the causes of EICF, however, there are many discrepancies within the findings (Table 
2.1). 
 
Table 2.1 provides an over-arching summary of the literature which includes past studies 
which assessed LV systolic and diastolic function before and after exercise using standard 
2D echocardiography, flow-Doppler and tissue-Doppler (TDI) indices. The table details 
the studies by mode (running, cycling, multimode), exercise distance (duration), the 
intensity of the exercise and environmental conditions, alongside the study’s findings.  
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Table 2.1 Studies utilising standard 2D, flow-Doppler and tissue-Doppler echocardiography following single bouts of prolonged exercise 
Author Exercise 
distance 
(duration) 
Intensity of 
Exercise 
Systolic Diastolic Environmental 
Conditions 
↑ = ↓ ↑ = ↓ 
RUNNING 
Shave et al., 
2002c 
Maximal 
ramping 
treadmill test 
30 min 
downhill 
running 
Maximal 
 
 
70% maximal 
running 
velocity 
 EF, SV, FS 
 
 
EF, SV, FS 
  E, A, E:A 
 
 
E, A, E:A 
 NR 
 
 
NR 
Weippert et al., 
2016 
Trial 1: 60 min 
 
 
 
 
 
Trial 1: 60 min 
Two blocks 
separated by 3 
mins (12 x 90% 
HRpeak (30 sec 
sprint with 15 
sec recovery)) 
70% HRpeak 
continuous 
 EF, FS 
 
 
 
 
 
EF, FS 
  E, E’ 
 
 
 
 
 
E, E’ 
 NR 
 
 
 
 
 
NR 
Alshaher et al., 
2007 
Test to 
exhaustion (84 
± 39 min)  
70% VO2max  EF SV   E:A NR 
Tian et al., 2014 Trial 1: 90 min 
Trial 2: 90 min 
95% VT 
95% VT 
 EF, SV 
EF, SV 
 A 
A 
 E, E:A 
E, E:A 
20oC, 50% RH 
20oC, 50% RH 
Vanoverschelde 
et al., 1991 
20 km (95 ± 15 
min) 
Self-paced   EF, SV, FS A  E, E:A NR 
Seals et al., 
1988 
Exercise to 
exhaustion (170 
± 10 min) 
Alternate high 
and low 
intensities 
  FS    NR 
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Fragasso et al., 
2004 
High Altitude 
race: 30 km (4 
h 27 min) 
High Altitude 
race: 25 km (2 
h 59 min) 
Self-paced 
 
 
Self-paced 
    A 
(A, E, E:A 
24 h post) 
A 
(A, E, E:A 
24 h post) 
E, E:A 
 
 
E, E:A 
1191 – 4559 m 
 
 
2100 – 4165 m 
Sahlén et al., 
2009a 
30 km cross-
country race 
(119 ± 28 min) 
Self-paced 
 
S’ EF SV A, A’  E, E:A, E’ NR 
Sahlén et al., 
2010 
30 km cross-
country race 
Self-paced 
 
 EF     NR 
Banks et al., 
2010 
150 min 
150 min 
60% VO2max 
80% VO2max 
 EF 
EF 
  E:A E’A’ 
E:A, E’:A’ 
NR 
NR 
Banks et al., 
2011 
150 min 
Younger cohort 
150 min 
Older cohort 
80% VO2max 
 
80% VO2max 
 EF, SV 
 
EF 
 
 
SV 
A, A’ 
 
A, A’ 
 
E 
 
 
E:A, E’, 
E’:A’ 
E, E:A, E’, 
E’:A’ 
NR 
Dalla Vecchia et 
al., 2014 
Half-marathon 
(96 min 30 s) 
Self-paced  EF  A  E, E:A, E’ 15oC 
Chan-Dewar et 
al., 2010b 
Marathon (229 
± 38 min) 
Self-paced  EF    E:A Midday 21oC 
Dawson et al., 
2008 
Marathon (229 
± 38 min) 
Self-paced  EF, S’    E:A, E’:A’ Midday 21oC 
George et al., 
2004 
Marathon (256 
± 46 min) 
Self-paced  EF, FS, 
SBP/LVES
V 
SV A E E:A 11oC, 40% RH 
George et al., 
2005 
Marathon (256 
± 46 min) 
Self-paced    A, A’ 
 
 E, E:A, E’, 
E’:A’ 
14oC, 50% RH, 
light winds 
George et al., 
2006 
Marathon (256 
± 46 min) 
Self-paced  EF, FS SV, S’    14oC, 50% RH 
Hart et al., 2007 Marathon (216 
± 40 min) 
Self-paced  EF  A, A’  E, E:A, E’, 
E’:A’ 
12.5oC 
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Hewing et al., 
2015 
Marathon (263 
± 37 min) 
Self-paced FS, S’   A, A’  E, E:A, E’ NR 
Kasikcioglu et 
al., 2006 
Marathon Self-paced  (FS 1 d 
post) 
  (E, A, E:A 1 
d post) 
 NR 
Knebel et al., 
2009 
Marathon (256 
± 37 min) 
Self-paced FS    A’ E:A, E’ 23.5oC, 46% 
RH at midday 
Knebel et al., 
2014 
Marathon: 
Premenopausal 
Marathon: 
Postmenopausa
l 
Self-paced 
 
Self-paced 
 FS 
 
FS 
 A’ 
 
A’ 
E’ 
 
 
(E:A, E’, A 
2 w post in 
both groups) 
E:A 
 
E:A, E’ 
12oC, 75% RH 
at midday 
Lucía et al., 
1999a 
Marathon Self-paced EF, FS   A  E, E:A 11-22oC, 60-
65% RH 
Middleton et al., 
2006b 
Marathon (212 
± 36 min) 
Self-paced S’ EF, 
SBP/LVES
V 
 A, A’  E, E:A, E’, 
E’:A’ 
 
Max 11oC, 
frequent rain 
showers 
Middleton et al., 
2007a 
Marathon: 2004 
(201 ± 29 min) 
 
Marathon: 2005 
(212 ± 50 min) 
Self-paced  EF, 
SBP/LVES
V 
EF, 
SBP/LVES
V 
   E:A, E’:A’ 
 
 
E:A, E’:A’ 
NR 
 
 
NR 
Mousavi, et al., 
2009 
Marathon (245 
± 68 min) 
Self-paced  EF, S’  A, A’ 
(A’ 1 wk 
post) 
 E, E:A, E’ 
(E’ 1 wk 
post) 
NR 
Neilan et al., 
2006a 
Marathon (4 h 5 
min) 
Self-paced  EF  A, A’  E, E:A, E’ NR 
Neilan et al., 
2006b 
Marathon (3.54 
± 0.56 h) 
Self-paced  EF  A, A’ 
(A 3-4 wk 
post) 
 E, E:A, E’ 
(E:A, E’ 3-4 
wk post) 
NR 
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Oxborough et 
al. 2006 
Marathon (230 
± 42 min) 
Self-paced    A  E, E:A NR 
Perrault et al., 
1986 
Marathon (2 h 
46 min) 
Self-paced  EF, FS     27.2oC, 94% 
RH 
Shave et al., 
2009 
Marathon (213 
± 41 min) 
Self-paced 
HRmean 161 ± 
12 beats.min-1 
 EF, FAC, S’  A, A’ 
 
 E, E:A, E’, 
E’:A’ 
 
NR 
Sierra et al., 
2016 
Marathon Self-paced  EF S’  A, E’, A’ E, E:A Race start: 
17.8oC, 55% 
RH, 1 m.s-1 
wind velocity 
Race end: 
22.8oC, 59% 
RH, 2 m.s-1 
wind velocity 
Wilson et al., 
2011 
Marathon (209 
± 19 min) 
Self-paced    A 
(A 6 h post) 
E 
(E 6 h post) 
E:A 
(E:A 6 h 
post) 
Max 10oC, 
Approx. 40% 
RH 
Whyte et al., 
2005 
Marathon 
(245.3 ± 46.0 
min) 
Self-paced  EF SV A, A’  E, E:A, E’, 
E’:A’ 
Max 14oC, 
Approx. 50% 
RH 
Carrió et al., 
1990 
6 hour race 
(mean distance 
54.7 km) 
Self-paced EF      13 – 15oC, 84% 
mean RH 
Jouffroy et al., 
2015 
80 km trail run 
(9 h 55 min ± 1 
h 19 min) 
Self-paced   EF, FS  A, A’ E, E:A, E’, 
E’:A’ 
NR 
Chan-Dewar et 
al., 2010a 
The Comrades 
Marathon: 89 
km (586 ± 80 
min) 
Self-paced   EF, S’   E:A, E’, A’ Midday 20oC 
21 
 
George et al., 
2009 
The Comrades 
Marathon: 89 
km (586 ± 80 
min) 
Self-paced   EF, FAC, 
SBP/LVES
V 
 A E, E:A 4 - 24oC 
Cote et al., 2015 100 km or 160 
km mountain 
marathon 
Sex differences 
Male: 4.7 ± 1.1 
km.h-1 
Female: 4.8 ± 
0.7 km.h-1 
 SBP/LVES
V 
SBP/LVES
V 
EF, SV 
 
EF, SV 
 E, A 
 
E, A 
E:A 
 
E:A 
6 – 30oC, ascent 
600 – 2300 m 
Niemela et al., 
1984 
24 h run (114 – 
227 km) 
Self-paced  SV, FS, 
SBP/LVES
V 
    7 – 15oC, 50 – 
60% RH, 1 - 7 
m.s-1 wind 
velocity 
Passaglia et al., 
2013 
24 h 
ultramarathon 
(140.32 km) 
Self-paced  EF  A, A’ E, E’:A’ E:A, E’ 9 - 21oC 
Dávila-Román 
et al., 1997 
163 km 
mountain 
ultramarathon 
Self-paced  EF     2 – 24oC, 10 – 
60% RH, 2350 
– 4300 m 
altitude 
Scott et al., 
2009 
100 mile trial 
race ( 25.5 ± 
3.2 h) 
Self-paced SBP/LVES
V 
EF, SV, 
FAC 
  A E, E:A NR 
Maufrais et al., 
2016 
300 km 
mountain 
ultramarathon 
(126 h 2 min) 
Self-paced SV EF  E A, E:A  Elevation gain 
+24000 m 
CYCLING 
Crawford et al., 
1979 
Exercise to 
exhaustion (9 – 
18 mins) 
Incremental   FS    NR 
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Ketelhut et al., 
1994 
5 min 
 
30 min 
130-140 
beats.min-1 
130-140 
beats.min-1 
EF, SV, FS   
 
EF, SV, FS 
   NR 
Eysmann et al., 
1996 
Exercise to 
exhaustion (95 
min) 
Self-paced   EF   E:A NR 
Stewart et al., 
2015 
60 min Self-paced  EF, SV    E:A, E’ NR 
Chan-Dewar et 
al., 2013 
8.00am: 40 km 
(76 ± 6 min) 
6:00pm: 40 km 
(76 ± 7 min) 
90-100% LT 
 
90-100% LT 
 EF, FS 
 
EF, FS 
SV, S’ 
 
SV, S’ 
 
A’ 
 
A’ 
E, A, E:A 
 
E, A, E:A 
E’, E’:A’ 
 
E’, E’:A’ 
20oC, 40% RH 
 
20oC, 40% RH 
Stewart et al., 
2016 
90 min 
120 min 
110% GET 
80% GET 
  
SV 
SV    22oC, ~55% 
RH 
Goodman et al., 
2009 
120 mins ~75% HRmax 
or 60-65%  
VO2max 
 EF, SV, 
SBP/LVES
V 
    NR 
Stickland et al. 
2004 
Exercise to 
exhaustion: 
(2.51 ± 0.86 h) 
25 watts below 
lactate 
threshold 
  SV    21oC 
Vitello et al., 
2013 
3 x 6 min 
incremental 
workloads 
preceded 180 
min  
20, 30 and 40% 
max aerobic 
power 
> 130 
beats.min-1 
 S’ EF, SV, FS  A, A’ E, E:A, E’ NR 
Dawson et al., 
2005 
4 h  5% below LT  SBP/LVES
V 
(SBP/LVES
V 24 h post) 
 A E 
(E, A, E:A 
24 h post) 
E:A NR 
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Shave et al. 
2004b 
50 mile (126 ± 
7 min) 
 
50 mile (125 ± 
6 min) 
LT 
 
 
LT 
 SV, FS 
 
 
SV, FS 
  E, A, E:A 
 
 
E, A, E:A 
 19oC, 
normobaric 
normoxia 
19oC, 
normobaric 
hypoxia 
Shave et al. 
2004c 
100 mile (256 ± 
15 min) 
100 mile (254 ± 
13 min) 
5% below LT 
 
5% below LT 
 EF, SV, 
SBP/ESV 
EF, SV, 
SBP/ESV 
 A  
 
E, A, E:A 
E, E:A 0 ± 0.1oC 
 
19 ± 0.4oC 
Serrano-Ostariz 
et al., 2013 
206 km 
(accumulated 
slope 3800 m) 
Self-paced   EF   E:A 16.0 - 32.5oC 
COMBINATION 
Scharhag et al., 
2006 
1 h running or 
cycling 
3 h running or 
cycling 
95-100% AT 
 
75% AT 
 EF, FS 
 
EF, FS 
 A 
 
A, A’ 
 E, E:A, E’, 
E’:A’ 
E, E:A, E’, 
E’:A’ 
NR 
 
NR 
McGavock et 
al., 2003 
Olympic 
Triathlon: 40 
km cycle, 10 
km run (121 ± 
8 min) 
90 ± 3% 
HRmax 
 FAC     NR 
Haykowsky et 
al., 1991 
Half-ironman 
triathlon 
Self-paced   FAC, 
SBP/LVES
V 
   NR 
Shave et al., 
2004a 
Half-ironman 
triathlon: 1.9 
km swim, 90 
km cycle, 21.1 
km run (5 h 01 
min ± 25 min) 
Self-paced   
 
(SBP/LVES
V 48 h post) 
SBP/LVES
V 
A  
 
(E, A, E:A 
48 h post) 
E, E:A 19oC, 50% RH 
24 
 
Welsh et al., 
2005 
Half-ironman 
triathlon: 2 km 
swim, 90 km 
cycle, 21 km 
run (5 h 01 min 
± 25 min) 
Self-paced   SBP/ESCA    18oC, 
precipitation 
0.8 cm, wind 
speed 7 km.h-1 
Whyte et al., 
2000 
Half-ironman 
triathlon: 1.9 
km swim, 90 
km cycle, 21 
km run (5 h 29 
min ± 20 min) 
Self-paced 
 
 
 
 
 
 EF, FS 
 
(EF, SV, FS 
48 h post) 
SV 
 
 
 
 
A 
 
 
 E, E:A 
 
(E, A, E:A 
48 h post) 
NR 
 
 
 
Leetmaa et al., 
2008 
Triathlon: 4 km 
swim, 120 km 
cycle, 30 km 
run (7 h 21 min) 
Self-paced  EF, S’   A E, E:A NR 
Whyte et al., 
2000 
Ironman 
triathlon: 3.8 
km swim, 180 
km cycle, 42.2 
km run (10 h 40 
min) 
Self-paced   
 
(EF, SV, FS 
48 h post) 
EF, SV, FS A  E, E:A 
 
(E, A, E:A 
48 h post) 
NR 
Douglas et al., 
1987 
Ironman 
triathlon: 2.4 
mile swim, 112 
mile cycle, 26.2 
mile run (12 h 
30 min) 
Self-paced   
 
(FS 1 d 
post) 
FS A 
 
(E, A, E:A 1 
d post) 
E, E:A  Air: 24 - 42oC, 
Water: 26oC, 
40-85% RH 
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Douglas et al., 
1990a 
Ironman 
triathlon: 3.9 
km swim, 180.2 
km cycle, 42.2 
km run 
Self-paced  FAC  E, A 
(E 28 h 
post) 
E:A 
(A, E:A 28 
h post) 
 Air: 24 - 42oC, 
Water: 26oC, 40 
- 85% RH 
Douglas et al., 
1990b 
Ironman 
triathlon: 3.9 
km swim, 180.2 
km cycle, 42.2 
km run 
Self-paced   
(EF 1 d 
post) 
EF    Air: 24 - 42oC, 
Water: 26oC, 40 
- 85% RH 
Douglas et al., 
1998 
Ironman 
triathlon (3.9 
km swim, 180.2 
km cycle, 42.2 
km run) 
Self-paced   EF    NR 
Hassan et al., 
2006 
Ironman 
triathlon: 3.8 
km swim, 180 
km cycle, 42.2 
km run (712 ± 
96 min) 
Self-paced  EF, SV   A E, E:A Air: 15.6 – 
20.9oC, Water: 
15oC, 48 - 79% 
RH 
La Gerche et al., 
2004 
Ironman 
triathlon: 3.8 
km swim, 180 
km cycle, 42.2 
km run (592 ± 
100 min) 
Self-paced  EF   E, A, E:A  16 - 27oC 
 
 
26 
 
La Gerche et al., 
2008 
Ironman 
triathlon: 3.8 
km swim, 180 
km cycle, 42.2 
km run (10 h 50 
min ± 1 h 15 
min) 
Self-paced  EF   E:A, E’  NR 
Tulloh et al., 
2006 
Ironman 
triathlon (694 
min) 
Self-paced   EF, SV    NR 
Rifia et al. 1999 Ironman 
triathlon (3.9 
km swim, 180.2 
km cycle, 42.2 
km run) 
Self-paced   EF    NR 
Ashley et al., 
2006 
300 miles 
Adventure race 
Self-paced   EF, FS  E, A  NR 
OTHER 
Poh et al., 2008 3000 m speed 
skating 
Self-paced EF, S’   E, A’ A, E’  NR 
Planer et al., 
2012 
Field training 
exercise (85 – 
103 h) 
Self-paced EF, S’    A, E:A, E’, 
A’ 
E Discomfort 
index: >28 day, 
25.2 ± 2.4 night 
 
EF: ejection fraction, SV: stroke volume, FS: fractional shortening, SBP/LVESV: systolic blood pressure/left ventricular end systolic volume, S’: peak systolic myocardial tissue 
velocity, FAC: fractional area change, SBP/ESCA: systolic blood pressure/end systolic cavity area, E: peak early trans-mitral flow velocity, A: peak atrial filling velocity, E:A: early 
to late diastolic filling ratio, E’: peak early diastolic myocardial velocity, A’: peak late diastolic myocardial velocity, E’/A’: peak early to late myocardial tissue velocity ratio, VT: 
ventilatory threshold, AT: anaerobic threshold, GET: gas exchange threshold, LT: lactate threshold, NR: not reported.  
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The increased sympathetic activity, increased preload, and/or alteration in blood flow in 
response to prolonged exercise, has in many cases led to an unchanged or improved 
systolic function, as measured by EF, SV, fractional shortening (FS), systolic blood 
pressure/left ventricular end systolic volume (SBP/LVESV) or peak systolic myocardial 
tissue velocity (S’; Table 2.1). No alterations in EF (Mousavi et al., 2009; Neilan et al., 
2006b) or S’ (Shave et al., 2009) were reported following a marathon run, whilst 1 h/3 h 
of running or cycling did not provoke any changes in FS (Scharhag et al., 2006). A lack 
of change in SV and SBP/LVESV has also been demonstrated following 100 miles of 
cycling (Shave et al. 2004c). Overall, short duration exercise appears to have little impact 
upon systolic function (Table 2.1). Conversely, Vanoverschelde et al. (1991) reported a 
reduction in EF following 20 km running, whilst Seals et al. (1988) reported a reduced 
FS following an exercise run to exhaustion. Whilst these changes may be mediated by 
lower levels of fitness in the participants, older imaging techniques provide a lower 
sensitivity and resolution. Decreases in LV systolic function following prolonged 
exercise has been reported in several studies (Table 2.1), more commonly following 
ultraendurance exercise. For example, Rifai et al., (1999) demonstrated a 24% reduction 
in EF following an ironman triathlon, which is greater than what would be expected from 
measurement variability. EF was also below the lower limit for normal LV systolic 
function, yet the clinical significance is yet to be elucidated. Following a single bout of 
exercise, systolic function has however, typically returned to normal after 24-48 hours of 
recovery (Shave et al., 2004a; Whyte et al., 2000). A meta-analysis has suggested that 
shorter duration exercise of < 6 hours exerts minimal impact upon LV systolic function 
(Middleton et al., 2006a). However, more recently it is suggested to be a combination of 
factors such as exercise duration, intensity and volume, participants training experience, 
as well as environmental factors that precipitate changes in ventricular function 
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(Oxborough et al., 2010) and will reviewed in Section 2.3.3. More research is required in 
this controversial area (Dawson et al., 2003) and will be a focus of this thesis. 
 
It is important to note however, that changes in EF indices should be interpreted with care 
as these are dependent upon changes in preload and afterload, especially when taking into 
consideration the effect of prolonged exercise on dehydration, hypovolemia and BM 
(Dawson et al., 2003). Therefore, it is possible that reported changes in LV function may 
represent an alteration in hemodynamics rather than a depression in inotropy or intrinsic 
relaxation properties (Scott and Warburton, 2008). For example, Goodman et al. (2009) 
found a depression in LV systolic performance following exercise, however, no change 
was observed during exercise. Possible explanations for this were attributed to an abrupt 
reduction in venous return and sympathetic withdrawal following exercise. 
 
Evidence for changes in LV diastolic function after prolonged exercise has been reported 
within numerous studies (Table 2.1), with changes in diastolic function reported to 
precede changes in systolic function (Shave et al., 2004c). The most common finding was 
a reduction in the early to late atrial (E:A) peak flow velocity filling ratio, as a 
consequence of a reduction in E and an increase in A (Neilan et al., 2006b; Shave et al., 
2009). The E:A ratio has previously been used to represent a global index of diastolic 
function, with a reduction often associated with LV diastolic stiffness in pathological 
conditions. A meta-analysis by Middleton et al. (2006a), reported an overall immediate 
post-exercise reduction in E:A ratio in all subgroups studied, reflecting altered diastolic 
filling dynamics. The change in E:A ratio was not correlated with changes in the loading 
variables of left ventricular internal dimension–diastole (LVIDd), SBP and HR, 
suggesting changes in LV diastolic function are not fully explained by changes in loading 
post-exercise. This is also supported by Whyte et al. (2005) and Dawson et al. (2008) 
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who both reported depressions in diastolic function did not correlate with changes in HR 
and loading, suggesting alterations in the intrinsic relaxation properties of the LV. Not all 
studies however, have found a decrease in diastolic function following prolonged exercise 
(Table 2.1). La Gerche et al. (2008) and Kasikcioglu et al. (2006) found insignificant 
changes in conventional measures of diastolic function (E:A) following an Ironman 
triathlon and marathon, respectively. The study by Kasikcioglu et al. (2006) should, 
however, be interpreted with caution due to a lack of statistical power by only recruiting 
6 participants, as well as post-exercise data collection being conducted 1 day following 
exercise cessation. Many studies have shown that upon follow-up, any alterations in 
diastolic function have returned to baseline levels. However, Mousavi et al. (2009) 
showed LV diastolic dysfunction remained 1 week following a marathon, whilst Neilan 
et al. (2006b) found that during a follow-up measure 3-4 weeks post-marathon, A and 
E:A remained abnormal. 
 
It is suggested that myocardial tissue velocities, measured through TDI are less load 
dependant compared to standard pulsed-wave Doppler imaging as a measure of diastolic 
function (Pela et al., 2002; Yalcin et al., 2002), though this remains controversial (Burns 
et al., 2007; Firstenberg et al., 2001). A number of studies (Table 2.1), including Whyte 
et al. (2005), demonstrated a reduction in peak early diastolic myocardial velocity (E’), 
an increase in peak late diastolic myocardial velocity (A’), which resulted in a reduced 
E’:A’. Whyte et al. (2005) also found a significant correlation between TDI and standard 
Doppler measures of diastolic function, suggesting either methods are appropriate tools 
in investigating diastolic functional changes. An alteration in E could originate from a 
change in left atrial pressure immediately prior to the opening of the mitral valve and/or 
a disturbance in the pressure decay in the LV during the diastolic period (Hees et al., 
2004). The ratio of E to E’ (E:E’) can be calculated as a non-invasive estimate of left 
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atrial pressure (Naugueh et al., 1998), and in some studies has been found to be 
maintained despite reductions in diastolic function, suggesting a decay in LV pressure 
(George et al., 2005). However, other authors have criticised this method as being too 
insensitive for detecting pressure changes (Neilan et al., 2006b). 
 
Whilst there are a number of studies which evidence a reduction in cardiac function 
following prolonged exercise, the mechanisms responsible for these exercise induced 
changes are not fully understood. Changes in cardiac loading i.e. LVEDV and SBP have 
accounted for some, but not all of the apparent functional reductions, with a multifactorial 
model of cardiac fatigue being proposed by Shave and Oxborough (2012; Figure 2.2). 
 
 
Figure 2.2 Potential mechanisms responsible for impaired cardiac function after 
prolonged exercise (From Shave and Oxborough, 2012; Reprinted with permission from 
Publisher). 
 
Two potential mechanisms have been proposed as intrinsic, non-load related mechanisms 
behind changes in cardiac function: 1) β-andrenergic receptor downregulation (Hart et 
al., 2006) and 2) Myocyte damage (Neilan et al., 2006b). The sustained exposure to 
catecholamine’s during prolonged exercise, has been found to result in a desensitization 
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or down regulation of cardiac β-andrenergic receptors (Banks et al., 2010; Oxborough et 
al., 2010) and autonomic responsiveness (Seiler et al., 2007), leading to a reduced force 
of contraction and impaired rate of LV relaxation. Previous single day studies have also 
suggested an association between cTn release and cardiac function (Neilan et al., 2006b; 
Rifai et al., 1999), whilst others have refuted this finding (Shave et al., 2004c). The 
following section of the literature review discusses the extant evidence of cardiac damage 
associated with single bouts of endurance exercise.  
 
2.3.2 The Appearance of Tissue-Specific Markers of Cardiac Damage 
The appearance of cardiac biomarkers, normally indicative of cell damage and 
myocardial infarction, have been observed in numerous individuals without coronary 
artery disease such as myocarditis, supra-ventricular tachycardia, pericarditis, as well as 
non-cardiac conditions such as high dose chemotherapy, renal failure, primary pulmonary 
hypertension, cerebrovascular accident and, more recently, endurance exercise such as 
marathons (Amman et al., 2004; Bakshi et al., 2002; Kelley et al., 2009). Participants in 
endurance exercise maintain an elevated cardiac output with a normal or elevated SBP 
for a prolonged period of time. This sustained elevation of cardiac work results in a 
considerable stress on the cardiovascular system, which may result in myocardial injury 
(Shave et al., 2007b). The appearance of tissue-specific markers of cardiac damage 
following prolonged exercise has been termed exercise-induced cardiac damage (EICD; 
Shave et al., 2004c; Whyte et al., 2005). 
 
Troponin is a protein component of the contractile apparatus within skeletal and cardiac 
myocytes, which regulate and facilitate the interaction between actin and myosin 
filaments during a muscle contraction (Garg et al., 2017). cTn is a complex comprising 
of three subunits: 1) troponin T attaches the troponin complex to the actin filament, 2) 
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troponin C which binds to calcium, and 3) troponin I which inhibits the ATPase activity 
of actomyosin complex (Katrukha, 2013). Whilst cTn C is synthesised in skeletal and 
cardiac muscle, cTn I (cTnI) and T (cTnT) isoforms are highly sensitive and specific 
markers to cardiac myocytes (Garg et al., 2017), with detection in the bloodstream 
indicative of myocardial injury (Amman et al., 2004). The use of cTn remains important 
in the diagnosis of AMI, or now commonly known as acute coronary syndrome (ACS; 
Ammann et al., 2004; Shave et al., 2007b). Following the onset of AMI, cTn’s appear in 
the serum 4-10 h (Jaffe et al., 1996), peaking following 12-48 h and remaining elevated 
for 4-10 days (Garg et al., 2017). A growing amount of research suggests an elevation in 
cTn, immediately following acute bouts of prolonged exercise (Shave et al., 2007a; Table 
2.2). As the number of individuals participating in endurance exercise continues to 
increase, medical personnel will more frequently have to assess patients presenting 
elevated cardiac biomarkers following prolonged exercise (Fortescue et al., 2007; Knebel 
at al., 2009) and should check for other symptoms before assuming that an athlete has 
suffered ischemic myocardial injury (Thompson et al., 2006). Misdiagnosis of 
myocardial injury following prolonged exercise can result in unnecessary invasive 
interventions and costs, delays in management decisions, as well as being a 
psychologically damaging process for the athlete (Bakshi et al., 2002; Kelley et al., 2009; 
Whyte, 2008).  
 
Table 2.2 provides an overview of the literature which assessed cardiac biomarkers before 
and after exercise. The table details the studies by mode (running, cycling, multimode), 
exercise distance (duration), the intensity of the exercise and environmental conditions, 
alongside the study’s findings. Details of the type of biomarkers used are also given, 
which include cTnT (1s/2nd/3rd generation), cTnI, highly sensitive assays (hs-cTnT and 
hs-cTnI) as well as markers of cardiac stress. 
33 
 
Table 2.2 Studies utilising cTnT, cTnI and other cardiac biomarkers during/following single bouts of prolonged exercise 
Author Exercise distance 
(duration) 
Intensity of 
Exercise 
Blood 
Measurement 
Elevated (Number > 
URL) 
Peak Environmental 
Conditions 
RUNNING 
Mingels et al., 
2010 
5.4 km fun run 
 
 
 
5 km (28 ± 4 min) 
 
 
 
15 km (78 ± 9 
min) 
 
 
21 km (118 ± 14 
min) 
 
 
42 km (228 ± 30 
min) 
Walk/run 
 
 
 
10.9 ± 1.3 km.h-1 
 
 
 
11.6 ± 1.3 km.h-1 
 
 
 
10.9 ± 1.1 km.h-1 
 
 
 
11.3 ± 1.5 km.h-1 
 
hs-cTnT (Roche) 
 
NT-proBNP 
(Elecsys/Roche) 
hs-cTnT (Roche) 
 
NT-proBNP 
(Elecsys/Roche) 
hs-cTnT (Roche) 
 
NT-proBNP 
(Elecsys/Roche) 
hs-cTnT (Roche) 
 
NT-proBNP 
(Elecsys/Roche) 
hs-cTnT (Roche) 
 
NT-proBNP 
(Elecsys/Roche) 
Increase in mean value 
(13/122) post 
Increase in mean value 
(9/122) post 
No increase in mean value 
(0/43) post 
Increase in mean value 
(1/43) post 
Increase in mean value 
(5/38) post 
Increase in mean value 
(0/38) post 
Increase in mean value 
(4/10) post 
No increase in mean value 
(0/10) post 
Increase in mean value 
(73/85) post 
Increase in mean value 
(4/85) post 
NR 
 
NR 
 
NR 
 
NR 
 
NR 
 
NR 
 
NR 
 
NR 
 
NR 
 
NR 
20oC 
 
 
 
23oC 
 
 
 
23oC 
 
 
 
23oC 
 
 
 
23oC 
Shave et al., 2002c Maximal ramping 
treadmill test 
 
30 min downhill 
running 
Maximal 
 
 
70% maximal 
running velocity 
cTnT (3rd Gen. 
Elecsys) 
cTnI (Immulite) 
cTnT (3rd Gen. 
Elecsys) 
cTnI (Immulite) 
0/8 post, 0/8 48 h post 
 
0/8 post, 0/8 48 h post 
0/8 post, 0/8 48 h post 
 
0/8 post, 0/8 48 h post 
NR 
 
NR 
NR 
 
NR 
NR 
 
 
NR 
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Shave et al., 2010 30 min treadmill 85-90% VO2max 
(HRmean 171 ± 6 
beats.min-1) 
cTnI (TnI-Ultra) 3/8 post, 2/8 1 h, 4/8 2 h, 
4/8 3 h, 4/8 4 h, 2/8 5 h, 
2/8 24 h 
NR NR 
Ranjbar et al., 
2017 
Trial 1: 40 min 
 
 
Trial 2: 40 min 
50% HRreserve (2 
min)/80% 
HRreserve (1 min) 
60% HRreserve 
continuous 
hs-cTnT (Roche) 
 
 
hs-cTnT (Roche) 
(0) post, (0) by 1 h post 
 
 
(1) post, (1) by 1 h post 
13.4 ng.L-1, 12.7 ng.L-1 
 
 
31.0 ng.L-1, 33.0 ng.L-1 
24oC, 50% RH 
 
 
24oC, 50% RH 
Nie et al., 2011 Run 1: 45 min 
255 min recovery 
Run 2: 45 min 
VT cTnT (3rd Gen. 
Elecsys) 
 
NT-proBNP 
(ECLIA, Roche) 
0/12 post run 1, 8/12 (3) 
pre run 2, 7/12 (2) post 
run 2, 4/12 (2) 4 h post 
Increase post run 1, 
Decrease pre run 2, 
Increase post run 2, 
Decrease 4 h post 
ND, 0.375 ng.mL-1, 
0.303 ng.mL-1, 0.110 
ng.mL-1 
178.4 pg.mL-1, 121.8 
pg.mL-1, 150.8 pg.mL-1, 
125.2 pg.mL-1 
20oC, 50% RH 
 
Weippert et al., 
2016 
Trial 1: 60 min 
Two blocks 
separated by 3 
mins (12 x (30 sec 
sprint with 15 sec 
recovery)) 
Trial 2: 60 min 
90% HRpeak 
 
 
 
 
 
70% HRpeak 
continuous 
hs-cTnT (5th gen. 
Roche) 
 
 
 
 
hs-cTnT (5th gen. 
Roche) 
(5) by 4 h post 
 
 
 
 
 
(0) by 4 h post 
NR 
 
 
 
 
 
NR 
NR 
 
 
 
 
 
NR 
Fu et al., 2009 45 min 
45 min 
90 min 
90 min 
80% VT 
100% VT 
80% VT 
100% VT 
cTnT (3rd Gen. 
Elecsys) 
0/13 post, 0/13 post 2 
0/13 post, 8/13 (3) post 2 
0/13 post, 2/13 (1) post 2 
7/13 post, 12/13 (8) post 2 
ND, ND 
ND, 0.375 ng.mL-1 
ND, 0.133 ng.mL-1 
0.071 ng.mL-1, 0.417 
ng.mL-1 
NR 
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Serrano-Ostáriz et 
al., 2011 
45 min 
45 min 
90 min 
90 min 
180 min 
180 min 
85% AT 
95% AT 
85% AT 
95% AT 
85% AT 
95% AT 
cTnI (AccuTnI) 
 
 
 
NT-proBNP 
(Elecsys/Roche) 
 
Significant effect for 
longer duration and 
higher intensity (0-9% 
across trials) 
Increase in mean value 30 
min and 3 h post (5-14% 
across all trials) 
NR 16.8 ± 2.0oC, 
67.7 ± 10.0% RH  
Tian et al., 2014 Trial 1: 90 min 
 
 
Trial 2: 90 min 
95% VT 
 
 
95% VT 
hs-cTnT (Roche) 
NT-proBNP 
(ECLIA, Roche) 
hs-cTnT (Roche) 
NT-proBNP 
(ECLIA, Roche) 
(10) by 3 h post 
(0) post 
 
(9) by 3 h post 
(0) post 
NR 
NR 
 
NR 
NR 
20oC, 50% RH 
 
 
20oC, 50% RH 
Tian et al., 2012 90 min 
Adult 
 
 
 
 
 
90 min 
Adolescent 
95% VT 
 
 
 
 
 
 
95% VT 
hs-cTnT (Roche) 
 
 
 
 
NT-proBNP 
(Elecsys/Roche) 
hs-cTnT (Roche) 
 
 
 
 
NT-proBNP 
(Elecsys/Roche) 
1/13 post, 5/13 1 h post, 
8/13 2 h post, 11/13 3 h 
post, 11/13 4 h post, 
10/13 5 h post, 9/13 6 h 
post, 2/13 24 h post 
Increase in mean value 
post to 24 h post 
8/13 post, 11/13 1 h post, 
12/13 2 h post, 12/13 3 h 
post, 12/13 4 h post, 
12/13 5 h post, 12/13 6 h 
post, 9/13 24 h post 
Increase in mean value 
post to 24 h post 
15.6 ng.L-1, 54.9 ng.L-1, 
171.0 ng.L-1, 305.6 ng.L-
1, 291.0 ng.L-1, 255.4 
ng.L-1, 208.3 ng.L-1, 24.7 
ng.L-1 
NR 
 
69.9 ng.L-1, 280.1 ng.L-1, 
591.9 ng.L-1, 794.5 ng.L-
1, 659.3 ng.L-1, 559.6 
ng.L-1, 437.4 ng.L-1, 80.6 
ng.L-1 
NR 
NR 
 
 
 
 
 
 
NR 
Nie et al., 2011 21 km (80.8 ± 0.8 
min) 
Adolescents 
Self-paced 
(HRmean 178 ± 
12 beats.min-1) 
cTnT (Elecsys) 
 
cTnI (AccuTnI) 
8/12 (7) 2 h post, 8/12 (8) 
4 h post, 1/12 24 h post 
8/12 (2) 2 h post, 11/12 
(3) 4 h post, 5/12 24 h 
post 
0.08 ng.mL-1, 1.22 
ng.mL-1, 0.05 ng.mL-1 
1.13 ng.mL-1, 2.21 
ng.mL-1, 0.17 ng.mL-1 
5 - 8oC, 30 - 40% 
RH 
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Tian et al., 2006 21 km (80.7 ± 0.6 
min) 
Adolescents 
Self-paced cTnT (3rd Gen. 
Elecsys) 
 
cTnI (AccuTnI) 
6/10 (3) 2 h post, 6/10 (4) 
4 h post, 1/10 (0) 24 h 
post 
10/10 (6) 2 h post, 10/10 
(6) 4 h post, 10/10 (1) 24 
h post 
NR, 0.29 ng.mL-1, NR 
 
 
NR, 0.51 ng.mL-1, NR 
 
5oC, ~35% RH 
Dalla Vecchia et 
al., 2014 
Half-marathon (96 
min 30 s) 
Self-paced cTnI (ELFA) 1/35 (1) post 0.45 µg.L-1 15oC 
Kong et al., 2017 Half-marathon 
(adolescents) 
Self-paced cTnT (3rd Gen. 
Elecsys) 
All: 37/38 (30) 4 h post 
Male: 19/19 (18) 4 h post 
Female: 18/19 (12) 4 h 
post 
1360 ng.L-1 
1360 ng.L-1 
550 ng.L-1 
5-10oC, 30-50% 
RH 
Lippi et al., 2008a Half-marathon Self-paced cTnT (3rd Gen. 
Elecsys) 
0/15 post, 3 h post, 6 h 
post, 24 h post 
NR 22-25oC, 55-60% 
RH 
Lippi et al., 2008b Half-marathon Self-paced cTnT (3rd Gen. 
Elecsys) 
NT-proBNP 
(0/17 post, 3 h post, 6 h 
post, 24 h post) 
Elevation post, 3 h post, 6 
h post, 24 h post (0/17 
post, 3 h post, 6 h post, 24 
h post) 
NR 
 
NR 
NR 
Lippi et al., 2008c Half-marathon Self-paced cTnI (Randox) 0/10 post, 3 h, 6 h and 24 
h post 
NR 22-25oC, 55-60% 
RH 
Vassalle et al., 
2018 
Half-marathon Self-paced hs-cTnT (Roche) 
 
hs-cTnI (STAT) 
 
 
NT-proBNP (Roche) 
(7/18) 20 min post, (0/18) 
24 h post, (0/7) 48 h post 
(2/18) 20 min post, (3/18) 
24 h post, (2/18) 48 h post 
(3/18) 20 min post, (1/18) 
24 h post, (0/7) 48 h post 
26.0 ng.L-1, 12.0 ng.L-1, 
9.0 ng.L-1 
57.0 ng.L-1, 58.0 ng.L-1, 
39.0 ng.L-1 
 
179.0 ng.L-1, 140.0 ng.L-
1, 93.0 ng.L-1 
NR 
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Vidotto et al., 2005 Half-marathon 
(121 min females, 
104 min males) 
Self-paced cTnT 
(Dimension/Dade) 
NT-proBNP 
(Elecsys/Roche) 
(3) 20 min post, (8) 2 h 
post  
25/25 (8) 20 min post, 
25/25 (4) 2 h post 
0.12 ng.mL-1, 0.16 
ng.mL-1 
319 pg.mL-1, 262 pg.mL-1 
17.1-18.8oC, 52-
62% RH, 217-
221 m altitude 
Niemelä et al., 
2016 
Half-marathon 
(132 ± 5 min) 
Marathon (199 ± 9 
min) 
Self-paced 
9.6 ± 0.3 km.h-1 
Self-paced 
12.7 ± 0.6 km.h-1 
cTnT (Roche) 
 
NT-proBNP 
Increased above baseline 
3 h and 48 h post 
Increased above baseline 
3 h and 48 h post 
NR 18-21oC, 40-50% 
RH, 15-22 km.h-
1 wind speed 
Sahlén et al., 2008 30 km cross-
country race (203 
± 32 min) 
Self-paced 
 
cTnT (Roche) 
NT-proBNP (Roche) 
23/43 (19) 
(21/43) 
0.09 µg.L-1 
NR 
Race 1 + 2: 13.4 
– 22.6oC, 50 - 
90% RH 
Sahlén et al., 
2009a 
30 km cross-
country race (119 
± 28 min) 
Self-paced 
 
cTnT (Roche) 
 
NT-proBNP (Roche) 
(9/15) post, (0/15) 1 d 
post 
(7/15) post, elevated 
above baseline 1 d post, 
Returned to baseline 6 d 
post 
NR 
 
NR 
NR 
Sahlén et al., 
2009b 
30 km cross-
country race 
(210.3 ± 33.7 min) 
Self-paced 
 
cTnT (Roche) 
NT-proBNP (Roche) 
(75/185) post 
(79/185) post 
NR 
NR 
NR 
Sahlén et al., 2010 30 km cross-
country race 
Self-paced cTnT (Roche) (14/43) post NR NR 
Jassal et al., 2009 Half-marathon 
(150 ± 20 min) 
Marathon (310 ± 
30 min) 
Self-paced cTnT (3rd Gen. 
Elecsys, Roche) 
19/61 post, 28/61 1 h post 
 
Increase in mean value 
post and 1 h post 
NR 
 
NR 
NR 
 
NR 
Apple et al., 2002 Marathon (4 h 49 
min) 
Self-paced cTnT (Elecsys, 
Roche) 
cTnI (Dimension 
RxL) 
(10/19) post, (1/19) 24 – 
48 h post 
(6/19) post, (1/19) 24 – 48 
h post 
NR, 0.04 µg.L-1 
 
NR, 0.5 µg.L-1 
NR 
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Baker et al., 2014 Marathon Self-paced cTnI (Alere Ltd) 
cTnT (Roche) 
hs-cTnT (Roche) 
BNP (Alere Ltd) 
5/48 post 
31/45 post 
45/45 post 
25/48 post 
NR 
NR 
NR 
NR 
NR 
Banfi et al., 2010 Mountain 
marathon (164 – 
262 min) 
Self-paced cTnI (Vitros) 
NT-proBNP  
(Vitros) 
(4) post 
(2) post 
0.262 ng.mL-1 
190 pg.mL-1 
16-24oC, 6000 m 
ascent/decent 
Cummins et al., 
1987 
Marathon (3.25 h) Self-paced cTnI 
(radioimmunoassay) 
(2/11) post NR NR 
Da Ponte et al., 
2017 
Uphill marathon (5 
h 50 min ± 54 min) 
Self-paced cTnI (AccuTnI) 22/22 (11) post NR Start: 28oC, 33% 
RH 
End: 2oC, 65% 
RH, 0 – 2850 m 
Dawson et al., 
2008 
Marathon (229 ± 
38 min) 
Self-paced cTnI (Ultra) 12/13 (7) post NR Midday 21oC 
Eijsvogels et al., 
2014a 
Marathon Self-paced cTnI (Ultra) (19/23) NR NR 
Eijsvogels et al., 
2014b 
Marathon (4 h 4 
min ± 41 mins) 
Control 
 
 
 
Statin use 
Self-paced cTnI 
 
hs-cTnI (Siemens) 
 
NT-proBNP  
(Siemens) 
cTnI 
 
hs-cTnI (Siemens) 
 
NT-proBNP  
(Siemens) 
29/41 (19) post, 23/41 
(12) 24 h post 
41/41 (21) post, 41/41 
(10) 24 h post 
Increase in mean value 
post, 24 h post 
26/30 (14) post 
16/30 (6) 24 h post 
30/30 (17) post 
30/30 (9) 24 h post 
Increase in mean value 
post, 24 h post 
NR 
 
NR 
 
NR 
 
NR 
 
NR 
 
NR 
NR 
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Eijsvogels et al., 
2015 
Marathon (227 ± 
28 mins) 
Self-paced 
11.3 ± 1.4 km.h-1 
HRmean 161 ± 9 
beats.min-1 
hs-cTnI (Centaur 
TnI-Ultra) 
77/80 (55/80) post 530 ng.L-1 Wet globe 
18.8oC, 52% RH 
Fortescue et al., 
2007 
Marathon Self-paced cTnT (3rd Gen. 
Elecsys) 
cTnI (Centaur) 
328/482 overall 
(54) 
(18) 
 
0.74 ng.mL-1 
4.17 ng.mL-1 
NR 
Gaudreault et al., 
2013 
Marathon (232 ± 
40 min) 
Self-paced cTnT 
NT-proBNP 
13/20 (3) post NR 35oC, 46% RH 
George et al., 2004 Marathon (256 ± 
46 min) 
Self-paced cTnT (3rd Gen. 
Elecsys) 
26/33 (6) post 0.080 µg.L-1 
 
11oC, 40% RH 
George et al., 2005 Marathon (256 ± 
46 min) 
Self-paced cTnT (3rd Gen. 
Elecsys) 
21/28 post 0.733 µg.L-1 
 
14oC, 50% RH, 
light winds and 
scattered cloud 
cover 
Herrmann et al., 
2003 
Marathon  Self-paced cTnT (2nd Gen. 
Elecsys) 
 
cTnI (AccuTnI) 
 
 
NT-proBNP (Roche 
Elecsys 2010) 
(23/45) 15 min post, 
18/45) 3 h post, (0/9) 24 h 
post 
(27/45) 15 min post, 
(33/45) 3 h post, (1/9) 24 
h post 
(38/45) 15 min post, 
(30/45) 3 h post, NR 24 h 
post 
0.103µg.L-1, 0.174 µg.L-
1, ND 
 
0.360µg.L-1, 0.930 µg.L-1, 
NR 
 
953 ng.L-1, 550 ng.L-1, 
194 ng.L-1 
NR 
Hewing et al., 
2015 
Marathon (263 ± 
37 min) 
Self-paced cTnT (4th Gen. 
Roche) 
NT-proBNP (Roche 
Elecsys 2010) 
62/167 post, 0/167 14 d 
post 
57/167 post 
NR 
 
NR 
NR 
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Hottenrott et al., 
2016 
Marathon: 
run/walk strategy 
(254 ± 19 min) 
 
 
Marathon: Run 
(247 ± 6 min) 
60 sec walking 
every 2.5 km 
(HRmean 158 ± 7 
beats.min-1) 
 
Self-paced 
(HRmean 154 ± 6 
beats.min-1) 
CTnI 
 
BNP 
 
 
cTnI 
 
BNP 
1/21 (1) post, 0/21 (0) 4 d 
post 
Increase in mean value 
post, return to baseline 4 d 
post 
1/19 (0) post, 0/19 (0) 4 d 
post 
Increase in mean value 
post and 4 d post 
0.28 ng.mL-1 
 
NR 
 
 
0.15 ng.mL-1 
 
NR 
 
180 m difference 
in altitude 
Hubble et al., 2009 Marathon (4 hr 5 
min) 
Self-paced cTnI (Ultra) 28/88 1.4 µg.L-1 NR 
Kim et al., 2015 Marathon Self-paced cTnI (ADVIA 
centaur) 
NT-proBNP 
(Modular Analytics 
E170) 
Increase in mean value 
 
Increase in mean value 
NR 
 
NR 
15oC, 35% RH 
pre-race (9am) 
Knebel et al., 2009 Marathon (256 ± 
37 min) 
Self-paced cTnT (4th Gen. 
Roche) 
NT-proBNP (Roche 
Elecsys 2010) 
30/78 (5/78) post, 0/78 2 
wk post 
24/78 post, 2/78 2 wk post 
NR 
 
NR 
23.5oC, 46% RH 
at midday 
Knebel et al., 2014 Marathon 
Premenopausal 
 
 
Postmenopausal 
Self-paced cTnT (4th Gen. 
Roche) 
NT-proBNP (Roche 
Elecsys 2010) 
cTnT (4th Gen. 
Roche) 
NT-proBNP (Roche 
Elecsys 2010) 
19/54 post, ND 2 w post 
 
24/54, no increase 2 w 
post 
13/35, ND 2 w post 
 
8/35, no increase 2 w post 
NR 
 
NR 
 
NR 
 
NR 
12oC, 75% RH at 
midday 
Koller et al., 1995 Marathon Self-paced cTnT (1st Gen. 
Boehringer) 
cTnI (ERIA) 
(1/19) 
 
(1/19) 
1.0 µg.L-1 
 
0.7 µg.L-1 
NR 
41 
 
Koller et al., 2008 Downhill 
marathon 
Self-paced cTnT (3rd Gen. 
ECLIA, Roche) 
cTnI (MEIA) 
 
NT-proBNP 
(ECLIA, Roche) 
(5/13) post, (1/13) ~ 12 h 
post 
(7/13) post, (9/13) ~ 12 h 
post 
Increase in mean value 
post and ~ 12 h post 
NR 
 
NR 
 
NR 
795 vertical 
difference 
Kratz et al., 2002 Marathon (4 h ± 30 
min) 
Self-paced cTnI (Triage) Increase in mean value 4 
h post, 0/11 24 h post 
NR 11.7 – 13.3oC, 
wind speed 1 – 5 
mph 
Leers et al., 2006 Marathon Self-paced cTnT (Elecsys) 
BNP (Advia) 
 
NT-proBNP 
(Elecsys/Roche) 
9/27 post, 0/27 24 h post 
No increase in mean value 
post and 24 h post 
Increase in mean value 
post, no increase in mean 
value (1) 24 h post 
NR 
NR 
 
NR 
NR 
Legaz-Arrese et 
al., 2011 
Marathon (202 ± 
14 min) 
 
 
Duration matched 
trial 
 
 
Duration matched 
trial 
 
 
 
 
85% AT 
 
 
 
95% AT 
cTnI (AccuTnI) 
 
NT-proBNP 
(Elecsys/Roche) 
cTnI (AccuTnI) 
 
NT-proBNP 
(Elecsys/Roche) 
cTnI (AccuTnI) 
 
NT-proBNP 
(Elecsys/Roche) 
Increase in mean value 30 
min and 3 h post (6/14) 
Increase in mean value 30 
min and 3 h post (0/14) 
Increase in mean value 30 
min and 3 h post 
Increase in mean value 30 
min and 3 h post (0/14) 
Increase in mean value 30 
min and 3 h post 
Increase in mean value 30 
min and 3 h post (0/14) 
NR 
 
NR 
 
NR 
 
NR 
 
NR 
 
NR 
NR 
Lucía et al., 1999a Marathon Self-paced cTnT (Elecsys) 
 
 
cTnI (ERIA) 
1/22 post, 1/22 6 h post, 
0/22 24 h post, 1/22 48 h 
post 
0/22 post, 6 h post and 24 
h post, 1/22 48 h post 
NR 
 
 
NR 
11 - 22oC, 60 - 
65% RH 
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Lucía et al., 1999b Marathon Self-paced cTnI (ERIA) (0/10) NR 11 - 22oC, 60 - 
65% RH 
Mair et al., 1992 Marathon Self-paced cTnT (1st Gen. 
Boehringer) 
(1/20) 2 d post 1.0 µg.L-1 NR 
Mehta et al., 2012 Marathon: highly 
trained (224 ± 38 
min) 
Marathon: less 
trained (285 ± 43 
min) 
Marathon 
Self-paced 
 
 
Self-paced 
 
 
Self-paced 
cTnI (Ultra assay) 22/27 (9) post 
 
 
24/25 (15) post 
 
 
93/104 (51) post 
NR 
 
 
NR 
 
 
NR 
NR 
Melanson et al., 
2006 
Marathon (250 ± 
33 min) 
Self-paced cTnT (3rd Gen. 
Roche) 
NT-proBNP (Roche 
Elecsys 1010) 
17/22 (11) post 
 
22/22 (2) post 
0.072 ng.mL-1 
 
397 pg.mL-1 
69-70oF, wind 
speed 3mph 
Middleton et al., 
2006b 
Marathon (212 ± 
36 min) 
Self-paced cTnT (3rd Gen. 
Roche) 
NT-proBNP (Roche 
Elecsys 1010) 
9/13 post, 9/13 1 h post, 
1/9 24 h post 
Increase in mean value 
post and 1 h post, 
recovery 24 h 
0.37 µg.L-1, 0.459 µg.L-1, 
NR 
NR 
 
Max 11oC, 
frequent rain 
showers 
Middleton et al., 
2007a 
Marathon: 
2004 (201 ± 29 
min) 
2005 (212 ± 50 
min) 
Self-paced cTnT (3rd Gen. 
Roche) 
 
4/8 post 
 
 
3/8 post 
0.128 µg.L-1 
 
 
0.033 µg.L-1 
NR 
Middleton et al., 
2008 
Treadmill 
Marathon 
NR cTnT (3rd Gen. 
Roche) 
During: 0/9 30 min, 5/9 
60 min, 5/9 90 min, 9/9 
120 min, 4/7 180 min 
Post: 1/9 Post, 0/9 1 h, 0/9 
3 h, 3/9 6 h, 7/9 12 h, 5/9 
24 h 
0.03 µg.L-1 
 
 
0.04 µg.L-1 
NR 
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Mingels et al., 
2009 
Marathon Self-paced hs-cTnT (Roche) 
cTnT (4th Gen. 
Roche) 
cTnI (Architect) 
73/85 
38/85 
 
69/85 
NR 
NR 
 
NR 
Max 23.4oC, 
south wind < 14 
m.s-1 
Mousavi, et al., 
2009 
Marathon (245 ± 
68 min) 
Self-paced cTnT (3rd Gen. 
Elecsys) 
14/14 (14) post, 0/14 (0) 1 
wk post 
NR NR 
Neilan et al., 2006a Marathon (4 h 5 
min) 
Self-paced cTnT (3rd Gen. 
Elecsys) 
NT-proBNP 
(Elecsys/Roche) 
38/60 (28) post 
 
(32) post 
0.82 ng.mL-1 
 
506 pg.mL-1 
NR 
O’Hanlon et al., 
2010 
Marathon (209 ± 
19 min) 
Self-paced cTnI (ADVIA 
centaur) 
NT-proBNP (Roche 
Elecsys 2010) 
(8/17) post, (11/17) 6 h 
post 
Increase in mean value 
post and 6 h post 
0.43 µg.L-1, NR 
 
NR 
NR 
Richardson et al. 
2018 
Marathon (265 ± 
52 min) 
 
Self-paced 
10.1 ± 2.4 km.h-1 
HRmean 157 ± 14 
beats.min-1 
hs-cTnT (5th Gen 
Roche) 
52/52 (52) post 
 
NR 18-23oC, 40-50% 
RH 
Roca et al., 2017 Marathon Self-paced hs-cTnT 
NT-proBNP 
(8/79) post and 24 h post 
Increase in median value 
post, no increase in 
median value 24 h post 
NR 
NR 
NR 
Saenz et al., 2006 Marathon Self-paced cTnT (3rd Gen. 
Roche) 
21/30 (7) post 0.098 ng.mL-1 
 
NR 
Scarhag et al., 
2005 
Marathon Self-paced cTnT (3rd Gen. 
Roche) 
cTnI (AccuTnI) 
NT-proBNP 
(Elecsys/Roche) 
(24/46) 
 
(34/46) 
Increase in mean value 
post 
NR 
 
NR 
NR 
NR 
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Scherr et al., 2011 Marathon (3 h 47 
min ± 26 min) 
Self-paced hs-cTnT (Roche) 
 
 
NT-proBNP (Roche) 
 (91/102) post, (27/102) 
24 h post, 43/102 (4) 72 h 
post 
Increase in mean value 
post, 24 h and 72 h post 
631 ng.L-1, NR, NR 
 
 
NR 
NR 
Shave et al., 2005 Marathon (253 ± 
48 min) 
Self-paced cTnT (3rd Gen. 
Roche) 
56/72 (26) 0.733 µg.L-1 NR 
Siegel et al., 1997 Marathon Self-paced cTnT (Rapid assay) 
cTnT (1st Gen. 
ELISA, Boehringer) 
cTnT (2nd Gen. 
Cardiac Enzymun, 
Boehringer) 
cTnI (Behring) 
cTnI (Cardiac 
STATus) 
6/43 4 h post 
1/43 4 h post, 1/43 24 h 
post 
0/43 4 h post 
 
 
1/43 post 
1/43 post 
NR 
NR 
 
ND 
 
 
NR 
NR 
NR 
Siegel et al., 2001 Marathon (1997) 
 
Marathon (1998-
2000) 
 
 
Marathon (2001) 
Self-paced cTnI (Cardiac 
STATus) 
cTnI (ACS) 
 
cTnI (Triage cardiac 
panel) 
cTnT (Elecsys 1010) 
BNP (Triage BNP) 
2/41 4 h post, 1/13 24 h 
post 
Increase in mean value 4 
h and 24 h post 
No significant increase 
 
No significant increase 
No significant increase 4 
h post, significant 
increase 24 h post 
NR 
 
NR 
 
NR 
 
NR 
NR 
NR 
 
NR 
 
 
 
NR 
Siegel et al., 2008 Marathon Self-paced cTnT (4h Gen. 
Elecsys, Roche) 
NT-proBNP (Roche 
Elecsys 2010) 
18/99 (8) post 
 
(5/99) post 
0.172 µg.L-1 
 
331 µg.L-1 
NR 
Smith et al., 2004 Marathon  Self-paced cTnI (Triage) (0/34) NR NR 
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Traiperm et al., 
2012 
Marathon  
Adolescent (4 h 53 
min) 
Self-paced cTnT (Roche) 
cTnI (Beckman) 
(30/37 cTnT and/or cTnI) 
post, 24 h post 
NR 16.6 – 24.5oC, 45 
– 82% RH 
Trivax et al., 2010 Marathon (256.2 ± 
43.5 min)  
Self-paced cTnI 
(chemiluminescence) 
BNP 
Increase in mean value 
 
Increase in mean value 
NR 
 
NR 
Start 33oF (1oC) 
Wilson et al., 2011 Marathon (209 ± 
19 min) 
Self-paced cTnI (ADVIA 
centaur) 
NT-proBNP 
(Elecsys/Roche) 
17/17 (8) post, 17/17 (13) 
6 h post 
Increase in mean value 
post and 6 h post 
0.13 µg.L-1, 0.43 µg.L-1 
 
136 ng.L-1, 159 ng.L-1 
Max 10oC, 
Approx. 40% 
RH 
Whyte et al., 2005 Marathon (245.3 ± 
46.0 min) 
Self-paced cTnT (3rd Gen. 
Elecsys) 
32/39 (20) post 0.73 µg.L-1 Max 14oC, 
Approx. 50% 
RH 
Lippi et al., 2012 60 km  Self-paced (82 ± 
4% VO2max) 
hs-cTnI (hs-
AccuTnI) 
cTnI (AccuTnI) 
15/15 (12) post 
 
12/15 (3) post 
NR 
 
NR 
6 – 8oC, 54 - 
87% RH 
Salvagno et al., 
2014 
60 km Self-paced (84 ± 
4% VO2max) 
hs-cTnI (hs-
AccuTnI) 
NT-proBNP 
(ECLIA, Roche) 
Increase in mean value 
post (4/18) 
Increase in mean value 
post (5/18) 
NR 
 
NR 
6 – 8oC, 54 - 
87% RH 
George et al., 2009 The Comrades 
Marathon: 89 km 
(586 ± 80 min) 
Self-paced cTnT (3rd Gen. 
Roche) 
5/12 post 0.272 µg.L-1 4 - 24oC 
Kim et al., 2012 100 km (819.6 ± 
54.6 min) 
Self-paced cTnI (ADVIA 
centaur) 
NT-proBNP 
(Modular Analytics 
E170) 
Increase in mean value 
 
Increase in mean value 
NR 
 
NR 
25oC, 65% RH 
pre-race (10pm) 
Musha et al., 1997 100 km (10 h 43 
min) 
Self-paced cTnT (1st Gen. 
ELISA, Boehringer) 
10/13 (7) post, 7/13 (1) 16 
– 18 h post 
2.38 ng.mL-1, 0.36 
ng.mL-1 
NR 
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Scarhag et al., 
2005 
100 km Self-paced cTnT (3rd Gen. 
Roche) 
cTnI (AccuTnI) 
NT-proBNP 
(Elecsys/Roche) 
(23/45) 
 
(39/45) 
Increase in mean value 
post 
NR 
 
NR 
NR 
NR 
Ohba et al., 2001 100 km (661 ± 52 
min) 
Self-paced cTnT (1st Gen. 
Enzymu-test) 
BNP (Siono-RIA) 
10/10 (9) post 
 
10/10 post 
3.36 ng.mL-1 
 
47.85 fmol.mL-1 
9.7 – 12.6oC, 82 
- 99% RH 
Dávila-Román et 
al., 1997 
163 km mountain 
ultramarathon 
Self-paced cTnI (Baxer) 1/14 post, 1/14 18 h post 5.0 ng.mL-1, 1.8 ng.mL-1 2 – 24oC, 10 – 
60% RH, 2350 – 
4300 m altitude 
Laslett et al., 1996 100 mile Self-paced cTnT (ELISA) 5/5 (5) post 8.55 ng.mL-1 NR 
Laslett and 
Eisenbud 
100 mile (23.5 h) Self-paced cTnT (1st Gen. 
ELISA) 
cTnT (2nd Gen. 
Enzymun-Test) 
21/23 post 
 
0/23 post 
9.23 ng.mL-1 
 
0.16 ng.mL-1 
NR 
Scott et al., 2009 100 mile trial race 
( 25.5 ± 3.2 h) 
Self-paced cTnT (3rd Gen. 
ECLIA, Roche) 
NT-proBNP 
(ECLIA, Roche) 
5/25 post 
 
24/24 (24) post 
0.05 ng.L-1 
 
3427 ng.L-1 
NR 
Passaglia et al., 
2013 
24 h ultramarathon 
(140.32 km) 
Self-paced cTnT 2/12 (0) post 0.015 ng.mL-1 9 - 21oC 
Roth et al., 2007 216 km ultra-
endurance 
marathon 
Self-paced cTnT (3rd Gen. 
Roche) 
 
0/10 post NR Max 54oC, 3962 
m ascent, 1433 
m descent 
Bartzeliotou et al., 
2007 
246 km footrace Self-paced cTnT (ECLIA, 
Roche) 
NT-proBNP 
(ECLIA, Roche) 
0/20 post and 48 h post 
 
Increase in mean value 
post and 48 h post 
NR 
 
NR 
5 - 36oC, 60 – 
85% RH 
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Klapcinska et al., 
2013 
48 h ultra-
marathon (183 – 
320 km) 
Self-paced hs-cTnT (Roche) 
 
 
 
NT-proBNP 
(Elecsys/Roche) 
Peak in mean value 12 h 
during exercise (3), 
detectable values 48 h 
post 
Peak in mean value 24 h 
during exercise (7), 
detectable values 48 h 
post 
NR 
 
 
 
NR 
Start: 22oC, 53% 
RH 
End: 12oC, 94% 
RH 
CYCLING 
Stewart et al., 2015 60 min Self-paced hs-cTnT (Roche) 
hs-cTnI (Abbott) 
Increase in mean value 
Increase in mean value 
NR 
NR 
NR 
Chan-Dewar et al., 
2013 
8.00am: 40 km (76 
± 6 min) 
 
 
6:00pm: 40 km (76 
± 7 min) 
90-100% lactate 
threshold 
 
 
90-100% lactate 
threshold 
cTnI (cTnI Ultra, 
ADVIA centaur) 
NT-proBNP 
(ECLIA, Roche) 
cTnI (cTnI Ultra, 
ADVIA centaur) 
NT-proBNP 
(ECLIA, Roche) 
1/12 (0) 10 min post, 1/12 
(0) 60 min post 
10/12 (0) 10 min post, 
8/12 (0) 60 min post 
1/12 (0) 10 min post, 1/12 
(0) 60 min post 
10/12 (0) 10 min post, 
10/12 (0) 60 min post 
0.04 µg.L-1, 0.04 µg.L-1 
 
NR, NR 
 
0.02 µg.L-1, 0.03 µg.L-1 
 
NR, NR 
20oC, 40% RH 
 
 
 
20oC, 40% RH 
Stewart et al., 2014 2 h GET hs-cTnT (Roche) Increase in mean value 60 
min post, no increase in 
mean value 24 h post 
NR 20oC, ~55% RH 
Stewart et al., 2016 90 min 
 
120 min 
110% GET 
80% GET 
hs-cTnI (Abbott) Increase in mean value 
above URL 
Increase in mean value 
NR 22oC, ~55% RH 
Shave et al. 2004b 50 mile (126 ± 7 
min) 
 
50 mile (125 ± 6 
min) 
Lactate threshold 
 
 
Lactate threshold 
cTnT (Elecsys 1010) 
 
 
cTnT (Elecsys 1010) 
0/8 post and 24 h post 
 
 
1/8 post, 0/8 24 h post 
ND 
 
 
0.016 µg.L-1 
19 oC, 
normobaric 
normoxia 
19 oC, 
normobaric 
hypoxia 
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Stickland et al. 
2004 
Exercise to 
exhaustion: (2.51 ± 
0.86 h) 
25 watts below LT cTnI (ADVIA 
centaur) 
 
1/11 20-24 h post 0.2 µg.L-1 21oC 
Dawson et al., 
2005 
4 h  5% below LT (151 
± 39 W) 
cTnT (3rd Gen. 
Elecsys) 
2/16 post, 0/16 24 h post 0.021 µg.L-1, ND NR 
Skadberg et al. 
2017 
91 km mountain 
bike race (4.2 h) 
Self-paced 
HRmean 158 
beats.min-1 
hs-cTnI (STAT) 
 
 
BNP 
97/97 (68) 15 min post, 
(80) 3 h post, (20) 24 h 
post 
Elevated highest 24 h post 
NR NR 
Skadberg et al. 
2018 
91 km mountain 
bike race (4.2 h) 
Self-paced 
HRmean 158 
beats.min-1 
hs-cTnT (Roche) 
 
hs-cTnI (STAT) 
90/94 15 min post, 89/94 
3 h post, 30/94 24 h post 
71/94 15 min post, 82/94 
3 h post, 22/94 24 h post 
NR NR 
Ortega et al., 2006 95 km mountain 
bike challenge 
(332 min) 
Self-paced cTnI (Beckman) Increase in mean value 
(0/11) 
0.39 µg.L-1 Altitude 
difference 2430 
m 
Scarhag et al., 
2005 
Mountain bike 
marathon (110 km) 
Self-paced cTnT (3rd Gen. 
Roche) 
cTnI (AccuTnI) 
NT-proBNP 
(Elecsys/Roche) 
(3/14) 
 
(8/14) 
Increase in mean value 
post 
NR 
 
NR 
NR 
Altitude 
difference 2800 
m 
Shave et al. 2004c 100 mile (256 ± 15 
min) 
100 mile (254 ± 13 
min) 
5% below lactate 
threshold 
5% below lactate 
threshold 
cTnT 
(Elecsys 1010) 
cTnT 
(Elecsys 1010) 
0/8 (0) post, 0/8 (0) 24 h 
post 
2/8 (0) post, 0/8 (0) 24 h 
post 
ND 
 
0.034 µg.L-1, ND 
0 ± 0.1oC 
 
19 ± 0.4oC 
Serrano-Ostariz et 
al., 2013 
206 km 
(accumulated slope 
3800 m) 
Self-paced cTnI (AccuTnI) 
NT-proBNP 
(Elecsys proBNP) 
(39/91) 
(59/91) 
NR 
NR 
16.0 - 32.5oC 
Mair et al., 1992 230 km Self-paced cTnT 1st Gen. 
Boehringer) 
(0/8) 2 d post NR Altitude 
difference 5000 
m 
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Neumayr et al., 
2001 
230 km  Self-paced cTnI (AxSYM) 13/38 post, 1/38 1 d post 4.9 µg.L-1, 4.0 µg.L-1 Altitude 
difference 5500 
m 
Neumayr et al., 
2005 
230 km  Self-paced cTnT (3rd Gen. 
Troponin T Stat) 
NT-proBNP 
(Elecsys proBNP) 
13/29 (8) post, 2/29 (0) 1 
d post 
Increase in mean value 
post, no increase in mean 
value 1 d post 
0.224 µg.L-1, NR 
 
NR 
Altitude 
difference 5500 
m 
Kim et al., 2012 308 km ultra-
marathon 
Self-paced 
Mean speed 5 
km.h-1 
cTnI (Dimension 
Xpand) 
NT-proBNP 
(Dimension Xpand) 
No difference in mean 
value 
Increase in mean value 
NR 
 
NR 
13.0 – 31.9oC 
Neumayr et al., 
2002 
509 km Self-paced 
 
cTnT (3rd Gen. 
Troponin T Stat) 
cTnI (AxSYM) 
1/16 (1) post, 0/16 24 h 
post 
6/16 (2) post, 0/16 24 h 
post 
0.11 µg.L-1, ND 
 
5.1 µg.L-1, ND 
Cumulative 
altitude 
difference 
12,200 m 
COMBINATION 
Scharhag et al., 
2006 
Marathon 
 
 
 
 
1 h running or 
cycling 
 
 
 
3 h running or 
cycling 
Self-paced 
 
 
 
 
95-100% AT 
 
 
 
 
75% AT 
 
 
cTnT (3rd Gen. 
Elecsys) 
cTnI (AccuTnI) 
NT-proBNP 
(Elecsys proBNP) 
cTnT (3rd Gen. 
Elecsys) 
cTnI (AccuTnI) 
NT-proBNP 
(Elecsys proBNP) 
cTnT (3rd Gen. 
Elecsys) 
cTnI (AccuTnI) 
NT-proBNP 
(Elecsys proBNP) 
18/20 (18) post 
 
20/20 (20) post 
(12) post 
 
3/20 (3) post 
 
20/20 (5) post 
(4) post 
 
4/20 (4) post 
 
20/20 (5) post 
(3) post 
0.56 µg.L-1 
 
1.93 µg.L-1 
523 ng.L-1 
 
0.02 µg.L-1 
 
0.06 µg.L-1 
267 ng.L-1 
 
0.06 µg.L-1 
 
0.14 µg.L-1 
231 ng.L-1 
NR 
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Koller et al., 1998 67km running 
 
230 km cycling 
Self-paced 
 
Self-paced 
cTnT (2nd Gen. 
Boehringer) 
cTnI (enzyme 
immunoassay) 
 
 
(0/28) post 
 
(0/12) post 
NR 
 
NR 
NR 
 
NR 
Park et al., 2014 Olympic triathlon: 
1.5 km swim, 40 
km cycle, 10 km 
run  
Elite (103.4 ± 1.6 
min) 
Amateur (164.1 ± 
14.7 min) 
Self-paced cTnT No increase in mean value 
post, increase in mean 
value 2 h post, no increase 
in mean value of group 7 
d post 
No increase in mean value 
of group post, 2 h post 
and 7 d post 
NR 
 
 
 
 
NR 
NR 
Shave et al., 2004a Simulated half-
ironman triathlon: 
1.9 km swim, 90 
km cycle, 21.1 km 
run (5 h 01 min ± 
25 min) 
Self-paced cTnT (Elecsys) Swim: 0/9 post 
Cycle: 2/9 post 
Run: 4/9 post 
1/9 24 h post 
ND,  
0.016 µg.L-1 
0.021 µg.L-1 
0.010 µg.L-1 
19oC, 50% RH 
Welsh et al., 2005 Half-ironman 
triathlon: 2 km 
swim, 90 km 
cycle, 21 km run 
(5 h 01 min ± 25 
min) 
Self-paced cTnI (ELISA) (1/9) post 
(0/9) 24 h post 
9.0 µg.L-1, NR 18oC, 
precipitation 0.8 
cm, wind speed 7 
km.h-1 
Whyte et al., 2000 Half-ironman 
triathlon: 1.9 km 
swim, 90 km 
cycle, 21 km run 
(5 h 29 min ± 20 
min) 
Self-paced 
 
cTnT (ELISA) Significantly increased 
post, 0/14 48 h post 
 
NR 
 
NR 
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Leetmaa et al., 
2008 
Triathlon: 4 km 
swim, 120 km 
cycle and 30 km 
run (7 h 21 min) 
Self-paced cTnT (Roche) 
 
NT-proBNP 
(Elecsys proBNP) 
(8/13) post, (1/13) 12 – 24 
h post 
Increase in mean value 
post (13/13), No increase 
in mean value 12 – 24 h 
post (4/13) 
0.14 µg.L-1, NR 
 
NR 
 
NR 
La Gerche et al., 
2004 
Ironman triathlon: 
3.8 km swim, 180 
km cycle and 42.2 
km run (592 ± 100 
min) 
Self-paced cTnI (Abbott 
AxSYM) 
1/15 post 0.9 µg.L-1 
 
 
16 - 27oC 
 
La Gerche et al., 
2008 
Ironman triathlon: 
3.8 km swim, 180 
km cycle and 42.2 
km run (10 h 50 
min ± 1 h 15 min) 
Self-paced cTnI (Abbott 
AxSYM) 
BNP (Biosite) 
15/26 post, 0/26 1 wk post 
 
26/26 post, 0/26 1 wk post 
NR 
 
NR 
NR 
Rifia et al. 1999 Ironman triathlon: 
3.9 km swim, 
180.2 km cycle 
and 42.2 km run 
1994 
1995 
Self-paced 
 
661 ± 89 min 
 
 
699 ± 95 min 
cTnT (1st Gen. 
ELISA) 
cTnT (2nd Gen. 
Enzymun) 
cTnI (Opus) 
cTnT (2nd Gen. 
Enzymun) 
11/23 post 
 
6/23 (2) post 
 
2/23 post 
6/19 (2) post 
0.37 µg.L-1 
 
NR 
 
NR 
0.19 µg.L-1 
 
NR 
 
 
 
 
NR 
Tulloh et al., 2006 Ironman triathlon 
(694 min) 
Self-paced cTnT (Roche) 32/36 (6) post, 9/36 (2) 24 
h post 
1.130 ng.mL-1, 0.221 
ng.mL-1 
NR 
Whyte et al., 2000 Ironman triathlon: 
3.8 km swim, 180 
km cycle and 42.2 
km run (10 h 40 
min) 
Self-paced cTnT (ELISA) Significantly increased 
post, 0/14 48 h post 
NR NR 
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Denvir et al. 1999 45 km run/ 155 km 
cycle/ 100 km 
canoe 
Self-paced cTnI (Beckman) (6/31 overall) NR NR 
Ashley et al., 2006 300 miles: 
trekking, mountain 
biking, kayaking, 
rope climbing and 
swimming 
Self-paced cTnI (AccuTnI) 
BNP (Bayer) 
22/54 
48/54 
0.36 µg.L-1 
20.4 pmol. L-1 
NR 
OTHER 
Legaz-Arrese et 
al., 2015 
30 min rowing test 
Elite 
 
 
 
 
Amateur 
All out cTnI (AccuTnI) 
 
 
 
NT-proBNP 
(Elecsys proBNP) 
cTnI (AccuTnI) 
 
 
 
NT-proBNP 
(Elecsys proBNP) 
(1/18) 5 min post, (3/18) 1 
h post, (8/18) 3 h post, 
(9/18) 6 h post, (5/18) 12 
h post, (1/18) 24 h post 
Increase in mean value (0) 
 
(1/14) 5 min post, (1/14) 1 
h post, (2/14) 3 h post, 
(3/14) 6 h post, (3/14) 12 
h post, (1/14) 24 h post 
Increase in mean value (0) 
NR 
 
 
 
NR 
 
NR 
 
 
 
NR 
18 – 21oC, 50 – 
60% 
Legaz-Arrese et 
al., 2017 
60 min maximal 
swimming test 
 
Adolescents and 
adults 
All out hs-cTnT (Roche) 
 
NT-proBNP 
(Elecsys proBNP) 
Elevated 5 min, 1 h, 3 h, 6 
h and 12 h post (41/66) 
Elevated 5 min, 1 h, 3 h, 6 
h, 12 h and 24 h post 
(1/66) 
335.0 ng.L-1 
 
144.3 ng.L-1 
Water: 26oC, air: 
29oC, 75% RH 
Lippi et al., 2010 40 min, walking 
downhill gradient -
25% 
6.4 km.h-1 hs-cTnT (Roche) 
 
 
hs-cTnI (ADVIA 
Centaur) 
Increase in mean value 30 
min post (0), recovery 24 
h, 48 h, 72 h and 96 h post 
No increase in mean value 
30 min, 24 h, 48 h, 72 h 
and 96 h post 
NR 
 
 
 
NR 
NR 
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Eijsvogels et al., 
2012 
Walking 30-50km 
Lean, Overweight 
and Obese 
Self-paced hs-cTnI (Centaur) Increase in mean value of 
all groups: 86/97 (11) 
NR NR 
Eijsvogels et al., 
2014a 
40.6 km walking Self-paced cTnI (Ultra) (4/23) NR NR 
Bauer et al., 2016 Dragon boat 
training 
Intermittent hs-cTnT (Elecsys, 
Roche) 
NT-proBNP 
(ECLIA, Roche) 
0/65 
 
Increase in mean value 
NR 15 – 26oC, 42% 
RH, wind speed 
3 km.h-1 
Planer et al., 2012 Field training 
exercise (85 – 103 
h) 
Self-paced cTnT (3rd Gen. 
Troponin T Stat) 
NT-proBNP 
(ADVIA-Centaur) 
0/39 
 
No increase in mean value 
NR Discomfort 
index: >28 day, 
25.2 ± 2.4 night 
 
1st gen.: first-generation assay, 2nd gen.: second-generation assay, 3rd gen.: third-generation assay, BNP: brain natriuretic peptide, NT-proBNP: N-terminal proB-type natriuretic peptide, 
cTnI: cardiac troponin I, cTnT: cardiac troponin T, HRmean: mean heart rate, VT: ventilatory threshold, AT: anaerobic threshold, GET: gas exchange threshold, LT: lactate threshold, 
NR: not reported, ND: not detectable. 
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Like EICF, studies of EICD have produced contradictory findings partially due to 
methodological variation among the studies, with a 0-100% incidence of elevated cTn’s 
following competitive endurance events (Table 2.2). Some studies, such as that by Koller 
et al. (1998), have shown no evidence for EICD, whilst more recently Mousavi et al. 
(2009) and Dawson et al. (2008) found a high incidence of biomarker appearance in 
participants (100% cTnT and 92% cTnI, respectively) following a marathon run, not only 
above the detection limit but also above the clinical cut-off criteria for AMI. Therefore 
laboratory staff and clinicians must have a knowledge of clinical entities other than ACS 
and heart failure in which increases in cTn’s may be displayed (Kelley et al., 2009). This 
is supported by Middleton et al. (2008) who presented elevated cTnT concentrations in 
some participants 24 hours post-exercise, therefore, 24 hour blood draws cannot be used 
to differentiate between an early onset of ACS or exercise induced cTn release. 
 
The interpretation of exercise related changes in cardiac specific biomarkers is 
problematic due to the high inter-individual variation in the field-based data available 
(Shave et al., 2007a). This has been attributed in some part, to the highly variable nature 
of exercise duration and intensity, whereby field-based competitive studies are based on 
set distance courses (Serrano-Ostáriz et al., 2009), with a lack of control over 
environmental conditions, which will be a focus of Section 2.3.3. It has been suggested 
that changes in cTn are related to exercise-induced changes in plasma volume (PV), 
however, Eijsvogels et al. (2010) reported no changes or increases in PV with elevations 
in cTnI, which suggests this is unlikely.  
 
The generation of assay used has also contributed to the discrepancy within findings in 
Table 2.2. The first-generation cTnT assay (ELISA) has demonstrated a 12% cross-
reactivity with skeletal troponin T (Wu et al., 1994) in the presence of higher levels of 
55 
 
creatine kinase. This is supported by Rifai et al. (1999), whom revealed detectable cTnT 
levels in participants who demonstrated higher levels of creatine kinase. Therefore, it is 
likely that a false positive identification of cardiac damage has occurred in these studies. 
A second-generation cTnT assay (ELISA) was developed and subsequently used within 
a number of studies (Rifai et al., 1999; Siegal et al., 1997). Siegal et al. (1997) compared 
the use of different assays following marathon running and reported a rise in cTnT of 
20% when using the first-generation assay, conversely, the second-generation assay 
showed no detectable values. The specificity of the second-generation assay in human 
populations has also been questioned as it employed a bovine troponin T calibrant. A 
third-generation assay which utilizes recombinant human cTnT as the calibration material 
was also developed, which is reported to be cardiac specific and thus a more reliable 
method for detecting cardiac damage (Dawson et al., 2003; Shave et al., 2002c). A 
number of studies have utilised this newer assay, with a range of findings apparent (Table 
2.2). The high incidence of cTn release demonstrated by Mousavi et al. (2009) and 
Dawson et al. (2008) was attributed to an increased sensitivity in the assay employed. 
This is supported by a descriptive review by Michielsen et al. (2008), which reported 
elevations of 59% of participants utilising the Roche third-generation cTnT assay. In 
comparison, only 44% and 13% of participants studied showed elevation using the first 
and second-generation assays and was attributed to the 10-fold lower detection limit of 
the newer assay. 
 
It is suggested that any elevation in cTn brought about by exertion can generate clinical 
concern (Shave et al., 2010), and whilst some researchers have reported all elevations 
(Chan-Dewar et al., 2013; Melanson et al., 2006), others have reported participants above 
the upper reference limit (URL; Tian et al., 2014), AMI criteria or changes in group mean 
values (Kim et al. 2012), confounding data interpretation (Table 2.2). Further to this, 
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many authors have used the AMI criteria of the publication year (e.g. Fortescue et al., 
2007), making comparisons between elevations above AMI cut-off limits difficult (Shave 
et al., 2005). Inter and intra-individual variability was apparent within a small number of 
studies whom reported individual findings (Middleton et al. 2008), highlighting the need 
for further investigation into the individual response to prolonged exercise. 
 
The vast majority of studies have arisen from individuals participating in organized field-
based events, whereby measures of cTn are taken before and immediately after exercise 
cessation. A controlled lab-based study by Middleton et al. (2008) was one of the first 
studies to show all participants displaying elevations in cTnT during a marathon run, with 
all but one participant showing further elevations post-exercise. The samples showed a 
biphasic release of cTnT, which along with repeated post-exercise blood samples, can 
also partially explain the discrepancy between previous findings due to pre-post exercise 
design. 
 
As previously mentioned, it has been advocated that EICD underpins EICF (Denvir et al., 
1999, Whyte et al., 2000), however, due to the lack of specificity of previous cTnT 
markers, these findings must be viewed cautiously (Shave et al., 2002c). More recently, 
Tulloh et al. (2006) found a moderate correlation between change in EF immediately 
post-race and peak cTnT level. Closer analysis revealed a trend of a greater reduction in 
EF and SV amongst those athletes that displayed cTnT values above 0.10 ng.mL-1. 
However, when individuals were split into groups according to troponin elevation (<0.10 
ng.mL-1 and > 0.10 ng.mL-1), no significant differences between groups in LV function 
were observed. This is also supported by George et al. (2004, 2005) who’s evidence of 
minor cardiac damage (cTnT) was not associated with changes in LV diastolic filling, 
suggesting a depression in cardiac function and EICD represent two unrelated 
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phenomena. It has been proposed there are 6 potentially interlinked mechanisms to 
explain elevated cTn levels: 1) an increased membrane permeability allowing unbound 
cTn in the cytosolic pool to enter the circulation; 2) cellular release of proteolytic troponin 
degradation products whilst membrane integrity remains; 3) formation and release of 
membranous blebs during temporary ischaemia of cardiac cells; 4) stimulation of 
myocyte turnover; 5) myocyte necrosis; and 6) increased rate of apoptosis (Eijsvogels et 
al., 2015). The exercise related release of cTn is characterised by a biphasic pattern with 
an initial rapid increase and decrease during exercise, with a secondary cTn increase post-
exercise (Middleton et al., 2008). Within the cytosol, 6-8% cTnT and 3.5% cTnI exists 
in an unbound form (Korff et al., 2006), however, assays are incapable of distinguishing 
between cytosolic and complex-bound troponin, complicating interpretation of cTn 
release post-exercise (Skadberg et al., 2018). George et al. (2004) suggested that along 
with subclinical threshold values and in most cases values rapidly returning to baseline, 
a transient cytosolic leakage may be occurring as opposed to cardiomyocyte necrosis, 
supported more recently by Vassalle et al. (2018). This theory is disputed by Whyte et al. 
(2005), who suggested if the rise in cTnT observed after a marathon was due to the release 
of the cytosolic component of cTnT, there would be no alteration in contractile function. 
Further research is therefore needed to determine the link between cTn release and cardiac 
function, in an attempt to understand the mechanisms behind both phenomena. 
 
Whilst markers of cardiac injury have been commonly measured following extreme 
exercise, markers of cardiac stress have less often been used (Table 2.2). B-type 
natriuretic peptide (BNP) is a cardiac natriuretic peptide hormone secreted from the 
ventricles in response to volume expansion and pressure overload (Hall, 2004). Within 
the circulation the BNP hormone is separated from the n-terminal part of the prohormone, 
known as N-terminal proB-type natriuretic peptide (NT-proBNP). NT-proBNP is a 76 
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amino acid and is a proposed marker of evaluating and monitoring cardiac abnormalities 
which are characterised by myocardial wall stress (Mottram et al., 2004). NT-proBNP is 
also reportedly elevated following exercise in response to altered hemodynamics, 
regional wall-motion abnormalities and exercise induced transitory myocardial wall 
ischemia (Scharhag et al., 2006). NT-proBNP has been found to be elevated following 
half-marathon running (Vassalle et al., 2018), marathon running (Gaudreault et al., 2013; 
Kim et al., 2015; Melanson et al., 2006), with fewer studies evaluating the effect of 
cycling (Chan-Dewar et al., 2013) or combined events (Table 2.2). Similarly to cTn, some 
researchers have reported all elevations (Chan-Dewar et al., 2013; Vidotto et al., 2005), 
whilst others have reported elevations above the URL (Banfi et al., 2010; Vassalle et al., 
2018; Vidotto et al., 2005) or changes in group mean values (Kim et al. 2012, 2015), 
confounding data interpretation. Whilst the mechanisms underlying its release are not 
fully understood, its release may be stimulated by systemic inflammation (McLachlan 
and Mossop, 2006) resulting in natriuesis, vasodilation and sympathetic nerve blockade. 
Its release is also hypothesised to be cytoprotective and exert growth-regulating effects 
(Hamasaki, 2016; Scharhag et al., 2006) by inhibiting the induction of inflammatory 
mediators such as interleukin-1 and reducing oxidative stress (Hamasaki, 2016). 
 
It has been suggested that a combination of many different factors predispose EICF and 
EICD and explain the differences/controversial results discussed previously. Factors such 
as exercise duration, intensity and volume, subjects training status and environmental 
conditions are amongst those that have been suggested (Dawson et al., 2003; George et 
al., 2008; Ortega et al., 2006). It is, therefore, pertinent to investigate the effect of such 
factors on EICF and EICD, as discussed in the following section. 
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2.3.3 Exercise Related Factors that may predispose to Exercise-Related Cardiac Fatigue 
and Damage 
As noted in the previous sections, there is a growing evidence base describing an 
immediate depression in LV systolic and/or diastolic function and an elevation in cardiac 
biomarkers immediately following a bout of prolonged exercise. Inconsistencies within 
the findings have been attributed to variations in the methods employed, research designs 
applied, exercise duration/intensity, participant training status (Middleton et al., 2006a; 
Shave et al., 2008) and the environment (Neilan and Wood, 2009).   
 
Changes in diastolic function are reported to precede changes in systolic function (Shave 
et al., 2004c), with diastolic dysfunction appearing to be present after exercise durations 
of greater than one hour (Shave et al., 2008). Speculation from a meta-analysis suggested 
that a transient depression of LV systolic function may be mediated by exercise durations 
of greater than 640 minutes (Middleton et al., 2006a). A significant reduction in EF within 
the ultra-duration group compared to the other groups studied immediately post-exercise, 
support the theory that the onset of LV systolic dysfunction is duration dependant. This 
is supported by Whyte et al. (2000), who compared the effects of exercise duration (half-
Ironman compared to an Ironman triathlon competition) upon LV function. The results 
showed a significant reduction in SV, EF and FS following the Ironman competition, 
whilst the half-Ironman competition showed a significant reduction in SV only. The 
authors concluded that the reduction in SV occurred as a result of a minor change in 
LVIDd, whilst the reductions in EF and FS were attributed to a reduced inotropic state as 
afterload (SBP) was significantly reduced and preload was unaltered.  Further to this, the 
meta-analysis by Middleton et al. (2006a) reported that whilst diastolic filling is 
compromised following exercise durations greater than 60 minutes, analysis across 
subgroups indicated that alterations in diastolic filling are unrelated to exercise duration 
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or training status. Exercise duration is also found to impact cTn release, with a number of 
studies failing to show any evidence of elevated cTn levels following shorter durations of 
steady-state exercise. Lippi et al. (2008a, 2008b) demonstrated no elevation in cTnT 
following a 21km, half marathon run. In contrast, Shave et al. (2010) reported elevations 
in cTn following just 30 min exercise. A meta-analysis by Shave et al. (2007) 
demonstrated lower levels of cTn in longer duration events, advocating the importance of 
exercise intensity in endurance events. Studies by Serrano-Ostáriz et al. (2011) and 
Legaz-Arrese et al. (2011) have shown elevated cTnI with higher intensity work set at a 
relative or competition intensity in comparison to fixed durations. Legaz-Arrese et al. 
(2011) also suggested there may be a critical exercise intensity or threshold that must be 
exceeded in order for a cTn elevation to occur. More recently, Richardson et al. (2018) 
found the magnitude of hs-cTnT rise is related to a greater relative exercise intensity but 
not duration. The relationship between exercise intensity and duration is difficult to derive 
and may more accurately be viewed as total load, otherwise it is advocated that study 
design should fix exercise intensity or duration (Eijsvogels et al., 2014a). 
 
Whilst the duration of exercise is often noted in studies involving competitive events, 
information on the intensity of exercise is not always available due to the competitive 
nature, whereby exercise intensity is self-selected (Table 2.1 and 2.2). Field studies 
include participants who complete distance events under widely contrasting finish times, 
corresponding to a wide range of exercising HR’s, and therefore exercise intensities 
(Banks et al., 2010). For this reason it makes it difficult to draw conclusions from 
currently available data collected within a based field study. The competitive stress may 
also add to the work imposed on the LV if HR’s are increased (Dawson et al., 2003).  
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Fortescue et al. (2007) found that out of 482 marathon runners, 55 had elevations in cTnT, 
cTnI or both. The results suggested cTn increases in runners were more likely to be 
women, younger aged, whilst runners with no marathon experience were almost 3 times 
likely to have cTn increases compared to those with experience. Neilan et al. (2006) 
suggested amateur athletes were more likely to experience elevated cardiac biomarkers 
in comparison to individuals with more extensive training backgrounds, however, the 
meta-analysis by Shave et al. (2010) and more recently Richardson et al. (2018) did not 
support this finding. An earlier study by George et al. (2004) found that age and finishing 
time had little impact upon LV function or cTnT. 
 
The majority of studies have been conducted at a competitive event whereby details on 
the ambient conditions are often not clearly reported or are subject to significant change 
due to the duration of such events (Table 2.1 and 2.2; Dawson et al., 2003). Lucía et al. 
(1999a) proposed that the effects of environmental strain may be more important than 
exercise duration in the development of functional changes post-exercise and indeed 
many of the field-based studies in this area have been carried out within hot, cold, humid 
and high altitude environments (Bonetti et al., 1996; Dávila-Román et al., 1997; Douglas 
et al., 1987; Gaudreault et al., 2013; Neumayr et al., 2001, 2002; Rifai et al., 1999). The 
nature of these events have not allowed for a systematically controlled approach, therefore 
making it impossible to eliminate the effects of the environment which have been 
implicated in the aetiology of EICF and EICD (Shave et al., 2004c) and consequently 
complicate data interpretation. Currently limited lab-based, and thus controlled data has 
been collected, investigating the impact of environmental temperature on LV function 
and cardiac biomarker release. Shave et al. (2004c) observed the effect of prolonged 
endurance exercise (100 mile cycle trial) within controlled ambient temperatures of 0oC 
and 19oC, reporting a significant decrease in diastolic function after exercise in 19oC but 
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not in 0oC, with no evidence of systolic dysfunction displayed in either trial. Detectable 
cTnT was only observed in two cyclists after exercise in the 19oC trial. This preliminary 
evidence suggests that ambient temperatures may play some part in exacerbating the post-
exercise response of LV function and cardiac biomarker release, but did not extend to 
warmer environmental conditions. The evidence presented from studies evaluating 
cardiac fatigue and biomarker release from single bouts of prolonged exercise reveal gaps 
in the knowledge, particularly within a controlled environment or with elevated 
environmental temperatures. Therefore a focus of this thesis will consider the effect of 
the environment and prolonged exercise upon cardiac fatigue and biomarker release. 
 
2.4 The Impact of Repeated Bouts of Endurance Exercise on Cardiac Function and 
Biomarker Release 
Whilst single bouts of prolonged exercise provide a substantial cardiovascular challenge, 
these events are typically followed by periods of rest or reduced activity allowing the 
athlete to recover. Participation in multi-day endurance events, with repeated endurance 
exercise exposure and limited recovery time, have proved increasingly popular (Knoth et 
al., 2012). It is also common for endurance athletes to undertake high volumes of exercise 
during training and competition with inadequate recovery between sessions. This likely 
represents the upper limit of physiological stress placed upon the human heart (George et 
al., 2011). The following section of the literature review discusses the extant evidence of 
cardiac fatigue and damage associated with repeated bouts of endurance exercise. 
 
2.4.1 Alterations in Cardiac Function 
It has been previously speculated by La Gerche et al. (2004) that repeated bouts of ultra-
endurance exercise, each producing sub-clinical effects, may have a cumulative effect 
upon cardiac function. There are a small number of studies that have focused upon the 
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cardiovascular consequences of engaging in repeated bouts of endurance exercise (Table 
2.3) which have employed a combination of exercise modes, participants and research 
designs.  
 
Table 2.3 provides an overview of the previous literature which have assessed LV systolic 
and diastolic function before and after repeated bouts of exercise using standard 2D 
echocardiography, flow-Doppler and TDI indices. The table details the studies by mode, 
exercise duration, the intensity of the exercise and environmental conditions, alongside 
the study’s findings. 
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Table 2.3 Studies utilising standard 2D, flow-Doppler and tissue-Doppler echocardiography following repeated bouts of prolonged exercise 
Author 
 
Mode of 
Exercise 
Duration Intensity of 
Exercise 
Systolic Diastolic Environmental 
Conditions 
↑ = ↓ ↑ = ↓  
WALKING/RUNNING 
Benda et al., 
2016 
 
3 days walking 
(30 or 40 km) 
Day 1: 424 ± 
91 min 
Day 2: 470 ± 
114 min 
Day 3: 416 ± 
111 min 
HRmean 109 ± 
23 beats.min-1 
HRmean 108 ± 
28 beats.min-1 
HRmean 109 ± 
27 beats.min-1 
S’ EF SBP/ESV  E, A, E:A, 
E’, A’ 
 NR 
Middleton et al., 
2007b 
 
Mountain run 
3-4 days 
 
15.3 miles per 
day 
Day 1: 138.8 ± 
13.5 mins 
Day 2: 138.6 ± 
13.9 mins 
Day 3: 143.0 ± 
23.4 mins 
Day 4: 139.3 ± 
8.2 mins 
HRmean 163 ± 
11 beats.min-1 
HRmean 157 ± 
18 beats.min-1 
HRmean 153 ± 
17 beats.min-1 
HRmean 145 ± 
14 beats.min-1 
 EF, 
SBP/ESV 
EF, 
SBP/ESV 
EF, 
SBP/ESV 
EF, 
SBP/ESV 
 
 
 
 
EF 
 
EF 
 
  
 
E:A 
 
E:A 
 
 
 
 
E:A 
 
E:A 
13.0 ± 2.7oC, 
63 ± 11% RH, 
3717 ft total 
elevation per 
day 
Shave et al., 
2002b 
 
2 day mountain 
marathon 
Day 1: 513 ± 
121 mins 
Day 2: 348 ± 
59 mins 
Self-paced   EF, SV, FS A  E, E:A NR 
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CYCLING 
Oosthuyse et al., 
2012 
 
Simulated 4-day 
cycling 
challenge 
3 h per day  
Day 1:  
Day 2:  
 
Day 3:  
 
Day 4: 
HRmean 154 ± 
12 beats.min-1 
HRmean 152 ± 
12 beats.min-1 
HRmean 142 ± 
20 beats.min-1 
HRmean 147 ± 
11 beats.min-1 
 SBP/ESV, 
SV 
EF, S’ A’ A E, E’, E:A, 
E’:A’ 
17.7 ± 1.4oC 
Williams et al., 
2011 
 
Race Across 
America (team) 
6 days, 10 h, 51 
min 
 
(Approximately 
75 h individual 
riding time) 
NR  S’   E’, A’, 
E’:A’ 
 NR 
Appelman et al., 
2015 
 
1580 km cycle 
tour in 8 days 
Average 
cycling time 10 
h per day 
Average speed 
27.9 km.hr-1 
 FS   E:A  Mean: 23-25oC 
Williams et al., 
2009 
 
Replicated Tour 
de France (20 
days cycling in 
22 day period) 
Range 200 to 
677 min 
Range HRmean 
55.0 ± 6.2 to 
67.5 ± 6.9 
beats.min-1 
  EF, SV, S’ A, A’ E E’, E:A, 
E’:A’ 
NR 
 
EF: ejection fraction, SV: stroke volume, FS: fractional shortening, SBP/LVESV: systolic blood pressure/left ventricular end systolic volume, S’: peak systolic myocardial tissue 
velocity, E: peak early trans-mitral flow velocity, A: peak atrial filling velocity, E:A: early to late diastolic filling ratio, E’: peak early diastolic myocardial velocity, A’: peak late 
diastolic myocardial velocity, E’/A’: peak early to late myocardial tissue velocity ratio, NR: not reported. Variables in bold highlight evidence of cumulative effect. 
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Shave et al. (2002b) studied athletes at a 2-day mountain marathon and observed cardiac 
dysfunction in 91% of participants following day 2, but no measures were taken at the 
end of the first day, confounding data interpretation. Middleton et al. (2007b) 
demonstrated a progressive decline in EF over 3 or 4 days of cross-country running in 
comparison to baseline levels. An increase in post-exercise HR after day 3 could only 
account for 48% of the change in EF, which was still depressed in a subset of athletes 20 
hours post day 4. Diastolic function was reduced pre-post exercise daily, but 
demonstrated no evidence for a cumulative effect. Benda et al. (2016) reported a 
cumulative decrease in SBP/LVESV over 3 days walking suggesting a decrease in 
contractility, however, no change in EF and an increase in S’ was observed. An unaltered 
diastolic function was also seen, with the lack of change in LV function being attributed 
to the low intensity of walking exercise. Oosthuyse et al. (2012) confirmed a consistent 
pattern of reduction in diastolic function each day following 3 hr-sessions of race-
simulated cycling for four days in well trained competitive cyclists but did not observe a 
cumulative decline in EF. Williams et al. (2009) also noted a consistent pattern of change 
in diastolic function with no accumulation effect on EF in a 22 day cycle study, although 
echocardiograms were only conducted following 4 of the 20 stages. In-event data by 
Williams et al. (2011) demonstrated no changes in septal systolic or diastolic tissue 
velocities during and after the Race Across America in well trained individuals. More 
recently, Appleman et al. (2015) reported no changes in systolic or diastolic function after 
7 days of an 8 day cycle tour, however, no measures were taken during the tour. Further 
research is warranted to better understand the extent of short term recovery on cardiac 
function in multi-stage exercise, particularly in less trained individuals, as well as to 
investigate individual differences in the response to endurance exercise and will therefore 
be a focus of this thesis. 
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2.4.2 The Appearance of Tissue-Specific Markers of Cardiac Damage 
Limited attention has also been given to the effect of multi-day exercise upon biomarkers 
of cardiac damage or stress (Table 2.4). Table 2.4 provides an overview of the literature 
which assessed cardiac biomarkers before and after repeated bouts of exercise. The table 
details the studies by mode (walking/running, cycling), exercise duration, the intensity of 
the exercise and environmental conditions, alongside the study’s findings. Details of the 
type of biomarkers used are also given, which include cTnT (1s/2nd/3rd generation), cTnI, 
highly sensitive assays (hs-cTnT and hs-cTnI) as well as markers of cardiac stress. 
 
Bonetti et al. (1996) reported the presence of cTnT (2nd generation) in 5 of the 28 cyclists, 
assessed prior to, after 1 week, 2 weeks and at the end of the Giro d’Italia cycle race. 
Limited blood draws and the fact that cTnT was present in the circulation of 3 of the 5 
cyclists before the cycle race started confounds data interpretation. Shave et al. (2002b) 
demonstrated a cTnT elevation above the detection limit of the assay in 13/26 participants 
after day 1 of a mountain marathon, with values returning to undetectable levels after day 
2. Conversely, Denissen et al. (2012) reported no increases in cTnT before and after a 3 
day trail run, which was also supported by Corsetti et al. (2012) who reported few changes 
in the high sensitivity cTnT assay over the course of the Giro D’Italia. Middleton et al. 
(2007b) reported a limited number of cTnT elevations with most occurring following the 
first day of exercise. Collectively these studies suggest no accumulation effect of repeated 
endurance exercise bouts on cTnT.   
 
Eijsvogels et al. (2010) reported no cumulative effect in cTnI or hs-cTnI release when 
exposed to the same exercise volume (prolonged walking) on 4 consecutive days, with 
only a few cases of elevated cTn levels. More recently, Benda et al. (2016) reported a 
significant increase in hs-cTnI across 3 days walking, however, only mean and SD values 
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were reported confounding data interpretation. Appleman et al. (2015) reported a cTnI 
elevation above the assay detection limit, but below the upper normal limit in 16/20 
participants after an 8 day cycling tour. Interestingly in one of the few papers to report 
case data, Williams et al. (2011) observed a high degree of individual variability in the 
cTnI response to the Race Across America. Sporadic increases in cTnI were also observed 
after a number of stages during a 20 day cycle study (Williams et al., 2009), with all 
participants demonstrating elevated values across the tour. 
 
Fewer data are available for NT-proBNP changes with repeated exercise bouts. Corsetti 
et al. (2012) described a progressive increase in NT-proBNP from baseline levels to the 
12th day and final day of the Giro d’Italia cycle race, which was also observed by 
Middleton et al. (2007b) over 3-4 days of cross-country running.  After 8 days of cycling, 
Appleman et al. (2015) reported BNP levels within the normal limits for all participants, 
a finding also observed by Benda et al. (2016) following 3 days of walking. This finding 
was also similar to Corsetti et al. (2012), who attributed lower NT-proBNP values to the 
high training status of the participants involved. In a 20 day cycle study Williams et al. 
(2009) observed an early peak NT-proBNP at stage 6 with values dropping close to 
baseline by stage 20. Inter and intra-individual variability was apparent within the data, 
as well as that by Williams et al. (2011), highlighting the need for further research to 
expose the response to multi-day exercise. 
69 
 
Table 2.4 Studies utilising cTnT, cTnI and other cardiac biomarkers during/following single bouts of prolonged exercise 
Author 
 
Mode of Exercise 
Duration Intensity of 
Exercise 
Blood 
Measurement 
Elevated (Number > 
URL) 
Peak Environmental 
Conditions 
WALKING/RUNNING 
Benda et al., 2016 
 
3 days walking (30 
or 40 km) 
Day 1: 424 ± 91 
min 
Day 2: 470 ± 114 
min 
Day 3: 416 ± 111 
min 
HRmean 109 ± 23 
beats.min-1 
HRmean 108 ± 28 
beats.min-1 
HRmean 109 ± 27 
beats.min-1 
hs-cTnI (ADVIA 
Centaur) 
 
BNP (ADVIA 
Centaur) 
Significant increase 
 
 
No change 
NR 
 
 
NR 
NR 
Eijsvogels et al., 
2010 
 
4 day walking 
event (30, 40 or 50 
km per day) 
 
Day 1: 
8 hrs 37 mins ± 1 
hr 38 mins 
Day 2:  
8 hrs 57 mins ± 1 
hour 33 minutes 
Day 3: 
8 hrs 36 mins ± 1 
hr 47 mins 
Day 4: 
9 hrs 8 mins ± 2 
hrs 9 mins 
 
Day 1: 
4.6 ± 0.6 km.hr-1 
 
Day 2: 
4.4 ± 0.6 km.hr-1 
 
Day 3: 
4.6 ± 0.6 km.hr-1 
 
Day 4: 
4.4 ± 0.6 km.hr-1 
(Variation of 72-
65% of predicted 
VO2max) 
cTnI (STAT) 
hs-cTnI (Centaur 
TnI-Ultra) 
cTnI (STAT) 
hs-cTnI (Centaur 
TnI-Ultra) 
cTnI (STAT) 
hs-cTnI (Centaur 
TnI-Ultra) 
cTnI (STAT) 
hs-cTnI (Centaur 
TnI-Ultra) 
 
4/103 (4) post 
4/103 (4) post 
 
1/103 (1) post 
1/103 (1) post 
 
2/103 (2) post 
2/103 (2) post 
 
2/103 (2) post 
2/103 (2) post 
NR 
1.17 µg.L-1 
 
NR 
0.74 µg.L-1 
 
NR 
0.79 µg.L-1 
 
NR 
0.44 µg.L-1 
 
Day 1: 
Min: 13.2oC 
Max: 20.6oC 
Day 2: 
Min: 14.2oC 
Max: 20.4oC 
Day 3: 
Min:12.3oC 
Max: 19.8oC 
Day 4: 
Min:12.5oC 
Max: 19.4oC 
Shave et al., 2002b 
 
2 day mountain 
marathon 
Day 1: 506 ± 123 
mins 
Day 2: 344 ± 54 
mins 
Self-paced cTnT (3rd Gen. 
Roche) 
 
Day 1: 13/26 
 
Day 2: 1/26 
0.035 µg.L-1 
 
0.017 µg.L-1 
NR 
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Middleton et al., 
2007b 
 
Mountain run 
3-4 days 
 
15.3 miles per day 
Day 1: 138.8 ± 
13.5 mins 
 
 
 
Day 2: 138.6 ± 
13.9 mins 
 
 
 
Day 3: 143.0 ± 
23.4 mins 
 
 
 
Day 4: 139.3 ± 8.2 
mins 
HRmean 163 ± 11 
beats.min-1 
 
 
 
HRmean 157 ± 18 
beats.min-1 
 
 
 
HRmean 153 ± 17 
beats.min-1 
 
 
 
HRmean 145 ± 14 
beats.min-1 
cTnT (3rd Gen. 
Roche) 
NT-proBNP 
(Roche Elecsys 
1010) 
cTnT (3rd Gen. 
Roche) 
NT-proBNP 
(Roche Elecsys 
1010) 
cTnT (3rd Gen. 
Roche) 
NT-proBNP 
(Roche Elecsys 
1010) 
cTnT (3rd Gen. 
Roche) 
NT-proBNP 
(Roche Elecsys 
1010) 
1/10 post, 4/10 1 h post, 
0/10 20 h post 
Elevated 
 
 
1/10 post, 1/10 1 h post, 
1/10 20 h post 
Elevated 
 
 
1/10 post, 1/10 1 h post, 
1/10 20 h post 
Elevated 
 
 
1/10 post 
 
Elevated 
 
 
0.079 µg.L-1, 0.125 µg.L-
1, ND 
NR 
 
 
NR 
 
NR 
 
 
NR 
 
NR 
 
 
0.013 µg.L-1 
 
NR 
 
13.0 ± 2.7oC, 63 ± 
11% RH, 3717 ft 
total elevation per 
day 
Denissen et al., 
2012 
 
3 day trial run 
Day 1: 29.3 km 
 
Day 2: 37.9 km 
 
Day 3: 27.8 km 
12 h 57 min ± 2 h 
51 min 
 
 
 
 
HRmean 150.8 ± 
21.3 beats.min-1 
HRmean 140.7 ± 
22.5 beats.min-1 
HRmean 138.5 ± 
23.3 beats.min-1 
cTnT (NR)  
 
 
 
0/19 post 
 
0/19 post 
 
0/19 post, 0/19 24 h post, 
0/19 72 h post 
NR 11.5 to 22.8oC, 54 
to 22.8% RH, max 
wind speed 2.8 
m.s-1 
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CYCLING 
Williams et al., 
2011 
 
Race Across 
America (team) 
6 days, 10 h, 51 
min 
 
(Approximately 75 
h individual riding 
time) 
NR cTnI (TnI-Ultra 
ADVIA Centaur) 
 
 
NT-proBNP 
(ECLIA, Roche) 
Day 1: 4/4 (0), Day 2: 1/4 
(0), Day 3: 2/4 (0), Day 4: 
0/4 (0), Day 5: 1/4 (1), 4 h 
post: 1/4 (1) 
Day 1: 4/4 (0), Day 2: 4/4 
(0), Day 3: 4/4 (0), Day 4: 
4/4 (1), Day 5: 3/4 (1), 4 h 
post: 1/4 (1) 
0.03 ng.mL-1, NR. NR, 
NR, 0.08 ng.mL-1, NR 
 
 
NR, NR, NR, 150 ng.L-1, 
NR, 310 ng.L-1 
NR 
Appelman et al., 
2015 
 
1580 km cycle tour 
in 8 days 
Average cycling 
time 10 hours per 
day 
Average speed 
27.9 km.hr-1 
cTnI (NR) 
 
BNP (NR) 
16/20 (0) post 
 
Within normal limits 
NR 
 
NR 
Mean: 23-25oC 
Bonetti et al., 1996 
 
Giro d’Italia (22 
days) 
NR Self-paced 
Average speed 
37.2 km.h-1 
cTnT (2nd Gen. 
Boehringer) 
2/25 post week 1, 3/25 
post week 2, 2/25 post 
event 
0.05 µg.L-1, 0.07 µg.L-1, 
0.10 µg.L-1 
Altitude difference 
25,985 m 
Corsetti et al., 2012 
 
Giro d’Italia (22 
days) 
86 h 47 min Average speed 
35.7 km.hr-1 
hs-cTnT (Roche) 
 
NT-proBNP 
(Elecsys proBNP) 
NR Day 12: 9.33 ng.L-1, Day 
22: 21.90 ng.L-1 
Day 12: 93.31 ng.L-1, Day 
22: 129.78 ng.L-1 
NR 
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Williams et al., 
2009 
 
Replicated Tour de 
France (20 days 
cycling in 22 day 
period) 
Range 200 to 677 
min 
Range HRmean 
55.0 ± 6.2 to 67.5 
± 6.9 beats.min-1 
cTnI (TnI-Ultra 
ADVIA Centaur) 
 
 
 
 
 
NT-proBNP 
(ECLIA, Roche) 
Stage 1: 3/10, Stage 2: 
1/10, Stage 3: 2/10, Stage 
6: 1/10, Stage 7: 2/10, 
Stage 9: 3/10, Stage 12: 
5/10, Stage 15: 6/10, 
Stage 17: 3/10, Stage 18: 
3/10, Stage 20: 1/10 
Stage 1: Elevated, Stage 
2: Elevated, Stage 3: 
Elevated above URL, 
Stage 6: Elevated above 
URL, Stage 7: Elevated 
above URL, Stage 9: 
Elevated, Stage 12: 
Elevated, Stage 15: 
Elevated, Stage 17: 
Elevated above URL, 
Stage 18: Elevated above 
URL, Stage 20: Elevated 
NR 
 
 
 
 
 
 
NR 
NR 
 
1st gen.: first-generation assay, 2nd gen.: second-generation assay, 3rd gen.: third-generation assay, BNP: brain natriuretic peptide, NT-proBNP: N-terminal proB-type natriuretic peptide, 
cTnI: cardiac troponin I, cTnT: cardiac troponin T, HRmean: mean heart rate, NR: not reported, ND: not detectable. 
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2.5 Exercise, Thermoregulation and the Impact of Environmental Heat Stress on 
Cardiovascular Function 
The maintenance of a normal Tc (~37
oc) is essential, as deviations as little as 3oc can 
severely strain physiological systems and lead to death (Crandall and González-Alonso, 
2010). Regulatory mechanisms within the human body maintain a homeostasis in internal 
temperature within a narrow range, with as little as 0.3oc increase initiating critical heat 
loss responses of cutaneous vasodilation and sweating (Crandall and Wilson, 2015). An 
increase in skin blood flow enhances convective heat dissipation through sweating, whilst 
a reduction in skin perfusion impedes heat loss (Rowell, 1974). These heat dissipating 
responses, along with autonomic and cardiovascular adjustments assist in regulating 
thermoregulation, blood pressure control and organ perfusion. These adjustments include 
an elevated cardiac output through increases in HR and cardiac contractility to account 
for the higher skin perfusion (Rowell, 1974), and an elevated sympathetic activity to 
reduce blood flow and blood volume to noncutaneous regions (Crandall and Wilson, 
2015). Exercise in the heat presents a greater challenge to the cardiovascular system, with 
an increased need for heat dissipation competing with a greater need for blood flow to the 
active muscle tissue (González-Alonso, 2007; González-Alonso et al., 2008). 
Furthermore, a number of studies have demonstrated an impaired exercise capacity (Ely 
et al., 2010; González-Alonso and Calbet, 2003; González-Alonso et al., 1999) when 
performing exercise in a thermally stressful environment, leading to a number of studies 
researching into the effect of pre-cooling immediately prior to exercising in thermally 
stressful environments. The following section summarises the cardiovascular adjustments 
to heat stress at rest and during exercise prior to a review of the literature of pre-cooling 
methods prior to prolonged exercise in hyperthermic environments. 
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2.5.1 Cardiovascular Adjustments to Heat Stress at Rest 
During heat stress at rest, skin blood flow is estimated to increase from ~300 ml.min-1 
towards 7500 ml.min-1 (Rowell et al., 1969). In order to maintain arterial blood pressure, 
cardiac output must increase alongside decreases in vascular resistance of non-cutaneous 
beds to counteract the effect of increases in total vascular conductance associated with 
cutaneous vasodilation (Crandall and González-Alonso, 2010). As a result, arterial blood 
pressure is maintained or minimally reduced. The elevation in cardiac output is driven 
primarily through increases in HR, as SV is either maintained or marginally increased 
(Rowell et al., 1969). Heat stress is reported to increase HR and ventricular contraction 
through a direct effect on cardiac nodal cells (sinoatrial and atrioventricular) and 
conduction velocity (positive dromotropic effect), accounting for 40% of the elevation in 
HR. Sympathetic activation and parasympathetic withdrawal account for the remaining 
effects on cardiac nodal cells (Crandall and Wilson, 2015). 
 
Several studies have demonstrated a reduction in central blood volume, central venous 
pressure and LV filling pressure during heat stress at rest, indicating a reduced venous 
return (Rowell et al., 1969; Wilson et al., 2007, 2009). Passive heat stress can induce 
reductions in central venous pressure, which can approach 0 mmHg depending on the 
magnitude of the heat stress (Rowell et al., 1969; Wilson et al., 2007), potentially as a 
result of a redistribution of blood from the central circulation to cutaneous vascular beds. 
Passive heat stress results in a parallel decrease in LV filling pressure (Wilson et al., 2007, 
2009), which alongside a reduced central blood volume and a preserved or increased SV, 
suggests an increase in inotropic state of the heart (enhanced LV function). Therefore, 
despite a reduced venous return, a maintained SV must be facilitated by an enhanced LV 
systolic and/or diastolic function. In an attempt to identify the cause of a maintained SV 
during passive heat stress, Brothers et al. (2009) measured LV systolic and diastolic 
75 
 
function using echocardiography. The authors demonstrated that despite a reduction in 
venous return, E and E’ remained unchanged with heat stress at rest, with improved LV 
systolic (S’) and late diastolic function (A). It was concluded that the maintenance of SV 
was caused by an increased LV systolic and ‘atrial systolic function’, however, the 
maintenance of E despite a reduced LV filling pressure also demonstrated an enhanced 
early diastolic function (Brothers et al., 2009). Whilst the cardiovascular response of 
passive heat stress has been demonstrated with relatively consistent findings, the 
cardiovascular response to combined exercise and heat stress have produced conflicting 
results and will be discussed in the next section. 
 
2.5.2 Cardiovascular Adjustments to Heat Stress during Exercise 
The combination of exercise and heat stress provides one of the most severe challenges 
to the regulation of the cardiovascular system (Crandall and González-Alonso, 2010). 
Compared to exercise in normothermic conditions, cardiac output during exercise in the 
heat has shown to be the same (Lafrenz et al., 2008), higher or lower (Rowell et al., 1966). 
Whilst these discrepancies are likely a consequence of differing exercise intensities, 
durations and protocols, an increased HR and reduced SV has been consistently observed 
in hot environments compared to normothermic conditions (Rowell et al., 1966; Lafrenz 
et al., 2008), suggestive of a decrease in LV function when the need for thermoregulation 
is elevated. The mechanisms behind the drop in SV is widely debated. A maintained or 
decreased mean arterial pressure (Rowell et al., 1969; Lafrenz et al., 2008), suggests an 
enhanced afterload cannot account for the lower SV during exercise in the heat. A 
reduction in venous return, as a result of a reduced central blood volume (Rowell et al., 
1966, 1969) caused by the combined demand for blood flow to the active skeletal muscles 
and to the skin has also been proposed. Alternatively, an increased HR leading to a 
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reduced filling time has also been suggested to contribute to the reduction in SV during 
exercise (Fritzsche et al., 1999). 
 
When performing dynamic exercise in the heat, blood flow to the active muscle tissue is 
required to meet the energetic demands of the activity, whilst blood flow to the skin is 
required to aid with temperature regulation (González-Alonso, 2007; González-Alonso et 
al., 2008). As a consequence, the combined demands for blood flow can result in a 
competition for the available cardiac output (Rowell, 1974). The increased demands on 
muscle and skin blood flow can be limited by the cardiac pumping capacity and the 
limited redistribution of blood flow. As a possible consequence, either: a) the mismatch 
between cardiac output and total vascular conductance leads to a loss in blood pressure, 
b) a reduction in muscle VO2 due to a mismatch between muscle blood flow and 
metabolism, or c) a compromised skin blood flow leading to a higher Tc (González-
Alonso et al., 2008). It is suggested that there is little or no role for a reflex 
thermoregulatory reduction in active muscle blood flow, but it is a passive event as a 
result of dehydration enhanced in a hot environment. Whilst blood pressure is generally 
well maintained during exercise in the heat (Rowell, 1974), a compromised skin blood 
flow is likely to be enhanced during exercise in the heat. An acute reduction in skin blood 
flow at the onset of exercise is observed, brought about by increased vasoconstrictor 
system activity. As exercise duration increases, the vasodilator system is activated and 
governed by two thresholds (González-Alonso et al., 2008). The first is the internal 
temperature at which vasodilation begins, which is delayed to a higher temperature during 
exercise compared to rest (Kellogg et al., 1991). As the internal temperature continues to 
rise (~38oC), a second threshold is met whereby skin blood flow reaches an upper limit 
despite further increases in internal temperature (González-Alonso et al., 1999), reducing 
the ability to dissipate heat. This reflects the inability of the cardiovascular system to 
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maintain arterial blood pressure and cutaneous vasodilation during prolonged exercise. 
Whilst the effect of heat during prolonged exercise on the cardiovascular system is well 
reported, the cardiovascular effects of a combination of prolonged exercise and heat 
exposure post-exercise is less clear and will be a focus of this thesis. 
 
2.5.3 Strategies to enhance exercise performance in the heat 
When exercising in the heat, the metabolic heat produced, coupled with the high ambient 
temperature and/or high humidity can result in an increased Tc (Ross et al. 2013), increase 
in heat related illnesses (Casa et al., 2015), along with an impaired exercise capacity (Ely 
et al., 2010; González-Alonso and Calbet, 2003; González-Alonso et al., 1999). The main 
limiting factor inhibiting exercise performance is suggested to be the attainment of a 
critically high body temperature (González-Alonso et al., 1999), with other adverse 
effects including cardiovascular strain and metabolic disturbances (Marino, 2002). The 
increased cardiovascular strain from the enhanced cardiovascular drift in a hyperthermic 
environment is in part attributed to a peripheral displacement of blood volume and a 
decreased ventricular filling time due to a hyperthermia-induced tachycardia (González-
Alonso et al., 2008). 
 
Heat transfer between the body and the environment occurs via heat flow down 
temperature or humidity gradients through thermal radiation, convection and evaporation 
(Brotherhood, 2008). Convective heat transfer is influenced by the thermal properties of 
the air and skin, as well as the air velocity over the body surface. Whilst evaporative 
cooling is dependent upon sufficient physiological sweat production, as well as the 
environments evaporative capacity i.e. air flow over the skin and absolute humidity 
(Brotherhood, 2008). Sweating can be initiated by central stimulation prior to a rise in 
body temperature, but also influenced by multiple factors including the amount of 
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mechanical work being performed, humoral factors i.e. dehydration, and environmental 
conditions i.e. temperature, humidity and wind flow (Ogawa and Sugenoya, 1993; 
Saunders et al., 2005; Shibasaki and Crandall, 2010). Thermoregulatory mechanisms can 
also be stimulated by an increase in central brain temperature (Holdcroft, 1980).  
 
Hyperthermia is a major influence upon the impaired exercise capacity (Ely et al., 2010; 
González-Alonso and Calbet, 2003; González-Alonso et al., 1999) observed when 
performing exercise in a thermally stressful environment. A number of strategies to 
attenuate the rise in Tc by increasing the body’s capacity to store metabolic and 
environmental heat have been investigated as a means to enhance exercise performance 
(Booth et al., 1997; Kay et al., 1999; Ross et al., 2013; Wegmann et al., 2012), including 
cooling, acclimation and fluid ingestion. Cooling interventions may increase the heat 
storage capacity (pre-cooling), attenuate the exercise-induced increase in Tc (per-cooling) 
and accelerate recovery following intense exercise (post-cooling; Bongers et al., 2017). 
Pre-cooling is described as the rapid removal of heat from the body prior to exercise, and 
is a popular method used to combat the effects of heat-stress induced fatigue/performance 
decrements (Périard et al., 2017; Ross et al., 2013). Pre-cooling utilises techniques 
including whole body pre-cooling such as cold water immersion and cold air exposure, 
local cooling such as cooling vests/packs or internal cooling strategies such as ingesting 
cold water/ice slurry (Bongers et al., 2017). Gradual cooling via whole-body water 
immersion is reported to offer four times greater heat loss to water that air at the same 
temperature (~4.2 kJ/kg oC versus ~1.0 kJ/kg oC, respectively; Ross et al., 2013). A recent 
meta-analysis has reported cold water immersion to be the most effective method of 
enhancing exercise performance over internal cooling or local cooling (Bongers et al., 
2015), suggesting cooling of a large surface area is more effective than local cooling 
methods. Additionally, the increase in core-to-skin thermal gradient is associated with the 
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‘after-drop’ effect, allowing for the continuation of cooling even upon the commencement 
of exercise (Kay et al., 1999). Furthermore, research into the effect of pre-cooling on the 
cardiovascular system during exercise has established that reducing the rate of rise in Tc 
coupled with the hydrostatic effects following immersion, displaces fluids from the 
extremities towards the thoracic cavity (Farhi and Linnarsson 1977), leading to a 
maintenance or increase of central blood volume and hence cardiac output as the need for 
skin blood flow is reduced (Stanley et al., 2014; Wegmann et al., 2012). A maintained 
SV and attenuated HR during steady state exercise after pre-cooling has been previously 
observed (Hessemer et al., 1984; Lee and Haymes, 1995; Schmidt and Brück, 1981), 
suggesting a reduced cardiovascular strain following pre-cooling. The pre-cooling effect 
of reducing cardiovascular strain during exercise in the heat upon post-exercise cardiac 
function has yet to be investigated and warrants further investigation. 
 
2.6 Summary and Link to Empirical Studies 
An acute bout of exercise can place a significant amount of stress upon the heart, 
potentially resulting in a transient reduction in LV systolic and/or diastolic function as 
well as the release of cardiac-specific biomarkers. Whilst a number of single day field 
based studies exist, little attention has been given to repeated bouts of exercise. 
Furthermore, the effect of prolonged exercise within a controlled or hyperthermic 
environment is unknown. Consequently, more work is required to fully understand these 
phenomena.  
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2.7 Thesis Aims and Hypotheses 
With the presented literature in mind, the overall aim of this thesis was to examine the 
impact of prolonged exercise and environmental temperature upon LV function and 
markers of cardiac damage in healthy individuals. Four empirical studies were completed 
based on the following aims and hypotheses. 
 
Study 1 
Study aim: To assess the cardiac function and cardiac biomarkers of recreational distance 
cyclists before, during and after a 10 day cycle challenge. 
Research hypothesis: A cumulative decrease in LV systolic (EF) and diastolic function 
(E:A) as well as a cumulative increase in cardiac biomarker (cTnI and NT-proBNP) 
concentrations would be evident across the 10 day cycle challenge. 
 
Study 2 
Study aim(s): To assess whether (1) a single bout of prolonged strenuous running in a hot 
ambient environment resulted in a reduction in cardiac function and increased levels of 
biomarkers of cardiac damage, (2) whether five consecutive days of prolonged strenuous 
running in a hot ambient environment resulted in cumulative decrements in cardiac 
function and increments in levels of biomarkers of cardiac damage, and (3) what degree 
of day-to-day recovery in cardiac function and biomarkers will occur. 
Research hypothesis 1: An increase in cardiac biomarkers (cTnI and NT-proBNP) and a 
decrease in cardiac function (EF and E:A) would be apparent after a single bout of 
exercise in the heat. 
Research hypothesis 2: Multi-day exercise in the heat would lead to an accumulation of 
changes in cardiac function and markers of cardiac damage. 
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Research hypothesis 3: There would be an insufficient recovery of cardiac function and 
markers of damage between days. 
 
Study 3 
Study aim: To examine the impact of prolonged exercise in a hyperthermic environment 
upon cardiac function (EF and E:A) and levels of biomarkers of cardiac damage (cTnI 
and NT-proBNP). 
Research hypothesis: Exercise of the same duration (60 min) and the same running speed 
performed in a hyperthermic environment (30oC) will result in greater changes in LV 
function and more frequent appearance of cardiac biomarkers than exercise in a 
normothermic environment (13oC). 
 
Study 4 
Study aim: To examine the effect of pre-cooling, prior to exercise in a hyperthermic 
environment, upon cardiac function (EF and E:A) and markers of cardiac damage (cTnI 
and NT-proBNP). 
Research hypothesis: Performing prolonged exercise in a hot environment, preceded by 
pre-cooling would result in a maintained LV function and a reduced appearance of cardiac 
biomarkers in comparison to a control trial. 
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CHAPTER 3 
A unique case series of alterations in left ventricular function 
and biomarkers of cardiac damage in recreational distance 
cyclists completing the 1666 km “John O’Groats to Lands 
End Cycle Challenge” 
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3.1 Introduction 
Clear evidence of a decrease in LV systolic and diastolic function and/or an elevation in 
cardiac biomarkers following single, prolonged bouts of physical activity is apparent 
(Chapter 2; Middleton et al., 2006a; Shave et al., 2007a), with functional and biomarker 
variables typically returning to baseline values after 24-48 hr of recovery (Middleton et 
al., 2006b; Neumayr et al., 2005; Shave et al., 2004a; Stewart et al., 2016). Whilst single 
bouts of prolonged exercise provide a substantial cardiovascular challenge, many athletes 
however, engage in repeated bouts of exercise either during competition, through the 
repetitive element of training, or a combination of the two. 
 
Participation in multi-day endurance events, with repeated endurance exercise exposure 
and limited recovery time, have proved increasingly popular (Knoth et al., 2012) and 
likely represent the upper limit of physiological stress placed upon the human heart 
(George et al., 2011). A small number of studies have focused upon the cardiovascular 
consequences of engaging in repeated bouts of endurance exercise with inconsistent 
outcomes (Appleman et al., 2015; Bonetti et al., 1996; Corsetti et al., 2012; Denissen et 
al., 2012; Middleton et al., 2007b; Oosthuyse et al., 2012; Shave et al., 2002b; Williams 
et al., 2009, 2011), whilst also employing a variety of exercise modes, participants and 
research designs. Most notably was the lack of data collection points, with a number of 
studies reporting either pre-post event data (Appleman et al., 2015; Denissen et al., 2012; 
Shave et al., 2002b) or minimal time points across the event (Bonetti et al., 1996; 
Williams et al., 2009) and thus provides part of the rationale for the initial study. 
 
Collectively, Chapter 2 highlighted limited evidence for an accumulation effect of 
repeated endurance exercise bouts on cardiac function or cardiac biomarkers. 
Interestingly in one of the few papers to report case data, Williams et al. (2011) observed 
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a high degree of individual variability in response to the Race Across America, however, 
these participants were highly trained individuals.  Whilst the cardiac response to multi-
day exercise in professional (Bonetti et al., 1996; Corsetti et al., 2012) and highly trained 
athletes (Middleton et al., 2007b; Oosthuyse et al., 2012) has been considered, the cardiac 
consequences of repeated bouts of cycling in amateur or less trained individuals is 
unknown. Previous research has suggested that training status may mediate both cardiac 
functional and biomarker responses to acute prolonged exercise (Middleton et al., 2006a), 
which combined with limited recovery time, may facilitate an accumulation effect. 
Therefore, a case series approach to better understand the extent of short term recovery 
during multi-stage exercise on cardiac function and biomarker appearance as well as to 
investigate individual differences in the response to endurance exercise was adopted. 
Whilst a laboratory-based study usually allows for the tighter control of extraneous 
variables, it may also impact on the external validity of the results, which a field-based 
study can offer. Specifically, a field-based approach also allows for a greater duration of 
exercise to be performed compared to a laboratory-based study. Consequently, the aim of 
this study was to assess the cardiac function and cardiac biomarkers of recreational 
distance cyclists before, during and after a 10 day cycle challenge. It was hypothesised 
that a cumulative decrease in LV systolic (EF) and diastolic (E:A) function as well as a 
cumulative increase in cardiac biomarker concentrations (cTnI and NT-proBNP) would 
be evident in amateur cyclists completing a 10-day cycle challenge. 
 
3.2 Method 
3.2.1 Participants and Study Design 
Three Caucasian male recreational cyclists (age 25, 37 and 35 years, height 1.87, 1.85 
and 1.82 m, body mass 83, 73 and 80 kg, respectively) volunteered to take part in the 
study. Ethical approval was obtained from the University Ethics Committee prior to data 
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collection. Before the study commenced, all participants provided written informed 
consent and self-reported no personal or early family history of cardiovascular disease. 
No cyclist was ill, injured or taking any medication prior to the start of the study. All 
cyclists were recreationally-active completing a minimum of 3 prolonged endurance 
training sessions per week.  
 
All cyclists completed a 1666 km cycle challenge, over a 10 day period, covering between 
112 and 198 km per day (Table 3.1) over a range of terrains. The study protocol employed 
a repeated measures design. Identical echocardiographic and venous blood-sampling 
procedures were conducted 12 hours prior to day 1 (PRE), post-exercise for all cycling 
day(s) and 22 hours post-completion of the challenge (POST). Pre and post-exercise body 
mass (BM) and BP were assessed every day, with BP also being measured POST-
challenge. Post-exercise assessments were conducted within 30 min of exercise 
completion. Total duration (time from exercise initiation to exercise cessation), exercise 
duration and HR during the exercise period were assessed daily. Cyclists were allowed to 
consume fluids and foodstuffs ad-libitum throughout the study. 
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Table 3.1 Details of each days distance, elevation, average temperature, average humidity, exercise duration, total duration and % HRmax. 
Day Distance (km) Elevation (m) Average 
Temperature 
(oC) 
Average 
Humidity (%) 
Exercise 
Duration 
(min) 
Total 
Duration 
(min) 
% HRmax 
1 126 +1373/ -1398 11.6 66 430 550 72 ± 6 
2 183 +1987/ -1982 9.8 66 572 726 65 ± 5 
3 137 +1536/ -1526 9.6 68 417 522 62 ± 5 
4 177 +1581/ -1581 13.2 71 471 654 59 ± 4 
5 189 +2170/ -2076 8.2 73 571 748 61 ± 1 
6 183 +1303/ -1313 10.3 71 512 652 60 ± 4 
7 112 +1108/ -1031 13.2 72 354 470 60 ± 3 
8 198 +2316/ -2389 12.7 82 524 773 60 ± 4 
9 183 +2175/ -2066 18.8 39 513 699 62 ± 4 
10 179 +2587/ -2769 15.6 60 539 674 61 ± 3 
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3.2.2 Protocols 
Each cyclist underwent resting echocardiographic examination in the left lateral decubitus 
position. A single sonographer was employed for both imaging and assessment to 
eliminate inter-observer reliability concerns (Kuecherer et al., 1991). All measurements 
were performed using a commercially available ultrasound system (MyLab CV 30, 
Esaote, Italy), using a 3.5-MHz transducer. Simultaneous recordings to assess HR were 
conducted via an integrated ECG. An apical four-chamber view allowed the digital 
recording of 3-5 complete cardiac cycles from which LVEDV (a measure of preload), 
LVESV, SV and EF (a measure of LV contractility) were calculated via the area-length 
method as per the American Society of Echocardiography guidelines (Lang et al., 2015). 
Variations in the acquisition of LV volumes may result in a technical variability of up to 
7% in EF. In addition, participant variability (i.e. autonomic tone, body position) of up to 
8% in healthy populations, may result in a total variability in EF typically of up to 13% 
(Kuecherer et al., 1991). Therefore, minimal clinical significant difference may be 
observed with changes up to 13% and will be considered alongside the clinical cut-off 
criteria. Diastolic filling was examined using pulsed-wave Doppler interrogation of mitral 
valve inflow velocities from a LV apical 4 chamber view. Peak E and A velocities were 
measured, allowing the calculation of E:A. Variability in the measurement of E and A 
may result in a consequent technical variability up to 0.45, with participant variability 
contributing to a 0.28 variation (Kuecherer et al., 1991). Overall, a typical variation of up 
to 0.9 in E:A ratio will therefore be considered as clinically insignificant. In addition, 
tissue-Doppler imaging of the septal wall at the mitral annulus allowed the recording of 
peak S’, E’ and A’ myocardial tissue velocities. This allowed the calculation of the E’:A’ 
ratio and the E:E’ ratio which is an index of left atrial pressure (Naugueh et al., 1998). 
The SBP: LVESV ratio was calculated as a preload-independent measure of LV 
contractility (Sunagawa et al., 1983, 1985). 
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Whole blood samples were collected by venepuncture without venostasis from an 
antecubital vein using a 21G butterfly syringe into one plain vacutainer tube (8.5 ml, 
Becton Dickinson, Oxford, UK). The samples were left to clot prior to centrifuging at 
1500 g for 10 minutes at 4˚C. Serum was aliquoted into eppendorfs and stored 
immediately (-20°C) for subsequent analysis of cTnI and NT-proBNP. cTnI was analysed 
using a cTnI-Ultra ADVIA Centaur CP System assay (Siemens Medical Solutions 
Diagnostics, Surrey, UK), which is a three-site sandwich immunoassay using direct 
chemiluminometric technology. The assay range was 0.006-50 µg.L-1, whilst the 
coefficient of variation was 20% (functional sensitivity) at 0.017 µg.L-1 and 10% at 0.03 
µg.L-1. Sample values which did not reach detectable levels for the assay were presented 
as zero. The upper reference limit (99th percentile) of an apparently healthy population is 
0.04 µg.L-1 (Uettwiller-Geiger et al., 2002). NT-proBNP was analysed using an 
IMMULITE 2500 NT-proBNP assay (Siemens Medical Solutions Diagnostics, Surrey, 
UK), which is a solid-phase, two-site chemiluminescent immunometric assay. The assay 
range was 20-35000 ng.L-1, with an analytical sensitivity of 10 ng.L-1. The upper 
reference limit of an apparently healthy population is 125 ng.L-1 (Silver et al., 2004). 
 
BM was measured using calibrated digital floor scales on a hard surface to the nearest 0.1 
kg (model 875, Seca, Hamburg, Germany). SBP (a measure of afterload) and DBP was 
measured after 5 minutes rest in a supine position using a Dinamap automated BP monitor 
(Critikon Corporation, Tampa, USA). Stage/exercise duration, stage distance and 
ascent/decent and exercising HR were recorded and downloaded daily using a GPS-
enabled HR monitor (Garmin Forerunner 305, Garmin Ltd, USA). Analysis of HR data 
against GPS data was conducted to determine an average daily exercising HR for each 
cyclist. Maximal HR (HRmax) was determined using the age-predicted equation (HRmax 
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= 220-age). Each cyclist’s daily average HR was then converted to a percentage of 
HRmax (% HRmax). 
 
3.2.3 Data Analysis 
Data are presented descriptively in each cyclist for all variables due to the study sample 
size. Where possible, comparisons to normal reference values have been made for 
echocardiographic data, according to Flachskampf et al. (2015), Lang et al. (2015), 
Nagueh et al. (2016) and Schneiderman et al. (2013). Echocardiographic data is expressed 
as raw data and a percentage change (Equation 3.1). Whilst cardiac biomarkers have been 
compared to the upper reference limits of an apparently healthy population. 
 
Equation 3.1 Percentage change. 
 
Percentage Change = Stage Value – Baseline x 100 
Baseline 
 
3.3 Results 
All cyclists completed the 10 day challenge in a total duration of 6468 minutes, of which 
4903 minutes was exercise time with the remaining time being brief breaks (e.g. for food; 
Table 3.1). Daily exercise duration and distance covered was partially mediated by the 
terrain (Table 3.1). Mean % HRmax during cycling was higher (72%) at the beginning of 
the challenge with a small decline over the 10 day period. Average BM change ranged 
between -0.8 and +2.1% across days. All data collection procedures were completed with 
the exception of the echocardiogram (cyclist 2; day 2) and blood sample (cyclist 2; day 8 
and cyclist 3; day 2) due to technical issues. 
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3.3.1 Echocardiographic Data 
3.3.1.1 Loading 
HR PRE-challenge ranged 48-56 beats.min-1 and was elevated in all cyclists for the 
majority of daily post-exercise measures (Figure 3.1a). BM change was also variable day-
to-day and between cyclists, with no cyclists showing a percentage daily BM loss of > 
1%. Values returned to near baseline measures POST-challenge. PRE-challenge, LVEDV 
was above normal reference values in all cyclists (Figure 3.1b), with a marked decrease 
following day 1 in all cyclists (13-18% change). Cyclists 1 and 2 demonstrated a sustained 
decrease in LVEDV across the challenge, which did not return to baseline levels POST-
challenge, whilst LVEDV returned to a PRE-challenge value similar across the remaining 
days in cyclist 3. Data for E:E’, were variable day-to-day and cyclist to cyclist (Figure 
3.1c), remaining within normal reference values across the entire challenge. As a general 
trend SBP and DBP were reduced at the end of each day compared to PRE-challenge data 
although this was again variable within and between cyclists (Figure 3.2). 
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a) 
 
c) 
 
b) 
 
 
Figure 3.1 Individual data for LV loading over the duration of the cycle challenge where 
a) post exercise HR, b) LVEDV and c) E:E’. The shaded area represents the normal 
reference values of an apparently healthy population (Flachskampf et al. 2015, Lang et 
al. 2015). 
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Figure 3.2 Individual data for SBP (filled markers) and DBP (empty markers) over the 
duration of the cycle challenge. Daily measures denoted by pre exercise (am) and post 
exercise (pm). 
 
3.3.1.2 LV Systolic Function 
EF was within normal reference values in all cyclists PRE-challenge. As a consequence 
of a drop in LVEDV, and a smaller drop in LVESV, both EF and SV were decreased for 
the majority of cycling days in cyclists 1 and 2 (+3 to -16 and -4 to -34% change in EF 
and SV respectively; Figures 3.3a and b). In cyclist 3 LVEDV was well maintained with 
a slow increase in LVESV across the challenge that resulted in a drop in EF and SV for 
the majority of stages (+3 to -19 and +6 to -29% change in EF and SV respectively; 
Figures 3.3a and b). Values for EF and SV remained below PRE-challenge for all cyclists 
22 hours POST. The pressure/volume ratio was below the normal reference values in 
cyclists 1 and 2 PRE-challenge, and showed a varied response across cyclists during the 
challenge (Figure 3.3c). Cyclist 1 displayed a sustained increase (1-19% change) in 
SBP/LVESV with little variability across days. Whilst cyclist 2 demonstrated changes -3 
to +18% and cyclist 3 decreases of up to 36%, both of which were highly variable. Values 
did not return to PRE-challenge levels by 22 hours POST. Data for S’ was within the 
normal reference values in all cyclists PRE-challenge and remained within the normal 
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reference limits for all cyclists until the final day. An accumulated decrease in S’ in cyclist 
2 up until day 4 was evident (17% change), after which an increase in values were seen 
to be highly variable (Figure 3.3d). Substantial day-to-day variability was apparent in 
cyclists 1 and 3 (changes +4 to +35% and -7 to +29%, respectively), who’s values 
remained elevated 22 hours POST. 
 
a) 
 
c) 
 
b) 
 
d) 
 
Figure 3.3 Individual data for LV systolic function over the duration of the cycle 
challenge where a) EF, b) SV, c) SBP/LVESV and d) S’. The shaded area represents the 
normal reference values of an apparently healthy population (Dalen et al. 2010, Lang et 
al. 2015, Schneiderman et al., 2013). 
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3.3.1.3 LV Diastolic Function 
Data for E and A was within normal reference values in all cyclists PRE-challenge (Figure 
3.4a and b), whilst E:A marginally exceeded the upper reference limit in cyclist 3 (Figure 
3.4c). E:A was consistently reduced in cyclists 1 and 3 across all cycle days and POST-
challenge, with values ranging -11 to -47% change (Figure 3.4c), as a consequence of a 
tendency for E to drop and A to increase. Cyclist 2 presented with changes between -30 
up to +53%, with values exceeding the reference values of an apparently healthy 
population on two occasions due to a maintained E and reduced A. All cyclists 
demonstrated similar PRE-challenge values for E’, A’ and E’:A’, all within normal 
reference values (Figures 3.4d, e and f). There was substantial within and between cyclist 
variations in E’ (Figure 3.4d). Cyclists 1 and 3 demonstrated a comparable % change 
ranging -9 to +14. Cyclist 2 had a consistent reduction in E’ until day 9 (10 – 26% change), 
at which point E’ increased above PRE-challenge values. Data for A’ was also variable 
within and between cyclists (Figure 3.4e) with a % change ranging -17 to +55. E’:A’ was 
consistently reduced in cyclists 1 and 2 with values ranging 2-48% change (Figure 3.4f) 
with cyclist 1 demonstrating a somewhat cumulative decrease in values up to day 6, after 
which values became more variable towards PRE-challenge values. Cyclist 3 presented 
changes between -18 to +28%, with values exceeding the upper reference limit of a 
healthy population on three occasions due to a maintained E’ and reduced A’. 
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a) 
 
d) 
 
b) 
 
e) 
 
c) 
 
f) 
 
Figure 3.4 Individual data for LV diastolic function over the duration of the cycle 
challenge where a) E, b) A, c) E:A, d) E’, e) A’ and f) E’:A’. The shaded area represents 
the normal reference values of an apparently healthy population (Lang et al. 2015, 
Nagueh et al. 2016). 
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3.3.2 Cardiac Biomarkers 
No detectable cTnI was present in serum samples taken PRE-challenge, but cTnI was 
elevated above the detection limit in two cyclists following day 1 (Figure 3.5). Cyclist 1 
displayed a double response with further detectable values on day 3 and a peak on day 4 
(0.04 µg.L-1). No detectable cTnI was reported on day 2 and day 6 to post, returning to 
undetectable values by day 6. Cyclist 2 had a peak cTnI on day 1 (0.027 µg.L-1) which 
decreased to undetectable levels from day 3 onwards. Cyclist 3 had no detectable values 
across all time points.  
 
 
Figure 3.5 Individual data for cTnI over the duration of the cycle challenge (zero values 
denote that sample values did not reach detectable levels for the assay). The shaded area 
represents the 99th percentile of an apparently healthy population (≤ 0.04 µg.L-1; 
Uettwiller-Geiger et al., 2002). 
 
Data for NT-proBNP were below the upper reference limit for a healthy population for 
all cyclists PRE-challenge. An increase in NT-proBNP to a peak value, above the upper 
reference limit over the first few days was followed by a decline over the course of the 
challenge in all cyclists (Figure 3.6). Some between and within cyclist variation was 
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present, with peak values occurring on different days. All values returned to near baseline 
levels, and below the upper reference limit 22 hours POST-challenge. 
 
 
Figure 3.6 Individual data for NT-proBNP over the duration of the cycle challenge. The 
shaded area represents the upper reference limit of an apparently healthy population (125 
ng.L-1; Silver et al., 2004). 
 
3.4 Discussion 
The results of this study extend the understanding of the consequences of prolonged and 
cumulative exercise by presenting the effects of 10 days cycling, in less trained 
individuals, on cardiac function and cardiac biomarker release. Our findings indicate that 
LV systolic and diastolic functions were depressed in some cyclists across the cycle 
challenge, although this was highly variable both between and within cyclists, with a 
general lack of a cumulative effect. Some aspects of systolic and diastolic function had 
not returned to PRE-challenge levels after 22 hours of rest POST-challenge. Cardiac 
biomarkers were elevated above detection levels and in some cases above the upper 
reference limits, showing a marked heterogeneity between cyclists and cycle days. There 
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was no consistent evidence of cTnI accumulation for any cyclist, whilst NT-proBNP 
displayed evidence of an accumulation in the earlier days of the challenge. 
 
The exercise duration and % HRmax represent a significant physiological stress placed 
upon the human heart. Despite this, all cyclists completed the challenge, and with a BM 
loss of less than 2% prior to each days exercise, it is suggested that cyclists remained 
relatively well hydrated throughout the challenge. The % HRmax during each stage is of 
a similar intensity observed in other multi-day cycling activities (Williams et al., 2009). 
The slight drop in % HRmax during multi-day endurance activities has been reported by 
other authors (Lucas et al., 2008; Williams et al., 2009) and is suggestive of a likely 
cumulative musculoskeletal and/or central fatigue (Halson et al., 2002). 
 
3.4.1 LV Systolic Function 
Changes in systolic function were apparent across cyclists, most notably by a reduction 
in EF. An absolute decrease in EF of up to 12% compared to PRE-challenge levels is 
marginally below what would be expected as a clinically significant change. The current 
study, alongside those by Shave et al. (2002b) and Williams et al. (2009), have 
demonstrated much larger changes in EF (9-12%), following less intense (55-72% 
HRmax) but longer duration exercise (> 7 hours) thus presenting a greater volume of 
stress on the heart. This may offer some support that the duration-dependent threshold for 
single bouts of prolonged exercise (Shave et al., 2004; Whyte et al., 2000) may also exist 
for exercise induced changes in systolic function during multi-day exercise. Furthermore, 
a meta-analysis by Middleton et al. (2006a) suggested training status as an important 
variable related to changes in systolic function, which may also be reflected in the large 
change in EF in the current study. Although the findings focused on moderate duration 
exercise, a training-induced cardioprotective adaptation was suggested. 
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The lack of evidence for a cumulative decrease in systolic function of both global (EF) 
and segmental (S’) measures is in agreement with Williams et al. (2009) and contrasts 
work by Middleton et al. (2007b). These differences are suggested to be attributed to 
several reasons, including: a) a recovery of LV systolic function in the short time period 
between consecutive days cycling; b) exercise duration and total cardiac work preclude 
an accumulation of cardiac fatigue; or, c) a combination of these factors (Williams et al., 
2009). Whilst the lack of accumulation suggests LV systolic function recovers, if only 
partially, very quickly between exercise bouts, we do not know the exact recovery time 
course of systolic function. In the present study, some aspects of systolic function were 
depressed 22 hours after exercise cessation, however, due to time constraints; it was not 
possible to determine when systolic function returned to PRE-challenge levels. The 
clinical significance of a reduction in systolic function is yet to be elucidated; however, 
it is important to note that the EF of all cyclists dropped below the lower limit for normal 
LV systolic function (52%; Lang et al., 2015) on at least one occasion. Similar exercise 
HR’s across each day, suggest alterations in EF did not seem to impact upon exercise 
performance, however, further investigation is warranted. 
 
The causes of the reduction in EF, an often widely used measure of LV contractility 
(Konstam and Abboud, 2017), are not fully understood, however, individual responses 
displayed two clear patterns. A drop in preload (LVEDV) and small increase in HR 
resulted in an increase in contractility (SBP/LVESV) in an attempt to maintain EF and 
SV in cyclists 1 and 2. Changes in EF were not always mimicked by changes in S’ 
(Dawson et al., 2008; Neilan et al., 2006b), likely due to the localised nature of this 
measure. Despite loading values returning towards PRE-challenge values 22 hours post 
exercise, values for EF and SV remained below PRE-challenge for these cyclists. 
Therefore, changes in loading may not fully explain the changes observed in global 
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measures of systolic function. Cyclist 3 demonstrated a maintained LVEDV despite an 
elevated HR, with a slow increase in LVESV without any large changes in afterload (BP), 
suggest loading time and volume had minimal impact upon this cyclist. These changes 
are associated with quite sporadic changes in EF compared to baseline levels. A reduction 
in LV contractility (SBP/LVESV) may largely explain changes in EF, with some 
increases in S’ coinciding with an increase in EF towards PRE-challenge values. Myocyte 
damage (Neilan et al., 2006b) and β-andrenergic receptor downregulation (Hart et al., 
2006) have been previously proposed as intrinsic, non-load related mechanisms behind 
changes in systolic function. Within the present study, the cyclist-to-cyclist and day-to-
day variability in biomarkers of cardiomyocyte damage (cTnI) and cardiac stress reduces 
the probability of a link between the two factors. An accumulation of circulating 
catecholamines during prolonged exercise (Seals et al., 1988) may result in a 
downregulation of β-andrenergic receptors but we cannot confirm that in the present 
study. 
 
3.4.2 LV Diastolic Function 
Highly variable post-exercise changes in E, E’, A and A’ resulted in a consistent reduction 
in E:A and E’:A’ for all cyclists at the majority of time points. For the majority of 
parameters and cyclists, the change in LV diastolic function were similar to LV systolic 
function in that progressive changes were not apparent although in cyclist 1, E’:A’ 
displayed a somewhat cumulative decrease until day 6. Similar to systolic function, 
diastolic filling parameters can be affected by changes in preload and HR (Prasad et al., 
2007). Whilst some changes in HR and LVEDV were observed alongside minimal 
changes in BM, it is unlikely that alterations in preload and HR can explain all of the 
differences in diastolic parameters. Typically LV diastolic dysfunction displays three 
clear progressive patterns of abnormal LV filling; 1) impaired relaxation: whereby a 
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reduced early diastolic filling and increased late diastolic filling results in a reduced E:A; 
2) pseudonormalization: an increased left atrial pressure augments the early diastolic 
filling phase; and 3) restrictive filling patterns: further increases in left atrial pressure 
restrict almost all LV filling to the early phase of diastole (Dokainish 2015; Nair et al., 
2000). Whilst cyclists 2 and 3 display changes that are likely to represent an intrinsic 
impairment in LV relaxation and/or compliance, cyclist 1 presented a somewhat different 
response. An increase in left atrial pressure (E:E’), coupled with an increased E and A, is 
suggestive of pseudo-normalization, a more progressive stage of diastolic dysfunction 
(Nair et al., 2000). Middleton et al. (2007b) reported a return to normal diastolic function 
between bouts of running. It may, therefore, be suggested that the severity of diastolic 
dysfunction could well influence the recovery pattern and thus explain the cumulative 
nature of diastolic dysfunction in cyclist 3. In addition, both E:A and E’:A’ did not fully 
recover 22 hours after exercise cessation. Whilst E:A was reduced at the majority of time 
points across cyclists, to a greater degree of what would be considered technical or 
participant variability, it did not decrease below the clinical cut-off for diastolic 
dysfunction (less than 1.0; Lang et al., 2015). Alterations in diastolic parameters did not 
seem to impact upon exercise performance, suggestive of limited clinical significance. 
 
3.4.3 Cardiac Biomarkers 
No detectable cTnI was present in serum samples taken PRE-challenge and is likely 
explained by the training status and smaller training load of the participants. Increases in 
cTnI displayed a clear heterogeneity in the individual response, given that cyclist 1 
displayed a biphasic response, whilst cyclist 3 demonstrated no elevations across the 
challenge. It is unclear why cyclist 1 displayed the most detectable samples of cTnI across 
the challenge; however, this cyclist also demonstrated a clear diastolic dysfunction. The 
relatively consistent changes in systolic and diastolic function alongside the marked 
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individual variability in cTnI release that is seen in other multi-day studies (Middleton et 
al., 2007b; Williams et al., 2009) supports two separate phenomenon with potential 
different mechanisms. The mechanism(s) behind exercise-induced cTn release remain 
unclear, however, a release of unbound cTn from the cytosol during periods of membrane 
stress or inflammation may occur (Scherr et al., 2011). Compared to rest, the increased 
contraction rate of the myocytes and afterload pressures would result in a greater 
myocardial wall stress and inflammation, provoking a release of cTn from the myocyte 
(Serrano Ostariz et al., 2009). Whilst not measured in this study, a positive relationship 
between pro-inflammatory cytokines and increases in cardiac biomarkers has been 
previously reported (La Gerche et al., 2015; Stewart et al., 2016) highlighting the link 
between inflammation and cTn release post-exercise. The lower concentration of cTnI 
release within the present study is likely representative of the low exercise intensity (59-
72% HRmax), which has previously been linked to lower concentrations of cTn release 
(Stewart et al., 2016). All cTnI values remained below the upper reference limit of a 
healthy population, which combined with the absence of any clinical signs and symptoms 
of an adverse cardiovascular event, the elevations in cTnI are more likely to represent an 
acute physiologic perturbation, as opposed to underlying cardiac damage or pathology 
(Shave et al., 2010). 
 
In contrast to cTnI, NT-proBNP demonstrated a progressive increase during each 
successive exercise bout at the start of the challenge, followed by a decline over the 
remaining days of the challenge in all cyclists. Cyclist to cyclist variation was present, 
with peak values occurring on different days. NT-proBNP levels above the 125 ng.L-1 
upper reference limit of an apparently healthy population were apparent, which in a 
clinical setting would be representative of LV dysfunction (Shave et al., 2007). The 
changes in the current study more likely represent an increased cardiovascular work, 
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supported by the fact NT-proBNP concentrations were reduced below the clinical cut-off 
value following 22 hours of recovery, a finding supported by other multi-day studies 
(Williams et al., 2009). 
 
3.4.4 Limitations 
Some research design and technical limitations in the present study are acknowledged. 
Firstly, it was not possible to collect echocardiograms and venous blood samples prior to 
each cycling day, nor were any samples taken following 30 minutes of exercise cessation 
each day. This was due to a reluctance of participants and time constraints. Whilst the 
limited blood samples may have missed transient elevations in biomarkers that could have 
been seen with more frequent sampling post-exercise, it is not believed this has impacted 
upon the main findings within the present data. It must also be acknowledged that cardiac 
biomarker concentrations were not corrected for plasma volume changes.  
 
3.5 Conclusion 
Ten days of repetitive prolonged cycling in less trained individuals produced evidence of 
LV systolic and diastolic dysfunction that could be mediated by changes in loading and/or 
intrinsic factors. There was limited support for a cumulative change in both systolic and 
diastolic function, however, LV function was still reduced 22 hours into recovery from 
the event. Any clinical and performance implications related to these changes are, at 
present, unclear.  
 
A variable release in cTnI and NT-proBNP was observed between individuals and across 
days. The rapid clearance in these biomarkers after recovery suggest limited clinical 
relevance in this data. Whilst the present findings add to the limited number of studies 
focusing upon the cardiovascular consequences of multi-day exercise, the exercise factors 
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that may contribute to these phenomenon are less clear. Environmental conditions varied 
across the 10 days and limited attention has been given to factors such as temperature or 
thermal load on the athletes, which may augment the cardiovascular load and stress 
response to exercise. This in turn may mediate the impact of prolonged exercise upon 
cardiac function and biomarker appearance. Therefore, the next Chapter will investigate 
the effect of single and multi-day prolonged running upon cardiac function and markers 
of cardiac damage when performed in a high temperature environment. 
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CHAPTER 4 
Alterations in left ventricular function and cardiac 
biomarkers as a consequence of single and repetitive 
endurance running in the heat 
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This data was presented as abstracts at the following conferences: 
 
Hankey, J., Gill, S., Costa, R. J. S., Gregson, W., Whyte, G. and George, K.  
(2014) The impact of a 37 km foot race in hot ambient conditions upon cardiac function. 
European College of Sports Science; July, Amsterdam. 
 
Hankey, J., Gill, S., Costa, R. J. S., Gregson, W., Whyte, G. and George, K. (2013) The 
impact of a 230 km multi-stage ultra-marathon in hot ambient conditions upon cardiac 
function. British Association of Sport and Exercise Sciences Annual Conference; 
September, University of Central Lancashire, Preston. 
 
4.1 Introduction 
An increasing amount of evidence suggests that single or multi-day bouts of prolonged 
exercise results in alterations in LV systolic and diastolic function (Chapter 3; Middleton 
et al., 2006a; Oxborough et al., 2010), as well as the appearance of cardiac biomarkers 
during recovery (Chapter 3; Shave et al., 2007a; 2010). In the previous Chapter, the 
impact of 10 consecutive days cycling in recreational cyclists was studied. The results 
demonstrated alterations in LV function and evidence of biomarker release, with limited 
evidence for a cumulative effect in post exercise measures. Whilst we have added to the 
limited number of multi-day exercise studies, data interpretation was confounded due to 
data collection points being restricted to daily post-exercise measures, providing a partial 
rationale behind the research design for the subsequent study. Inter and intra-individual 
variability was apparent, highlighting the need for further research to describe and explain 
personal or exercise factors that may contribute to these phenomenon. 
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Others have highlighted that environmental factors associated with any exercise bout may 
mediate the cardiovascular response to exercise (Dawson et al., 2003) and this could, in 
theory, be extended to cardiac function during recovery and the appearance of 
biomarkers. When exercise is performed under heat stress, there are competing demands 
between blood flow to the skin to aid temperature regulation and blood flow to the active 
muscle to meet the metabolic demands of muscular activity (González-Alonso et al., 
2008). This will increase the overall demand on the cardiovascular system during exercise 
and may mediate greater changes in LV function or preclude an accumulation of cardiac 
fatigue/markers of cardiac damage, particularly with a short time period between 
consecutive days exercise. Limited attention has been given to single or multi-stage bouts 
of prolonged exercise in a hyperthermic environment (Chapter 2) and will be the focus of 
this Chapter. Observing the progression of changes in cardiac function and markers of 
cardiac damage pre and post exercise each day of a multi-stage running event will 
significantly add to our knowledge of the cardiovascular consequences of prolonged 
exercise in the heat.  
 
The aims of this study were to assess; (1) whether a single bout of prolonged strenuous 
running in a hot ambient environment resulted in a reduction in cardiac function and 
increased levels of biomarkers of cardiac damage, (2) whether five consecutive days of 
prolonged strenuous running in a hot ambient environment resulted in cumulative 
decrements in cardiac function and increments in levels of biomarkers of cardiac damage, 
and finally (3) what degree of day-to-day recovery in cardiac function and biomarkers 
will occur. It was hypothesised that changes in cardiac biomarkers (cTnI and NT-
proBNP) and function (EF and E:A) would be apparent after a single bout of exercise in 
the heat and that this phenomenon would present with evidence of accumulation of 
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changes with multi-day exercise in the heat, largely due to insufficient recovery between 
days.  
 
4.2 Method 
4.2.1 Participants and Study Design 
Thirty trained long distance runners (male n = 20, female n = 10) volunteered to take part 
in the study. All participants were healthy and free of known or early family history of 
cardiovascular disease, injury or illness and were not taking medications. Ethical approval 
was obtained from the University Ethics Committee before data collection. Before the 
study commenced, all participants provided written informed consent. The study was 
conducted during the 2011 Al Andalus Ultra Trail Race, during the second week in July, 
in the region of Loja, Spain. The multi-stage ultramarathon (MSUM) was conducted over 
5 stages (5 consecutive days), totalling a distance of 230 km (Table 4.1). Running stages 
commenced at 09.00 h and consisted of a variety of terrains; predominantly off-road trails 
and paths, but also including steep and narrow mountain passes, and occasional road 
section (Table 4.1). Weekly training mileage prior to the MSUM was self-reported to 
range from 20 to 200 km per week. The MSUM runners were “semi” self-sufficient, 
whereby participants planned and provided their own foods and beverages (except plain 
water). Participants were allowed to drink ad libitum during the run, with aid stations 
situated every 10 km along the route providing plain water, fruit (oranges and 
watermelon) and electrolyte supplementation.  
 
To address the aims of the study, two distinct data collection phases are reported. Phase 
1 examined cardiac function and markers of cardiac damage pre- and post-stage 1 of the 
MSUM. Phase 2 examined cardiac function and markers of cardiac damage, pre- and post 
each of the 5 stages of the MSUM. 
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Table 4.1 Details of each stages distance, altitude of ascent-descent range, maximum 
temperature and maximum relative humidity. 
Stage Distance 
(km) 
Altitude of 
ascent-
descent range 
(m) 
Ambient 
temperature 
(oC) 
Ambient 
relative 
humidity 
(%) 
Predominant course 
terrain 
1 37 503 to 1443 30 to 32 31 to 32 Off-road trails and 
paths, steep and 
narrow mountain 
passes. 
2 45 830 to 1338 30 to 34 32 to 33 Off-road trails and 
paths, steep and 
narrow mountain 
passes, and 
occasional road. 
3 40 689 to 1302 32 to 38 35 to 37 Off-road trails and 
occasional road. 
4 65 671 to 1152 32 to 40 31 to 33 Off-road trails and 
road. 
5 38 473 to 1065 37 to 40 37 to 40 Off-road trails and 
road. 
 
Phase 1 
Thirty trained long distance runners (male n = 20, female n = 10) were assessed (mean ± 
SD; age 41 ± 9 years, height 1.74 ± 0.08 m, BM 71.4 ± 9.6 kg). This phase employed a 
repeated measures design, with testing procedures taking place immediately prior to stage 
1 (PRE) and within 30 minutes of finishing stage 1 (POST). Identical echocardiographic 
examinations followed by venous blood-sampling procedures were conducted at each 
assessment point, along with BM. Due to time constraints, 15 participants completed PRE 
and POST-exercise echocardiographic examination, whilst blood-sampling procedures 
were carried out in 24 participants. 
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Phase 2 
Fourteen trained long distance runners (male n = 9, female n = 5, mean ± SD; age 42 ± 9 
years, height 1.75 ± 0.06 m, BM 70.8 ± 8.3 kg) were assessed in this phase which 
employed a repeated measures design, with testing procedures taking place immediately 
prior to (PRE) and immediately post (POST) each stage of the MSUM. Identical 
echocardiographic and venous blood-sampling procedures were conducted at each 
assessment point, along with BM. Due to time logistical constraints, 9 participants 
completed echocardiographic examinations, whilst blood-sampling procedures were 
carried out in 9 participants. 
 
4.2.2 Protocols 
Participants underwent a resting echocardiographic examination, as described in Section 
3.2.2, with corresponding measurement variability and critical cut-off limits.  
 
Whole blood samples were collected by venepuncture without venostasis from an 
antecubital vein using a 21G butterfly syringe into one K3EDTA vacutainer tube (6 ml, 
1.6 mgml-1of ethylenediaminetetraacetic acid; Becton Dickinson, Oxford, UK), and one 
plain vacutainer tube (4 ml, Becton Dickinson, Oxford, UK). Plasma volume (PV) 
changes were estimated from changes in haemoglobin and haematocrit (Dill & Costill, 
1974; Maughan et al., 2001) content of K3EDTA whole blood samples (100 µl) 
immediately after sample collection, by coulter counter method (Coulter Ac T diff, 
Beckman Coulter, Carnaxide, Portugal) as previously reported (Garrett et al., 2009, 
Garrett et al., 2011, Nielsen et al., 1993; Costa et al., 2012). Whole blood samples 
collected into plain vacutainer tubes were left to clot prior to centrifuging at 1500 g for 
10 minutes at 4˚C. Serum was aliquoted into eppendorfs and stored frozen, initially at -
20C during the MSUM competition before being transferred to -80C storage after 
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completion of the experimental procedure. Subsequent analysis of cTnI and NT-proBNP 
was completed (See Section 3.2.1).  Results of cTnI and NT-proBNP were corrected for 
percentage change in PV. 
 
BM was measured using calibrated digital floor scales (BF510, Omron Healthcare, Ukyo-
ku, Kyoto, Japan) on a hard surface. For practical reasons, throughout the entire study, 
participants were weighed with their race clothing and shoes on. Height was recorded 
PRE-stage 1 only by a wall mounted stadiometer. Stage duration was recorded daily by 
the race organisation team. 
 
4.2.3 Data Analysis 
Descriptive data are presented as mean ± SD and were supported by assessing the mean 
difference (mean diff) and 95% confidence interval [95% CI]. The Shapiro-Wilk test was 
applied to all data in order to assess for normal distribution. All statistical analyses were 
conducted using IBM SPSS Statistics 22 (IBM Corp., Armonk, NY, USA). An alpha level 
of p < 0.05 was considered statistically significant. Furthermore, effect size using Cohen’s 
d: defined as trivial, small (> 0.2), moderate (> 0.5) and large (> 0.8; Cohen, 1992) and 
partial eta squared ( 2P ): defined as small (> 0.01), moderate (> 0.06) and large (> 0.14), 
were calculated. Cardiac biomarkers were also compared to the upper reference limits of 
an apparently healthy population. cTnI were analysed descriptively because of the 
likelihood of undetectable PRE-exercise values. 
 
Phase 1 
All PRE-POST exercise variables, excluding cTnI, were analysed using Student’s paired 
t-tests. The delta change in cardiac biomarkers were correlated to all variables. 
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Phase 2 
All PRE-stage and POST-stage exercise variables, excluding cTnI, were analysed using 
a Two-way (Time (PRE-POST) x Stage) repeated-measures ANOVA. Sphericity was 
analysed by Mauchly’s test of sphericity followed by Greenhouse-Geisser adjustment 
where appropriate. Where any differences were identified, pairwise post hoc comparisons 
with a Bonferroni correction were used in order to show where they lay. The change in 
PRE to POST PV was analysed using a One-way repeated-measures ANOVA. Due to 
only 4 participants completing both echocardiographic and blood sample evaluation, 
markers of cardiac damage were not correlated with cardiac function. 
 
4.3 Results 
4.3.1 Phase 1 
All 30 participants completed the stage (completion time 292 ± 39 min, average running 
speed 7.54 ± 1.12 km.hr-1). BM was significantly reduced (mean diff = -1.9; t(14) = 8.148, 
p < 0.001; 95% CI -2.4, -1.5]; d = 0.28) from 72.0 ± 9.6 kg to 70.1 ± 9.1 kg POST-
exercise, a 2.6 ± 1.7% change. A variable reduction in PV of -4 ± 11% [95% CI -26, 19] 
was also observed. 
 
4.3.1.1 Echocardiographic Data 
4.3.1.1.1 Loading 
LVEDV was unchanged POST exercise, whilst HR demonstrated a large increase (mean 
diff = 23; t(14) = -7.357, p < 0.001; 95% CI [16, 30]; d = 2.70) in all participants (Table 
4.2). BP was reduced in all participants from PRE to POST exercise for both SBP (mean 
diff = -26; t(14) = 6.684, p < 0.001; 95% CI [-34, -18]; d = 2.71) and DBP (mean diff = -
9; t(14) = 5.771, p < 0.001; 95% CI [-13, -6]; d = 1.99; Table 4.2). The E:E’ ratio was 
reduced post-exercise (mean diff = -1; t(14) = 2.443, p = 0.028; 95% CI [0, 2]; d = 0.87), 
however, there was some variation in the individual responses (Table 4.2). 
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Table 4.2 LV loading before (PRE) and after (POST) exercise (n = 15, mean ± SD). 
 PRE POST p-value 
LVEDV (ml) 149 ± 23 139 ± 21 0.100 
HR (beats.min-1) 60 ± 11 83 ± 12 < 0.001 
SBP (mmHg) 141 ± 13 115 ± 12 < 0.001 
DBP (mmHg) 81 ± 7 71 ± 6 < 0.001 
E/E’ 7 ± 2 6 ± 1 0.028 
 
LVEDV: left ventricular end diastolic volume, HR: heart rate, SBP: systolic blood pressure, DBP: diastolic 
blood pressure, E/E’: peak early trans-mitral flow/peak early myocardial tissue velocity 
 
 
4.3.1.1.2 LV Systolic Function 
A large significant reduction in EF (mean diff = -9; t(14) = 4.617, p < 0.001; 95% CI [-11, 
-4]; d = 1.53) and SV (mean diff = -17; t(14) = 5.360, p < 0.001; 95% CI [-21, -9]; d = 
1.26) was observed from PRE-POST exercise (Figure 4.1 a and b, respectively). 
SBP/LVESV was decreased to a large extent POST compared to PRE (mean diff = -0.63; 
t(14) = 4.641, p < 0.001; 95% CI [-0.85, -0.31]; d = 1.55; Figure 4.1c), whilst S’ was 
unchanged post-exercise (Figure 4.1d). 
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a) 
 
c) 
 
b) 
 
d) 
 
Figure 4.1 A comparison of LV systolic function showing PRE and POST-exercise values 
(individual and mean ± SD) where, a) EF, b) SV, c) SBP/LVESV and d) S’. Significant 
change from PRE to POST-exercise, * p < 0.001 (n = 15). 
 
4.3.1.1.3 LV Diastolic Function 
Peak E was largely reduced from PRE-POST exercise (mean diff = -20; t(14) = 11.759, p 
< 0.001; 95% CI [-23, -16]; d = 2.45: Figure 4.2a). There was no change in peak A which 
resulted in a large drop in E:A (mean diff = -0.42; t(14) = 6.827, p < 0.001; 95% CI [-0.55,-
0.29]; d = 1.84; Figures 4.2b and c, respectively). Peak E’ demonstrated a large reduction 
PRE-POST exercise (mean diff = 2; t(14) = 2.188, p = 0.046; 95% CI [0, 3]; d = 0.84; 
Figure 4.2d). Peak A’ was unchanged contributing to no change in E’:A’ (Figures 4.2e 
and f, respectively). 
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a) 
 
d) 
 
b) 
 
e) 
 
c) 
 
f) 
 
Figure 4.2 A comparison of LV diastolic function showing PRE and POST-exercise 
values (individual and mean ± SD) where, a) E, b) A, c) E:A, d) E’, e) A’ and f) E’:A’. 
Significant increase from PRE to POST-exercise, * p < 0.001; # p < 0.05 (n = 15). 
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4.3.1.2 Cardiac Biomarkers 
PRE-exercise, 10 participants demonstrated cTnI values above the detection limit, with 1 
participant above the upper reference limit of a healthy population (Figure 4.4). Following 
exercise, 13 participants demonstrated an elevation in cTnI, 3 of which were above the 
upper reference limit. Data for NT-proBNP were above the upper reference limit for a 
healthy population in 19 participants PRE-exercise (Figure 4.5). Although moderately 
changed, there was no statistically significant change POST-exercise. 19 participants 
demonstrated an increase in NT-proBNP concentration. Two participants remained below 
the upper reference limit, whilst 3 participants showed a reduction in concentration below 
this threshold. 
 
 
Figure 4.4 Individual participant data for cTnI PRE and POST exercise (zero values 
denote that sample values did not reach detectable levels for the assay). The dotted line 
represents the 99th percentile of an apparently healthy population (≤ 0.04 µg.L-1; 
Uettwiller-Geiger et al., 2002; n = 24). 
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Figure 4.5 Individual participant data for NT-proBNP PRE and POST exercise. The 
dotted line represents the upper reference limit of an apparently healthy population (125 
ng.L-1; Silver et al., 2004; n = 24). 
 
4.3.2 Phase 2 
All 14 participants completed the entire MSUM in a total time of 1672 ± 238 min and 
overall average running speed of 8.3 ± 1.2 km.hr-1 (Table 4.4 for exercise duration and 
average running speed for each stage). BM was not changed across stages but 
demonstrated a large effect over time (mean diff = -1.5; F(1,13) = 27.960, p < 0.001; 95% 
CI [-2.1, -0.9]; 2P  = 0.68), whereby BM decreased POST-exercise (Figure 4.6). % change 
in BM exceeded 2% at each stage (Table 4.4). Changes in PV PRE to POST were small 
with mean PV changes across stages ranging -6.2 ± 7.0% to 3.0 ± 6.2% (Table 4.4). 
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Table 4.4 Details of each stages exercise duration, average running speed, POST stage % 
BM loss and % PV change compared to PRE-stage one 
Stage Exercise 
Duration (mins) 
Average running 
speed (km.hr-1) 
POST stage %  
BM loss 
compared to 
PRE-stage one 
POST stage %  
PV change 
compared to 
PRE-stage one 
1 267 ± 35 8.4 ± 1.1 2.6 ± 1.9 -4.9 ± 14.3 
2 422 ± 71 6.6 ± 1.1 2.2 ± 4.8 -4.3 ± 6.9 
3 291 ± 47 8.5 ± 1.4 2.9 ± 2.1 -1.7 ± 9.5 
4 418 ± 61 9.5 ± 1.4 3.7 ± 2.0 3.0 ± 6.2 
5 275 ± 37 8.4 ± 1.2 3.4 ± 2.0 -6.2 ± 7.0 
 
 
Figure 4.6 A comparison of measures of BM (kg) showing PRE and POST-exercise 
values on 5 consecutive stages (mean ± SD; The dotted line represents the mean BM PRE 
stage 1; n = 14). 
 
4.3.2.1 Echocardiographic Data 
4.3.2.1.1 Loading 
LVEDV demonstrated a small insignificant interaction between stage and time, with no 
effect noted for time. A large significant effect was apparent across stages (F(4,32) = 4.564, 
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p = 0.005; 2P  = 0.36), with post-hoc analysis revealing stage 3 to be lower than stage 5 
(mean diff = -15; p = 0.005; 95% CI [-26, -5]; Table 4.5). HR showed an insignificant 
large interaction between condition and time, as well as in insignificant moderate effect 
between stages. However, HR was increased POST compared to PRE (mean diff = 19; 
F(1,8) = 83.654, p < 0.001; 95% CI [14, 23]; 
2
P
  = 0.91; Table 4.5). A large significant 
interaction between stage and time was displayed for SBP (F(4,32) = 6.519, p = 0.001; 
2
P
  
= 0.45; Table 4.5), with significant reductions POST following stages 1 (mean diff = -27; 
p = 0.001; 95% CI [-40, -15]), 4 (mean diff = -18; p = 0.001; 95% CI [-27, -10]) and 5 
(mean diff = -9; p = 0.001; 95% CI [-14, -5]). DBP demonstrated a large insignificant 
interaction between stage and time, whilst there was a large but insignificant effect for 
stage, a large significant decrease POST compared to PRE occurred (mean diff = -6; F(1,8) 
= 8.780, p = 0.018; 95% CI [-10, -1]; 2P  = 0.52; Table 4.5). Similarly, a moderate 
insignificant interaction was observed between stage and time for E:E’, with an 
insignificant large effect across stages and a large significant reduction POST compared 
to PRE (mean diff = -1; F(1,8) = 22.775, p = 0.001; 95% CI [-1, 0]; 
2
P
  = 0.74; Table 4.5). 
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Table 4.5 LV loading before (PRE) and after (POST) exercise for each stage of the MSUM (n = 9, mean ± SD). 
 Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 
Variable PRE POST PRE POST PRE POST PRE POST PRE POST 
LVEDV (ml) 144±25 137±23$ 143±13 133±21 135±17* 130±12* 146±12 141±18$ 152±14 144±20$ 
HR (beats.min-1) 58±8 83±13 67±14 89±17 70±24 82±8 73±31 87±31 63±6 82±10 
SBP (mmHg) 141±14 114±13 125±14 119±12 127±11 124±12 137±13 119±10 128±11 119±9 
DBP (mmHg) 79±7 70±4 75±9 71±5 73±7 72±7 82±7 73±5 75±8 70±6 
E/E’ 6±2 6±1 6±1 6±2 7±1 6±1 7±1 6±1 7±1 6±2 
 
LVEDV: left ventricular end diastolic volume, HR: heart rate, SBP: systolic blood pressure, DBP: diastolic blood pressure, E/E’: peak early trans-mitral flow/peak early myocardial 
tissue velocity. * Significantly different compared to stage 5, p < 0.05. $ Significantly different POST compared to PRE. 
 
121 
 
4.3.2.1.2 LV Systolic Function 
A large significant interaction between stages and time was displayed for EF (F(4,32) = 
2.688, p = 0.049; 2P  = 0.25), with a significant reduction POST stage 1 (mean diff = -10; 
p = 0.005; 95% CI [-16, -4] and a post-hoc power analysis of 0.7. A large effect was 
observed across stages (F(4,32) = 3.609, p = 0.015; 
2
P
  = 0.31), with post-hoc analysis 
revealing stage 3 to be higher than stage 5 (p = 0.016; 95% CI [0.87, 8.94]). A large effect 
of time was also noted with a decrease POST compared to PRE (F(1,8) = 9.265, p = 0.016; 
95% CI [1.36, 9.83]; 2P  = 0.54; Figure 4.7a). SV showed a large significant interaction 
between stage and time (F(4,32) = 5.601, p = 0.002; 
2
P
  = 0.41; Figure 4.7b) with a 
significant reduction POST stage 1 (mean diff = -17; p = 0.002; 95% CI [-26, -8]), stage 
2 (mean diff = -8; p = 0.019; 95% CI [-14, -2]), stage 3 (mean diff = -8; p = 0.017; 95% 
CI [-15, -2]) and stage 5 (mean diff = -20; p < 0.001; 95% CI [-28, -12]). An insignificant 
large interaction between stage and time was observed for SBP/LVESV. A large 
significant effect of stage was noted (F(1.865, 14.916) = 4.859, p = 0.026; 
2
P
  = 0.38), with 
post-hoc analysis revealing stage 5 to be lower than stage 3 (mean diff = -0.38; p = 0.009; 
95% CI [-0.67, -0.10]; Figure 4.7c). A large drop was noted POST-exercise (mean diff = 
-0.29; F(1,8) = 15.126, p = 0.005; 95% CI [-0.46, -0.12]; 
2
P
  = 0.65). A large significant 
interaction between stages and time for S’ (F(4,32) = 3.380, p = 0.020; 
2
P
  = 0.30; Figure 
4.7d) was noted with a significant reduction POST stage 2 (mean diff = -1; p = 0.025; 
95% CI [0, 2]. 
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a) 
 
c) 
 
b) 
 
d) 
 
 
Figure 4.7 A comparison of LV systolic function showing PRE and POST-exercise values 
on 5 consecutive stages (mean ± SD) where, a) EF, b) SV, c) SBP/LVESV and d) S’. * 
Significantly different compared to day 5, p < 0.05. $ Significantly different POST 
compared to PRE. (n = 9). 
 
4.3.2.1.3 LV Diastolic Function 
E demonstrated an insignificant trivial interaction between stage and time. A large 
significant effect for stage was observed (F(4,32) = 5.328, p = 0.002; 
2
P
  = 0.40), with post-
hoc analysis revealing stage 2 to be lower than stage 3 (mean diff = -8; p = 0.025; 95% 
CI [-14, -1] and stage 2 lower than stage 4 (mean diff = -11; p = 0.05; 95% CI [-23, 0]; 
Figure 4.8a). A significant large effect of time was also noted (mean diff = -18; F(1,8) = 
104.46, p < 0.001; 95% CI [-22, -14]; 2P  = 0.93), whereby E decreased POST-exercise. 
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An insignificant large interaction was between stage and time was found for A, which 
was also not altered by stage or time (Figure 4.8b). As a result, E:A showed an 
insignificant large interaction between stage and time. There was a large insignificant 
effect across stages but a large decline across time for E:A (mean diff = -0.50; F(1,8) = 
25.412, p = 0.001; 95% CI [-0.73, -0.27]; 2P  = 0.76; Figure 4.8c), with a post-hoc power 
analysis of 0.7. E’ demonstrated an insignificant small interaction between stage and time. 
No impact of stages was noted for E’, although E’ decreased to a large extent across time 
(mean diff = -2; F(1,8) = 17.157, p = 0.003; 95% CI [-3, -1]; 
2
P
  = 0.68; Figure 4.8d). An 
insignificant moderate interaction between stage and time was apparent for A’, with a 
moderate effect for stage but a large significant increase POST compared to PRE (mean 
diff = 1; F(1,8) = 9.380, p = 0.016; 95% CI [0, 3]; 
2
P
  = 0.54; Figure 4.8e). As a result, 
E’:A’ showed an insignificant moderate interaction between stage and time, with an 
insignificant moderate effect for stage but a large decrease POST-exercise (mean diff = -
0.36; F(1,8) = 12.106, p = 0.008; 95% CI [-0.60, -0.12]; 
2
P
  = 0.60; Figure 4.8f). 
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a) 
 
d) 
 
b) 
 
e) 
 
c) 
 
f) 
 
 
Figure 4.8 A comparison of LV diastolic function showing PRE and POST-exercise 
values on 5 consecutive stages (mean ± SD) where, a) E, b) A, c) E:A, d) E’, e) A’ and f) 
E’:A’. * Significantly different compared to day 2, p < 0.05 (n = 9). 
  
125 
 
4.3.2.2 Cardiac Biomarkers 
Two participants had detectable cTnI concentrations in serum samples taken PRE stage 
1, however, both of these were below the upper reference limit at this time point (Figure 
4.9). Three participants had no detectable concentrations across all time points, whilst 
two participants had detectable elevations POST stage 4, which also corresponds with the 
longest stage. Participant-to-participant variability was marked with peak values in 
participants R1, R3, R5, R6 and R9 all occurring at different time points. Data for NT-
proBNP was elevated above the upper reference limit for a healthy population in 6 
participants PRE stage 1. There was an insignificant moderate interaction between stage 
and time for NT-proBNP, with an insignificant large effect of stage and small effect of 
time (Figure 4.10).  
 
 
Figure 4.10 Individual participant data for cTnI on 5 consecutive stages (zero values 
denote that sample values did not reach detectable levels). Daily measures denoted by 
PRE (a) and POST-exercise (b). The dotted line represents the 99th percentile of an 
apparently healthy population (≤ 0.04 µg.L-1; Uettwiller-Geiger et al., 2002; n = 9). 
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Figure 4.11 A comparison of NT-proBNP showing PRE (a) and POST-exercise (b) values 
on 5 consecutive stages. The dotted line represents the upper reference limit of an 
apparently healthy population (125 ng.L-1; Silver et al., 2004; n = 9). 
 
4.4 Discussion 
The present study adds to the limited research related to the impact of a single bout of 
exercise in a hot environment as well as being the first research to examine the effect of 
multiple prolonged bouts of exercise in a hot environment upon cardiac function and 
markers of cardiac damage. Phase 1 of the present study indicated evidence of both 
systolic and diastolic functional change after 37 km running in hot ambient conditions. 
We also observed detectable or elevated levels of cardiac biomarkers PRE and/or POST 
exercise in all runners. Both data sets present with notable heterogeneity between 
participants. The findings of phase 2 indicate that systolic and diastolic functions were 
depressed POST exercise at different points across the MSUM, with a general lack of a 
cumulative effect of repeated bouts. Cardiac biomarkers were elevated above detection 
levels and in some cases above the upper reference limit but with a heterogeneity between 
runners. Again there was no evidence of an accumulative effect of exercise upon these 
biomarkers. 
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4.4.1 Phase 1 
The exercise duration, combined with the environmental stress, represents a significant 
challenge to the cardiovascular system. The decrease in BM was unrelated to all variables 
including the reduction in PV, with the change in BM likely due to metabolic factors such 
as substrate loss and muscle breakdown (Hoffman et al., 2018; Maughan et al., 2007) 
rather than intravascular fluid loss alone. 
 
To date this is the first study to report a statistical reduction in global measures of systolic 
function (EF and SV) following exercise of a near marathon distance. The maintenance 
of preload (LVEDV), combined with a reduced afterload (BP) suggests impairment of 
LV intrinsic contractility. This is also supported by a decrease in SBP/LVESV, commonly 
used as a load-independent marker of LV contractility. The changes in EF were not 
mimicked by a significant reduction in S’, likely due to the localised nature of S’. It is 
likely that the combination of exercise and thermal stress has placed the heart under 
greater workload stress that may have mediated a decline in systolic function POST-
exercise.  
 
We can only speculate how changes POST-exercise reflect the cardiovascular 
hemodynamics, and potential for “cardiac fatigue”, during exercise. During prolonged 
exercise, an enhanced cardiovascular drift (increased HR and reduced SV) has been 
consistently observed in hot environments compared to normothermic conditions (Rowell 
et al., 1966; Lafrenz et al., 2008), suggestive of a decrease in LV function when the need 
for thermoregulation is elevated. A tolerable sympathetic load/threshold has been 
suggested (Stewart et al., 2016), which if exceeded for prolonged periods of time could 
induce a desensitization or down regulation of cardiac β-andrenergic receptors (Banks et 
al., 2010; Oxborough et al., 2010) and autonomic responsiveness (Seiler et al., 2007) 
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leading to a reduced force of contraction. Whilst the exercise distance of the current study 
is shorter than a marathon distance, the duration of the exercise was much greater, which 
has previously been implicated in the aetiology of systolic dysfunction (Middleton et al., 
2006a; Oxborough et al., 2010). The added demands of the course alongside the increased 
environmental heat stress may also provide sufficient cardiac load to depress LV 
contractile function. Individual variation was also apparent with a maintenance or 
reduction in systolic function POST-exercise observed. 
 
The changes in diastolic function observed are consistent with previous studies of single 
day exercise of a similar distance or duration (George et al., 2004, 2005; Middleton et al., 
2006b; Mousavi et al., 2009; Oxborough et al., 2006; Whyte et al., 2005), but may in 
some part be impacted upon by the thermoregulatory effect on pre-load and HR, indicated 
by the reduction in left atrial driving pressure (E:E’). The decrease in early filling, with 
little or no compensation in late filling reflect an intrinsic alteration in LV pressure decay 
due to impaired relaxation/myocardial stiffening during diastole, compliance and atrial 
contractility (Middleton et al., 2006b). 
 
PRE-exercise, cTnI and NT-proBNP were elevated in some runners above the upper 
reference limit of a healthy population, which may partially be explained by the nature of 
the runners in the current field-based study with a large training load prior to the event 
and no control over athlete behaviour. POST-exercise, 13 participants demonstrated an 
elevation in cTnI, 3 of which were above the upper reference limit. The concentrations of 
cTnI were lower than those reported in some previous studies (Fortescue et al., 2007; 
George et al., 2005; Whyte et al., 2005), likely due to the longer exercise duration, and 
therefore, probable lower intensity/HR (Eijsvogels et al., 2015), due to cTn being released 
from the cytosol during periods of membrane stress or inflammation (Scherr et al., 2011). 
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POST-exercise, a highly variable change in NT-proBNP concentration was apparent. This 
may be due to the fact NT-proBNP is released in response to a hemodynamically stressed 
heart during prolonged exercise (Corsetti et al., 2012). It has been previously suggested 
the increase in NT-proBNP is associated with exercise duration (Serrano-Ostáriz et al., 
2011). Legaz-Arrese et al. (2011) further suggested the NT-proBNP release post-exercise 
is independent to exercise intensity once HR exceeds 100-120 beats.min-1, after which 
exercise duration exerts a bigger influence on NT-proBNP. Therefore, the higher HR 
induced by exercising in a hot environment (Rowell et al., 1966; Lafrenz et al., 2008) 
within the current study may not explain the changes in NT-proBNP observed. Baseline 
values for NT-proBNP can be influenced by age, gender, malnutrition, obesity, HR, 
volume overload, BP (Chen et al., 2008) and have been implicated in explaining the 
complex variations in exercise response (Legaz-Arrese et al., 2011). 
 
4.4.2 Phase 2 
The multiple stage race in the heat with prolonged stage duration represents a significant 
cardiovascular challenge. All runners completed the MSUM, with BM losses of greater 
than 2% following each stage compared to PRE stage 1. An increase in PV across the 
MSUM compared to PRE stage 1 suggests runners remained relatively well hydrated, 
therefore, the change in BM again is likely indicative of metabolic factors (Hoffman et 
al., 2018; Maughan et al., 2007) rather than fluid loss alone. 
 
Global measures of systolic function (EF and SV) were reduced POST-exercise compared 
to PRE across some but not all stages, with no support for a cumulative effect as partial 
recovery between exercise bouts was apparent. A tendency for LVEDV to decrease by 
stage 3 then increase above PRE stage 1 values by the final stage of the MSUM is difficult 
to explain but previous authors have demonstrated PV expansion following 4 or more 
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days of multistage exercise (Fellmann et al., 1999; Wirnitzer and Faulhaber, 2007). 
Alternatively, transient chamber dilation as a result of excessive prolonged ventricular 
overload in order to maintain cardiac output has previously been observed following 
marathon running (Trivax et al., 2010). Within the current study, if the observed increase 
in LVEDV was due to transient chamber dilation, a reduction in EF, SV and SBP:LVESV 
would follow a similar pattern to LVEVD. PRE-exercise levels of EF and SBP:LVESV 
at stage 5 were similar to PRE stage 1. Therefore, suggesting any changes in LVEDV are 
the cause of changes in PV and did not limit changes in systolic function, which are due 
to a reduced LV contractility, with no systolic accumulative effect being observed. The 
changes in EF and SV were not mimicked by changes in S’ data, a common finding due 
to its localised nature. 
 
A depression in E:A and E’:A’ POST compared to PRE-exercise across all stages was 
apparent, with no strong evidence of a cumulative effect. The changes observed at each 
POST stage assessment were similar to those observed in Phase 1. The significant drop 
in early diastolic filling and the E:A ratio POST-exercise each day suggests an increase 
in LV pressure during diastole and/or a drop in left atrial pressure (Nishimura and Tajik, 
1997). A lack of change in LVEDV PRE to POST-exercise along with increased LV 
pressure may result from a reduced compliance or impaired rate of LV relaxation (Scott 
and Warburton, 2008). In the earlier stages PRE-exercise, an increase in PV and E:E’, 
and concomitant increase in E with a decrease in LVEDV, may actually represent an 
impaired relaxation/myocardial stiffening of the LV during diastole as opposed to an 
increase in function. The changes in diastolic filling were not reflected by any changes 
across stages in myocardial tissue velocities, which are known to be less load-dependant 
than filling parameters (Gianakki et al., 2008). As previously noted, a decline in β-
andrenergic receptor sensitivity during prolonged exercise may exist (Banks et al., 2010; 
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Stewart et al., 2016), which may impair the rate of LV relaxation. Whilst there is evidence 
for a decrease in LV diastolic function during the MSUM, there is little support for a 
progressive decline in function as the MSUM progressed. 
 
Cardiac troponin I and NT-proBNP was elevated in some runners PRE stage 1, likely 
explained by the nature of the athletes in the current study with a large training load prior 
to the MSUM. Increases in cTnI across the stages were variable across runners and stages. 
In the present study, each stage varied in terrain, with some stages including steep and 
narrow mountain passes where running was not possible. Some runners also typically 
walk on uphill sections and run on downhill sections. Therefore, the walk/run nature of 
the event may have placed variable hemodynamic loading and stress on the cardiac 
muscle at irregular intervals, permitting periods of recovery in some runners (Denissen et 
al., 2012). As in-exercise HR data was not collected, this may only be speculated. This 
may also partially explain the varied response between runners, however, previous multi-
stage event have also shown to evidence a heterogeneous response between participants 
(Chapter 3; Williams et al., 2011). Transient elevations in cTnI were evident with 
elevated samples after one stage followed by an undetectable level at the next sample 
point. Therefore, it is more likely that elevated cTnI levels are representative of a 
physiological rather than a pathological response (Eijsvogels et al., 2011, 2015). 
However, we cannot speculate as to which mechanisms may explain elevated cTn levels 
in the current study. 
 
Variable NT-proBNP concentrations were observed whereby there were no significant 
changes PRE to POST-exercise or across stages. This may be explained by the high 
concentration within samples PRE stage 1, which may be a result of prior exercise or heat 
exposure. A high degree of inter- and intra-individual variation in NT-proBNP was 
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apparent, which are suggested to occur in response to an exercise-induced increase in 
end-diastolic ventricular pressure (Urhausen et al., 2004). Previous research has 
suggested those participants who covered less training distance per week demonstrated a 
greater elevation in NT-proBNP (Neilan et al., 2006a). A large difference in participant 
weekly training distance in the present study was apparent and could partially explain the 
inter-individual variation. A complex interaction of baseline (age, gender, volume 
overload, HR, BP; Chen et al., 2008), prior exercise (training history; Neilan et al., 2006a) 
and exercise-related factors (exercise duration; Serrano-Ostáriz et al., 2011) are suggested 
to explain the variability in detection levels (Legaz-Arrese et al., 2011). 
 
4.4.3 Implications 
In a few cases EF dropped below the lower limit for normal LV systolic function (52%; 
Lang et al., 2015) in phases 1 and 2, however, the change appeared to be transient as EF 
typically recovered partially, if not fully by the PRE-exercise measurement point each 
day. The E:A ratio was significantly reduced in phases 1 and 2, in some runners below 
the clinical cut-off for diastolic dysfunction (less than 1.0), but appearing to be transient 
in nature. Whilst both variables showed a significant physiological change, neither 
reached a level which would be classified as a clinical significant change (See Section 
3.2.2). Furthermore, neither were associated with any clinical signs and symptoms and 
did not appear to impact upon exercise performance. 
 
Within phases 1 and 2, runners displayed concentrations of cTn above the clinical cut-off 
value. As no runners reported any clinical signs and symptoms, again it is likely that 
elevated cTn levels represent a physiological rather than a pathological response 
(Eijsvogels et al., 2011, 2015). It is suggested an increased NT-proBNP during and after 
exercise is related to a growth-regulating property of BNP, leading to myocardial 
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adaptation in healthy athletes (Scharhag et al., 2006), rather than a sign of heart damage. 
Concentrations of NT-proBNP were increased above clinical cut-off values in phases 1 
and 2 of the present study, which would be suggestive of LV dysfunction in a clinical 
setting (Shave et al., 2007). The changes in NT-proBNP are more likely to represent the 
elevated cardiovascular work within each phase of this study. 
 
4.4.4 Limitations 
It is possible that some form of heat acclimatization may have occurred before or within 
the course of the MSUM, as it has previously been reported that 75-80% of the 
acclimation process occurs within the first 4-7 days of heat exposure (Périard et al., 2015; 
Shapiro et al., 1998). Heat acclimatization has been proven to increase submaximal 
exercise performance (Lorenzo et al., 2010) and enhance thermal comfort in the heat 
(Gonzalez and Gagge, 1976). Adaptations to the heat exposure include PV expansion, 
increased maintenance of fluid balance, enhanced sweating and cutaneous blood flow, 
thermal tolerance and a lower exercise metabolic rate (Horowitz 2014; Périard et al., 
2015). Acute PV expansion occurs following 3-4 days of heat exposure (Sawka and Coyle 
1999), with values reaching 3-27%, typically peaking around the fifth day of exercise-
heat acclimation (Périard et al., 2016). An increase in PV serves to support cardiovascular 
stability by enhancing vascular filling pressure and therefore increasing SV and BP 
(Périard et al., 2016). Whilst the increase in PV observed may have reduced the 
cardiovascular demand of the MSUM, it could be also be speculated that the enhanced 
PV may well mask the degree of cardiac dysfunction in the latter stages of the MSUM. 
Therefore, further research within this area is warranted. The reluctance of some runners 
to participate in the study resulted in phase 2 of the present study being slightly 
underpowered. 
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Time constraints led to a single POST-exercise assessment of function and cardiac 
biomarkers in both phases. It was, therefore, not possible to determine the time point in 
which LV systolic and diastolic function peaked or indeed returned to PRE stage 1 levels. 
It has also been previously reported by Middleton et al. (2008) that a time-dependant 
change in cTn exists, therefore, peak elevations in cTn may have also been missed. Due 
to the reluctance of participants, no in-exercise data relating to exercise intensity was 
obtained, which did not allow for a direct comparison to other studies in relation to the 
acute cardiovascular stress of the exercise bouts. Whilst collecting data in a field setting 
presents a real life stimulus, a lack of control over the exercise intensity (i.e. some runners 
using different pacing strategies than others) and environmental conditions made it more 
difficult to draw comparisons between stages and also other studies.  
 
4.5 Conclusion 
In summary, a single bout of prolonged exercise in a hot environment led to a decrease 
in LV systolic and diastolic function and an elevation in cardiac biomarkers. Whilst 5 
days of consecutive prolonged running produced evidence of a depression in LV systolic 
and diastolic function, there was limited support for any progressive accumulation in 
dysfunction.  
 
Across the 5 days individual changes in cTnI and NT-proBNP were sporadic, with limited 
support for an accumulation across the exercise exposure. The results also presented a 
high degree of individual variation between participant’s responses to the exercise 
stimulus in both phases of the study.  
 
Whilst the present findings add to the limited number of studies focusing upon the 
cardiovascular consequences of single and multi-day exercise with the additional stress 
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of a hyperthemic environment, the field-based setting did not allow for the control of 
other exercise-related parameters (e.g. pace etc.) or the adoption of a control trial. 
Consequently the real impact of the environmental factors upon the cardiovascular 
response to exercise require further study. Therefore, the next Chapter will investigate the 
effect of controlled, laboratory-based bouts of steady state exercise undertaken at 
different but controlled environmental temperatures upon cardiac function and markers 
of cardiac damage.  
  
136 
 
 
 
 
 
CHAPTER 5 
Left ventricular function and cardiac biomarker release after 
prolonged steady state exercise in laboratory controlled 
hyperthermic and normothermic environments. 
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5.1 Introduction 
In Chapter 4, a reduction in cardiac function was observed alongside elevations in cardiac 
biomarkers following single and multi-day exercise in the heat. As highlighted in Chapter 
4, this was the first study to report a reduction in global measures of systolic function (EF 
and SV) following exercise of a near marathon distance which may be attributed to an 
increased cardiovascular load compared to a normothermic environment. 
 
The nature of the study in Chapter 4 and previous field-based research has not allowed 
for a controlled approach to the determination of the impact of environmental strain on 
cardiac function. To the best of our knowledge only one lab-based, and thus controlled 
study, has investigated the impact of environmental temperature upon LV function and 
cardiac biomarker release. Shave et al. (2004c) provided preliminary evidence to suggest 
that ambient temperatures may play some part in exacerbating the post-exercise response 
of LV function and cardiac biomarker release but did not extend to warmer environmental 
conditions. To date, the effect of prolonged exercise, within a controlled normothermic 
and hyperthermic environment, upon LV function and cardiac biomarker release has not 
been studied and will be the focus of this study. Furthermore, the majority of the field-
based research has only looked at pre and post-event measurements of cardiac function 
and biomarkers. A controlled laboratory-based study allows for repeat assessments of LV 
function during recovery as well as multiple blood draws during exercise and again into 
recovery, a limitation of the previous two chapters.  
 
Whilst moderate intensity steady-state exercise of as little as 10 minutes requires an 
athlete to maintain a high cardiac workload to ensure adequate muscle perfusion (Dawson 
et al., 2003), exercise durations of 60 mins or greater places a substantial strain upon the 
cardiovascular system due to increased thermal load and blood volume 
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redistribution/reduction (Coyle and González-Alonso, 2001) and are common exercise 
durations in healthy individuals. Additionally, Lucía et al. (1999a) proposed that the 
effects of environmental strain may be more important than exercise duration in the 
development of functional changes post-exercise, consequently, a shorter duration of 
prolonged exercise will be considered within this study in comparison to previous 
Chapters. Therefore, the aim of this study was to examine the impact of prolonged 
exercise in a hyperthermic environment upon cardiac function (EF and E:A) and levels 
of biomarkers of cardiac damage (cTnI and NT-proBNP). It was hypothesized that 
exercise of the same duration (60 min) and the same running speed performed in a 
hyperthermic environment (30oC) will result in greater changes in LV function and more 
frequent appearance of cardiac biomarkers than exercise in a normothermic environment 
(13oC). 
 
5.2 Method 
5.2.1 Participants and Study Design 
In line with Shave et al. (2004b), eight male recreational athletes initially volunteered to 
take part in the study. All participants were healthy and free of known or early family 
history of cardiovascular disease, injury or illness and were not taking medications. 
Ethical approval was obtained from the Human Ethics Committee of Liverpool John 
Moores University prior to the start of data collection. Before the study commenced, all 
participants provided written informed consent. 
 
A preliminary laboratory session was used to determine the VO2PEAK of the athletes and 
to allow familiarization with the treadmill and all other equipment. In two subsequent 
laboratory sessions, participants completed identical 60 min runs (at 65% VO2PEAK) at 
two different ambient temperatures (conditions; 13oC [COOL] and 30oC [HEAT]) with 
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constant relative humidity (50%) in a randomised, counterbalanced crossover design. 
Trial 1 and 2 were separated by 3-7 days.  
 
Baseline assessment occurred 1 h prior to each trial (PRE). Post-trial assessments were 
then carried out immediately after run completion (POST) and then 1 (1 h POST) and 2 
h (2 h POST) into recovery. During PRE and post-trial testing measurements included; 
BM, HR, BP, echocardiographic imaging and venous blood sampling. A venous blood 
sample was also obtained after 30 min of each exercise trial. Tc, skin temperature (Tsk), 
HR, and rating of perceived exertion (RPE) were assessed every 10 min during the 60 
min trials. Fingertip blood samples for blood lactate (BLa) were obtained at rest and after 
30 and 60 min of each trial.  
 
5.2.2 Protocols 
VO2PEAK protocol and measurements: 
The VO2PEAK test and both 60 min trials were conducted upon a HP-Cosmos treadmill 
(Nussdorf-Traunstein, Germany). Each participant completed a 5 minute warm up at 8 
km.hr-1 before the online gas analysis equipment (Metamax, Cortex Biophysic GMbH, 
Leipzig, Germany) was then fitted, which had been calibrated before each participants 
test, using gases of known concentrations and volume by a 3 litre syringe. Each test was 
started at 9 km.hr-1 at a 0% gradient. In 2 min incremental stages, the speed was increased 
by 2 km.hr-1 until voluntary exhaustion. In the present study, VO2PEAK was recorded as 
the highest 30 second average during the test, and the corresponding treadmill running 
speed identified. 
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60 min run protocol and measurements: 
On the day of the each trial, participants arrived at the laboratory at least 3 h postprandial 
having refrained from alcohol, tobacco and caffeine consumption as well as exercise 
during the previous 24 h. All participants recorded dietary intake for 24 h prior to the 
initial experimental trial. This diet was then replicated before the subsequent experimental 
trial. A volume of 5 ml of water per kg BM (386 ± 29 ml) was consumed 2 h before 
arriving at the laboratory to achieve euhydration (Montain and Coyle, 1992). An 
additional 5 ml of water per kg BM was ingested during exercise to ensure similar 
hydration between trials. All trials were conducted at the same time of day in order to 
avoid the circadian variation in internal body temperature (Reilly and Brooks, 1986). 
During both trials participants were required to run at 65% of their measured VO2PEAK at 
a gradient of 0%. To provide an environment replicable to outdoor conditions whereby 
the movement of air aids convective and evaporative heat loss (Jones and Doust, 1996; 
Saunders et al., 2005), for both trials a fan was placed 2 metres in front of participants, 
with a wind speed relative to the participants running speed. 
 
On arrival at the laboratory, nude BM was recorded to the nearest 0.1 kg (model 875, 
Seca, Hamburg, Germany) and a rectal probe was inserted. SBP (a measure of afterload) 
and DBP was measured after 5 minutes rest in a supine position using a Dinamap 
automated BP monitor (Critikon Corporation, Tampa, USA). Each participant then 
underwent a resting echocardiographic examination, as described in Section 3.2.2. A 
venous cannula was inserted into the brachial vein and 5 ml of saline was flushed through 
the cannula to keep it patent each time a blood sample was drawn. Each 5 ml blood draw 
was made into a serum gel tube and the blood was left to clot. After being centrifuged 
serum was aliquoted and stored (–80°C) for subsequent analysis of cTnI and NT-proBNP. 
cTnI was measured using an ADVIA Centaur TnI-Ultra assay within the Elecsys 1010 
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automated batch analyser (Roche Diagnostics, Lewes, Sussex), with a sensitivity range 
of 0.006-50 µg.L-1. The assay coefficient of variation was 20% (functional sensitivity) at 
0.015 µg.L-1 and 10% at 0.03 µg.L-1. The upper reference limit (99th percentile) of an 
apparently healthy population is 0.04 µg.L-1 (Uettwiller-Geiger et al., 2002). NT-proBNP 
was determined using an Elecsys NT-proBNP electrochemiluminescent immunoassay 
(ECLIA) on the Roche Elecsys 1010 (Roche Diagnostics, Lewes, Sussex), with an 
analytical range of 5 – 35,000 ng.L-1and intra-assay and inter-assay imprecision of 0.7-
1.6% and 5.3-6.6%, respectively (Vidotto et al., 2005). NT-proBNP levels below the 
detection limit were recorded at the lower limit of 19 ng.L-1. The upper reference limit of 
an apparently healthy population is 125 ng.L-1 (Silver et al., 2004). 
 
Tc was measured using a rectal probe and data logger (1000 Series Squirrel Data Logger, 
Grant Instruments, Cambridge, UK). Skin temperature (Tsk) was also measured using the 
data logger and stainless steel mounted skin thermistors (EUS-U-VS5-0, Grant 
Instruments, UK) placed at four sites (sternum, forearm, thigh and calf) on the right side 
of the body using a single layer of waterproof tape. A mean weighted Tsk was then 
calculated using the method of Ramanathan (1964; See Equation 5.1). Heat storage was 
calculated from the equation employed by Havenith et al. (1995) whereby values were 
calculated from changes in Tc (∆Tc) and Tsk (∆Tsk) from resting values at 10, 20, 30, 40, 
50 and 60 min of exercise. Where Cb is the specific heat capacity of the body tissue (3.49 
J.g-1.oC-1; See Equation 5.2). A HR monitor (Polar A1, Polar Electro, Finland) was fitted 
and worn throughout the 60 min trials. RPE (Borg, 1970) was also measured during both 
trials. Two BLa measurements were drawn from the finger using the Lactate Pro (LT-
1710, Arkray Factory Inc, KDK Corp, Japan) and both values averaged. At the 30 min 
collection point, participants straddled the treadmill for blood samples and BLa measures 
to be taken. The difference in nude BM between PRE and POST-exercise, corrected for 
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the volume of fluid ingested and urine output was used to calculate exercise-induced BM 
loss. 
 
Equation 5.1 Mean weighted Tsk 
Tsk = (0.3 x sternum) + (0.3 x forearm) + (0.2 x thigh) + (0.2 x calf) 
 
Equation 5.2 Heat storage 
Heat Storage (J·g-1) = (0.8∆Tc + 0.2∆ Tsk) x Cb 
  
5.2.3 Data Analysis 
Descriptive data are presented as mean ± SD and were supported by assessing the mean 
difference (mean diff) and 95% confidence interval [95% CI]. The Shapiro-Wilk test was 
applied to all data in order to assess for normal distribution. All PRE and POST-exercise 
variables, excluding cTnI, were analysed using a Two-way (Condition: HEAT-COOL x 
Time: PRE, POST, 1 h POST, 2 h POST) repeated-measures ANOVA. Sphericity was 
analysed by Mauchly’s test of sphericity followed by Greenhouse-Geisser or Huynh-Feldt 
adjustment where appropriate. Where any differences were identified, pairwise post-hoc 
comparisons with a Bonferroni correction were used in order to show where they lay. The 
change in PRE to POST BM was analysed using a Student’s paired t-test. Cardiac 
troponins were analysed descriptively because of the likelihood of undetectable PRE-
exercise values. All statistical analyses were conducted using IBM SPSS Statistics 22 
(IBM Corp., Armonk, NY, USA). An alpha level of p < 0.05 was considered statistically 
significant. Furthermore, effect size using Cohen’s d and partial eta squared ( 2P ) were 
calculated, as described in Section 4.2.3. Cardiac biomarkers were also compared to the 
upper reference limits of an apparently healthy population. 
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5.3 Results 
Six male recreational athletes (mean ± SD; age 29 ± 7 years, height 1.84 ± 0.04 m, BM 
76.7 ± 6.0 kg and VO2PEAK 59.2 ± 3.5 mL.kg
-1.min-1) completed both trials, with two 
participants being withdrawn due to Tc reaching the safety cut-off criteria. A large 
difference in BM loss was observed between conditions (HEAT: 1.6 ± 0.3 kg, COOL 0.8 
± 0.2 kg; mean diff = -0.9; t(5) = 5.545, p = 0.003; 95% CI [-1.3, -0.5]; d = 2.26), with 
relative BM loss being significantly greater in the HEAT (2.1 ± 0.5%) compared to the 
COOL (1.0 ± 0.2%). A large interaction between condition and time for exercise HR was 
observed (F(2.450,12.252) = 775.723, p = 0.022; 
2
P
  = 0.50), whereby HR was significantly 
higher in the HEAT from 30 min onwards (Figure 5.1a). A large effect was seen across 
time (F(2.079,10.397) = 128.639, p < 0.001; 
2
P
  = 0.96) with 0 min being lower than all 
exercise time points (p < 0.001). An insignificant large interaction between condition and 
time for Tc was observed, however, Tc was significantly higher in the COOL at 20 mins 
only. An insignificant large effect was seen between conditions for Tc, whilst a large 
significant effect across time was observed (F(1.319,6.596) = 46.761, p < 0.001; 
2
P
  = 0.90) 
with post-hoc analysis revealing a progressive increase in Tc from 0 min onwards (Figure 
5.1b). A large interaction between condition and time was observed for Tsk (F(2.098,10.488) 
= 52.427, p < 0.001; 2P  = 0.83), whereby Tsk was higher in the HEAT from 10 min 
onwards, with both Tsk in both conditions reaching a steady-state level (Figure 5.1c). This 
was supported with a large effect for condition (mean diff = 6.62; F(1.000,5.000) = 545.350, 
p < 0.001; 95% CI [5.89, 7.35]; 2P  = 0.99), whereby HEAT was higher than COOL 
(Figure 5.1c), but no effect for time. Heat storage demonstrated no interaction between 
condition and time, with a large effect for condition (mean diff = 4; F(1.000,5.000) = 109.115, 
p < 0.001; 95% CI [4, 6]; 2P  = 0.96), whereby HEAT was higher than COOL. A large 
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effect for time was also seen (F(1.000,5.000) = 29.482, p = 0.001; 
2
P
  = 0.86) with post-hoc 
analysis revealing a progressive increase in heat storage from 20 min onwards (Figure 
5.1d). BLa demonstrated no significant interaction between condition and time, nor effect 
of condition or time (Figure 5.1e). A large significant interaction between condition and 
time was displayed for RPE (F(5,25) = 7.462, p < 0.001; 
2
P
  = 0.60), whereby HEAT was 
higher than COOL from 20 mins onwards (Figure 5.1f).  A large effect was observed for 
condition (F(1.000,5.000) = 9.853, p = 0.026; 95% CI [0.24, 2.38]; 
2
P
  = 0.66) with HEAT 
being higher than COOL (Figure 5.1f). A large effect for time was also demonstrated 
(F(1.588,7.940) = 13.944, p = 0.003; 
2
P
  = 0.74), however, post-hoc analysis revealed no 
differences within time points. 
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a)  
 
d) 
 
b) 
 
e) 
 
c) 
 
f) 
 
Figure 5.1 The mean ± SD of a) HR, b) Tc, c) Tsk, d) Heat Storage, e) BLa and f) RPE 
across assessment time points in both trials (n = 6). * Significantly different to 0, p < 0.05. 
# Significantly different to 10, p < 0.05. $ Significantly different to 20, p < 0.05. § 
Significantly different to 40, p < 0.05. ¥ Significantly different to 50, p < 0.05. 
€ Significantly different between HEAT and COOL.
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5.3.1 Echocardiographic Data 
5.3.1.1 Loading 
LVEDV showed a large insignificant interaction between condition and time, with a small 
insignificant effect for condition and time. HR showed a large insignificant interaction 
between condition and time. A large effect between conditions as well as across time 
(F(3,15) = 13.765, p < 0.001; 
2
P
  = 0.73) was observed, with post-hoc analysis revealing 
POST to be higher than PRE (mean diff = 19; p = 0.004; 95% CI [8, 30]; Table 5.1) and 
2 h POST (mean diff = 11; p = 0.043; 95% CI [0, 22]; Table 5.1). An insignificant large 
interaction between condition and time was observed for SBP. A large insignificant effect 
for condition but significant for time (F(3,15) = 4.287, p = 0.023; 
2
P
  = 0.46; Table 5.1) was 
displayed for SBP, with post-hoc analysis revealing no differences between time points. 
Similar data was apparent for DBP, where a moderate insignificant interaction between 
condition and time was shown, with an insignificant large effect for condition and time 
(Table 5.1). E:E’ showed an insignificant moderate interaction between condition and 
time, with an insignificant large effect for condition and a moderate effect for time also 
shown (Table 5.1). 
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Table 5.1 LV loading across assessment points in both conditions (n = 6, mean ± SD). 
 HEAT COOL 
Variable PRE POST 1 h POST 2 h POST PRE POST 1 h POST 2 h POST 
LVEDV (ml) 181±21 173±26 178±31 168±25 181±21 152±26 183±13 171±15 
HR (beats.min-1) 53±8 78±9 68±14 63±4 53±8 67±9 59±6 60±10 
SBP (mmHg) 122±6 118±6 118±7 120±11 122±6 114±4 114±5 118±5 
DBP (mmHg) 67±3 65±5 66±3 67±3 67±3 64±4 63±4 66±1 
E:E’ 6±2 6±1 6±1 6±2 6±2 6±1 6±1 6±1 
 
LVEDV: left ventricular end diastolic volume, HR: heart rate, SBP: systolic blood pressure, DBP: diastolic blood pressure, E:E’: peak early trans-mitral flow/peak early myocardial 
tissue velocity. PRE, POST, 1 h POST and 2 h POST: before, immediately after, and one hour and 2 hours after each run, respectively. 
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5.3.1.2 LV Systolic Function 
A large insignificant interaction was observed between condition and time for EF, with a 
post-hoc power analysis of 0.3. A large insignificant effect for condition was also 
observed. A significant large effect was displayed for time (F(3,15) = 3.102, p = 0.058; 
2
P
  
= 0.38) with post-hoc analysis revealing a reduction POST compared to PRE (mean diff 
= 6; p = 0.027; 95% CI [-11, -1]; Table 5.2). A tendency for POST exercise values to be 
lower during the HEAT condition was observed (Figure 5.2a). An insignificant moderate 
interaction between condition and time for SV was apparent as well as a small 
insignificant effect for condition. A large significant effect for time (F(3,15) = 3.953, p = 
0.029; 2P  = 0.44) was observed, however, post-hoc analysis revealed no significant 
comparisons (Table 5.2). Some individual variation was apparent, with some individuals 
demonstrating elevated levels POST, whilst others showed reduced values (Figure 5.2b). 
SBP/LVESV displayed a large insignificant interaction between condition and time. 
Small insignificant effects for condition as well as time (Table 5.2) were observed for 
SBP/LVESV, with a varied individual response (Figure 5.2c). S’ showed an insignificant 
large interaction between condition and time. A moderate insignificant effect for 
condition and a large insignificant effect for time was apparent for S’ (Table 5.2), with a 
small variation between participants (Figure 5.2d).
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Table 5.2 LV systolic function across assessment points in both conditions (n = 6, mean ± SD). 
 HEAT COOL 
Variable PRE POST 1 h POST 2 h POST PRE POST 1 h POST 2 h POST 
EF (%) 53 ± 3 44 ± 6 53 ± 5 48 ± 6 53 ± 3 50 ± 5 52 ± 4 50 ± 6 
SV (ml) 96 ± 14 77 ± 18 95 ± 18 80 ± 7 96 ± 14 77 ± 14 95 ± 6 86 ± 13 
SBP/LVESV 
(mmHg.ml-1) 
1.46 ± 0.15 1.26 ± 0.19 1.48 ± 0.30 1.43 ± 0.38 1.46 ± 0.15 1.56 ± 0.35 1.31 ± 0.16 1.41 ± 0.23 
S’ (cm.s-1)  8 ± 1 7 ± 1 8 ± 1 8 ± 1 8 ± 1 8 ± 1 8 ± 0 8 ± 1 
 
EF: ejection fraction, SV: stroke volume, SBP/LVESV: systolic blood pressure/left ventricular end systolic volume, S’: peak systolic myocardial tissue velocity. PRE, POST, 1 h POST 
and 2 h POST: before, immediately after, and one hour and 2 hours after each run, respectively. 
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a) 
 
c) 
 
b) 
 
d) 
 
Figure 5.2 Individual heterogeneity for LV systolic function across assessment points in 
both conditions where a) EF, b) SV, c) SBP/LVESV and d) S’ (n = 6). PRE, POST, 1 h 
POST and 2 h POST: before, immediately after, and one hour and 2 hours after each run, 
respectively. 
 
5.3.1.3 LV Diastolic Function 
E showed a large insignificant interaction between condition and time, with a small 
insignificant effect between conditions. A large insignificant effect for time was also 
observed (Table 5.3), with some variation between participants (Figure 5.3a). A moderate 
insignificant interaction between condition and time was demonstrated for A. A large 
insignificant effect for condition was seen for A, with a large insignificant effect for time 
(Table 5.3). Participants showed a much greater variation across time points, with some 
demonstrating large elevations, whilst others displayed large reductions (Figure 5.3b). As 
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a result, E:A showed a moderate insignificant interaction between condition and time, 
with a post-hoc power analysis of 0.1. A large insignificant effect for condition as well as 
time was observed (Table 5.3), with a varied response between participants was also 
shown for E:A (Figure 5.3c). E’ showed a large insignificant interaction between 
condition and time. An insignificant large effect for condition as well as a moderate 
insignificant effect for time was also seen for E’ (Table 5.3). Participants with a higher 
PRE value tended to show a larger reduction in E’ POST, whilst those with a lower E’ 
tended to show an increased or maintained E’ value POST (Figure 5.3d). A large 
insignificant interaction between condition and time was apparent for A’, with a small 
insignificant effect for condition.  A large insignificant effect for time for A’ was also 
observed , however, post-hoc analysis revealed POST to be significantly lower than 1 h 
POST (mean diff = 1; p = 0.013; 95% CI [-3, 0]; Table 5.3). A’ showed a varied response 
between the participants across time points (Figure 5.3d). As a result, E’:A’ showed a 
large insignificant interaction between condition and time. A large insignificant effect for 
condition as well as time was also seen for E’:A’ (Table 5.3), with some participants 
showing a small variation across time points, whereas others showed a much larger 
variation (Figure 5.3f).
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Table 5.3 LV diastolic function across assessment points in both conditions (n = 6, mean ± SD). 
 HEAT COOL 
Variable PRE POST 1 h POST 2 h POST PRE POST 1 h POST 2 h POST 
E (cm.s-1)  76 ± 7 66 ± 9 72 ± 5 72 ± 9 76 ± 7 71 ± 8 70 ± 7 70 ± 8 
A (cm.s-1) 44 ± 7 45 ± 11 52 ± 5 50 ± 6 44 ± 7 42 ± 9 45 ± 9 45 ± 8 
E:A 1.76 ± 0.29 1.56 ±0.43 1.41 ± 0.20 1.47 ± 0.23 1.74 ± 0.27 1.74 ± 0.34 1.65 ± 0.48 1.64 ± 0.48 
E’ (cm.s-1) 13 ± 4 11 ± 2 13 ± 3 12 ± 3 13 ± 4 13 ± 2 13 ± 3 13 ± 2 
A’ (cm.s-1) 7 ± 2 7 ± 1 8 ± 1 7 ±1 7 ± 2 6 ± 1 8 ± 1 7 ± 1 
E’:A’ 1.95 ± 0.64 1.73 ± 0.49 1.69 ± 1.42 1.67 ± 0.50 1.95 ± 0.64 2.26 ± 0.79 1.62 ± 0.45 1.73 ± 0.35 
 
E: peak early trans-mitral flow velocity, A: peak atrial filling velocity, E:A: early to late diastolic filling ratio, E’: peak early diastolic myocardial velocity, A’: peak late diastolic 
myocardial velocity, E’/A’: peak early to late myocardial tissue velocity ratio. PRE, POST, 1 h POST and 2 h POST: before, immediately after, and one hour and 2 hours after each 
run, respectively. 
 
153 
 
a) 
 
d) 
 
b) 
 
e) 
 
c) 
 
f) 
 
Figure 5.3 Individual heterogeneity for LV diastolic function across assessment points in 
both conditions where a) E, b) A, c) E:A, d) E’, e) A’ and f) E’:A’ (n = 6). PRE, POST, 
1 h POST and 2 h POST: before, immediately after, and one hour and 2 hours after each 
run, respectively. 
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5.3.2 Cardiac Biomarkers 
No detectable cTnI was present in serum samples taken PRE-exercise in both conditions 
(Figure 5.4). Within the HEAT condition, cTnI was elevated in runner 1 at 1 h POST 
(0.06 µg.L-1) and 2 h POST (0.11 µg.L-1), exceeding the upper reference limit, and in 
runner 6 at 2 h POST (0.03 µg.L-1). Participant 1 also displayed an elevation in cTnI 
within the COOL condition at 2 h POST (0.03 µg.L-1). All other participants had no 
detectable values across all time points in either condition. Data for NT-proBNP was 
below the upper reference limit for a healthy population for all runners PRE-exercise 
(Figure 5.5) and remained below this limit across all time points. A small insignificant 
interaction between condition and time was observed for NT-proBNP, with a large 
insignificant effect being observed for time. NT-proBNP showed a large significant effect 
for condition (mean diff = 6; F(1.000,5.000) = 11.085, p = 0.021; 95% CI [1.37, 10.63];
2
P
  = 
0.69), with higher levels being observed within the HEAT condition at with values 
ranging from 19.96-109.94 ng.L-1 compared to the COOL condition 19.96-106.56 ng.L-
1.  
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Figure 5.5 Individual data for cTnI across assessment points in both conditions. The 
dotted line represents the 99th percentile of an apparently healthy population (≤ 0.04 
µg.L-1; Uettwiller-Geiger et al., 2002; n = 2). 
 
 
Figure 5.6 Individual data for NT-proBNP across assessment points in both conditions (n 
= 6). 
 
5.4 Discussion 
The present study represents the first to compare exercise in a controlled hyperthermic 
and normothermic environment upon cardiac function and markers of cardiac damage, 
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one of the extraneous factors suggested to precipitate changes in ventricular function and 
biomarker appearance (Chapter 4; Gresslien and Agewall, 2016; Oxborough et al., 2010; 
Sedaghat-Hamedani et al., 2015). The key findings indicate that some measures of 
systolic function were reduced POST-exercise compared to PRE, with no consistent 
evidence of diastolic dysfunction. A tendency for a larger reduction in both systolic and 
diastolic function within the HEAT condition was apparent, with a marked heterogeneity 
between participants in response to both conditions and exercise time points. cTnI was 
elevated above detection levels in two participants POST-exercise within the HEAT and 
one participant POST-exercise within the COOL, again demonstrating heterogeneity 
between participants and conditions. There was no significant change in NT-proBNP 
across time points, however, values were significantly greater during the HEAT condition 
as opposed to the COOL condition. 
 
RPE was significantly higher within the HEAT trial likely reflecting a greater Tsk. The 
magnitude of cardiovascular drift was significantly greater during the HEAT condition, a 
common finding observed during exercise in hot environments compared to 
normothermic conditions (Rowell et al., 1966; Lafrenz et al., 2008). It is likely that a 
peripheral vasodilation (evidenced by the elevated Tsk), stimulated in an effort to dissipate 
heat within the HEAT condition, may have led to a reduction in central blood volume 
during exercise (Coyle and Gonzalez-Alonso, 2001). It is also likely that the rate of 
intravascular fluid loss through sweat production was also a confounding factor to the 
observed difference in cardiovascular drift as evidenced by the greater loss of BM during 
the HEAT trial compared to the COOL. A combination of blood volume redistribution 
and intravascular fluid loss encountered during the HEAT trial may have resulted in a 
reduction in venous return (Rowell et al., 1966, 1969), therefore, leading to an elevated 
HR in order to maintain cardiac output in the HEAT. Therefore, it is likely that the total 
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myocardial work performed during the HEAT trial would have been greater than that 
performed during the COOL. It cannot be disregarded, however, that the change in BM 
may also be due to metabolic factors such as substrate loss and muscle breakdown 
(Maughan et al., 2007).  Despite evidence of different cardiovascular stress in the HEAT 
and COOL trial we should acknowledge that similar BLa concentrations were observed 
between conditions despite a greater heat gain and BM loss (~2%) within the HEAT, 
suggestive that any change in blood flow to the working muscle may be minimal. 
Likewise, Tc was similar between both trials suggesting that the moderate exercise 
intensity allowed for a maintenance of exercise performance (completion of the exercise 
at the desired intensity) as well as temperature regulation. This is also supported by the 
similar rate of increase in heat storage between both conditions. 
 
5.4.1 LV Systolic Function 
Systolic function (EF) was significantly reduced POST-exercise compared to PRE in both 
conditions with a tendency for function to be lower within the HEAT condition. The 
average 5% reduction in EF POST within the COOL is likely attributed to participant and 
technical variability, however, the 16% reduction within the HEAT trial is greater than 
what would be expected from measurement variability. It is possible that the greater BM 
loss in the HEAT compared to the COOL may partially explain some of the changes in 
EF. It is also likely that the rate of fluid loss through sweat production, along with 
peripheral vasodilation within the HEAT may have led to a reduction in venous return 
and therefore, reduced LV preload. As a consequence, a significantly elevated exercise 
HR was observed within the HEAT in order to maintain cardiac output, resulting in a 
greater myocardial work performed within the HEAT through a greater sympathetic 
activity. It is suggested once a tolerable sympathetic load/threshold has been exceeded 
for a prolonged period of time, a desensitization or down regulation of cardiac β-
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andrenergic receptors (Banks et al., 2010; Oxborough et al., 2010) and autonomic 
responsiveness (Seiler et al., 2007) may occur. Whilst the duration of the current study 
may not be prolonged enough to exceed this threshold, it may explain the tendency for 
cardiac function to be reduced further within the HEAT in this study and in the previous 
Chapter. 
 
The changes in EF and SV were not mimicked by a significant reduction in S’, likely due 
to the localised nature of S’. Therefore, it is likely that changes in systolic function were 
a result of a combination of reduced filling time, fluid loss and blood volume distribution 
rather than a shift in the inotropic state of the myocardium (Shave et al., 2004). This is 
supported by the insignificant changes in SBP/LVESV (a surrogate of LV contractility) 
after both trials. The current and previous data (Scharhag et al. 2006) suggests that 60 
minutes of exercise rarely results in a decrement in systolic function, and whilst a 
tendency for function to be reduced more in the HEAT exists, the exercise duration is 
unlikely to unmask any effects of environmental temperature on systolic function. Whilst 
it is pertinent to assess the impact of environmental temperature in a setting where a 
greater volume of exercise is performed, this is unlikely to occur in a controlled laboratory 
setting and thus be problematic to make comparisons in a field based setting. 
 
5.4.2 LV Diastolic Function 
Within the present study, small and sporadic changes in indices of diastolic function were 
observed with no significant impact of 60 minutes of running and no mediating effect of 
environmental temperature. The lack of significance in the current study may be due to 
the study being underpowered through a low sample size as a result of the difficulty in 
recruiting participants for prolonged exercise in a laboratory. A high variance exists for 
diastolic flow and tissue velocities compared to other functional parameters, thus a larger 
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sample size is often necessary for an appropriate statistical power. As a marker of left 
atrial pressure, E:E’ was not significantly reduced following prolonged exercise. 
Myocardial tissue velocities were also not altered by the exercise or related to measures 
of HR or loading, therefore, suggesting any possible changes in preload and the exercise 
undertaken did not influence filling patterns.  
 
5.4.3 Cardiac Biomarkers 
No detectable cTnI was present in serum samples taken pre-exercise and is likely 
explained by the training status and control of exercise exposure prior to this laboratory-
based study. Detectable cTnI values were observed in two participants after the HEAT 
trial and one after the COOL trial, with peak values being demonstrated at the 2 h POST 
assessment point. Whilst cTn has been detected in individuals in as little as 30 minutes 
exercise (Middleton et al., 2006; Shave et al., 2010), it is suggested an elevation in cTn 
in response to exercise is evident in all individuals, but may not always be detected due 
to the time of sampling (Gresslien and Agewall, 2016). Therefore, within the current 
study, we cannot rule out that detectable values in other participants may have been 
missed due to blood sampling time. In one participant the peak value was greater than the 
upper reference limit for a healthy population, however, below the cut-off for AMI, 
indicative of minimal cardiac damage within the present study. Whilst the exact 
mechanism for cTn release is unknown (Gresslien and Agewall, 2016; Shave et al. 2010), 
previous studies suggest it is likely to be a physiological response, due to the high 
percentage of participants with increased cTn post-exercise, low absolute levels and a 
rapid normalization of values, representing cTn release from the “unbound” cytosolic 
reservoir (Gresslien and Agewall, 2016; Shave et al. 2010). Within the present study, it 
was not possible to evaluate the normalization of elevated values due to the absence of 
blood sample collection at either 24 or 48 hours post-exercise. 
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Data for NT-proBNP were below the upper reference limit for a healthy population for 
all participants PRE-exercise and remained below this limit across all time points. Within 
the present study, a greater magnitude of cardiovascular drift was evidenced within the 
HEAT, signifying a greater total myocardial work performed during the heat trial. 
Coupled with a greater NT-proBNP concentration within the HEAT trial, a complex 
interaction between exercise intensity and duration may exist which is not surprising since 
NT-proBNP is elevated in response to volume overload and myocyte stretch (Shave et 
al., 2007b). This is further supported by the high concentrations of NT-proBNP 
demonstrated in Chapter 4. In contrast to cTnI, NT-proBNP demonstrates a half-life of 
around 120 minutes, being eliminated mainly through the kidneys (Hall, 2004), therefore, 
any peak values were likely to have been detected within the sampling points of the 
present study. 
 
5.4.4 Limitations 
A controlled laboratory-based study design was chosen to allow the appropriate control 
and comparison of two environmental conditions in a repeated measures design. The 
exercise duration selected ensured participants completed both trials before an unethical 
Tc was reached and exercise was terminated. As a consequence, a limitation of the study 
is the exercise dose performed, which may have limited the expression of cardiac 
functional change and the appearance of cardiac biomarkers in comparison to other 
studies. This also reduced the ability to differentiate between the two environmental 
conditions. Therefore, future studies should consider increasing the volume of the 
exercise (either intensity or duration) to evaluate whether environmental temperature 
mediates changes in cardiac function and markers of damage. As previously mentioned, 
another limitation was the low participant number which reduced the statistical power of 
the study. The measurement variance in flow and tissue velocities, coupled with 
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participant heterogeneity may explain the lack of statistical significance within the 
present study. Data collection points were limited to immediately, 1 and 2 h post exercise. 
Therefore any transient elevations in cTn which could have been observed with more 
frequent analysis may have been missed whilst it was also unclear when the elevated cTnI 
normalised. 
 
5.5 Conclusion 
Both LV systolic and diastolic function were not significantly altered following 60 min 
of running in either a controlled normothermic or hyperthermic environment. The release 
of cardiac biomarkers was limited, with a tendency for markers to be higher in the 
hyperthemic condition. The results also presented a high degree of individual variation to 
the exercise stimulus in both trials of the study, but overall suggests the CV system of the 
participants coped well with the exercise stress imposed.  
 
Participation in prolonged exercise, such as training for and participating in endurance 
and ultra-endurance events is becoming increasingly popular, particularly in 
environmentally stressful conditions. The method of pre-cooling immediately prior to 
exercise in thermally stressful environments, is popular and has been shown to be an 
effective means of reducing physiological strain, prolonging performance and improving 
perceptual tolerance. The impact of pre-cooling and subsequent prolonged exercise in a 
thermally stressful environment upon cardiovascular function has yet to be examined. 
Therefore, the next Chapter will investigate the effect of pre-cooling prior to a single bout 
of steady state exercise within a hyperthermic environment upon cardiac function and 
markers of cardiac damage. 
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CHAPTER 6 
The effect of whole body pre-cooling upon left ventricular 
function and cardiac biomarker release after prolonged 
steady state exercise in laboratory controlled hyperthermic 
environment. 
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6.1 Introduction 
Despite a large amount of evidence to support LV systolic and/or diastolic dysfunction 
and an elevation in cardiac biomarkers, contradictory evidence does exist (Chapter 2), 
likely due to the differences in research design, sample size, data interpretation, 
participant heterogeneity, intensity and duration of exercise and environmental factors 
(Chapter 4; Gresslien and Agewall, 2016; Oxborough et al., 2010; Sedaghat-Hamedani 
et al., 2015). Most of the existing literature also employs a field-based design, whereby 
the nature of these studies has not allowed for a controlled approach to the determination 
of the impact of environmental strain on cardiac function. To the best of our knowledge 
only two lab-based, and thus controlled studies, have investigated the impact of 
environmental temperature upon LV function and cardiac biomarker release. Shave et al. 
(2004c) suggested that ambient temperatures may play some part in exacerbating the post-
exercise response of LV function and cardiac biomarker release, attributed to the greater 
myocardial work performed in the 19oC trial than the 0oC trial. In Chapter 5 we did not 
observe any changes in systolic or diastolic function, independent of changes in preload 
after 60 min of running in ambient temperatures of either 13oC or 30oC. Therefore, 
suggesting a depression in LV function may have an exercise duration threshold even in 
times of high thermal stress. A tendency for function to be reduced following the 30oC 
trial was apparent, with cTnI being detectable in one participant following the 13oC trial 
and two participants following the 30oC trial, thus warranting further laboratory-based 
investigation with a greater exercise duration. A limitation of Chapter 5 was the limited 
post-exercise data collection points which may have missed any transient elevations in 
cTn which could have been observed with more frequent analysis. Therefore, the present 
study will employ more frequent assessment points post-exercise, which will be more 
indicative of the normalisation of any elevated values. 
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The method of pre-cooling immediately prior to exercising in thermally stressful 
environments has been shown to be an effective means of reducing physiological strain, 
prolonging performance and improving perceptual tolerance (Cuddy et al., 2014). A 
maintained SV and attenuated HR during steady state exercise after pre-cooling has been 
previously observed (Hessemer et al., 1984; Lee and Haymes, 1995; Schmidt and Brück, 
1981), suggesting a reduced cardiovascular strain following pre-cooling. Therefore, cold 
water immersion will be employed as a method of manipulating the cardiovascular 
response to prolonged exercise by reducing the participants Tc. 
 
At present, no study has specifically examined the manipulation of Tc through pre-
cooling, prior to exercise in a hyperthermic environment upon cardiac function and 
markers of cardiac damage. Therefore, the aim of this study was to examine the effect of 
pre-cooling, prior to exercise in a hyperthermic environment, upon cardiac function, 
specifically EF and E:A, and markers of cardiac damage (cTnI and NT-proBNP). It was 
hypothesised that performing prolonged exercise in a hot environment, preceded by pre-
cooling may reduce the myocardial load during exercise, resulting in a maintained LV 
function and a reduced appearance of cardiac biomarkers in comparison to a control trial. 
 
6.2 Method 
6.2.1 Participants and Study Design 
Ten male recreational athletes (mean ± SD; age 29 ± 7 years, height 1.76 ± 0.08 m, body 
mass 72.8 ± 11.6 kg and VO2PEAK 54.1 ± 7.9 mL.kg
-1.min-1) were recruited for the study. 
All participants were healthy and free of known or early family history of cardiovascular 
disease, injury or illness and were not taking medications. Ethical approval was obtained 
from Coventry University prior to the start of data collection. Before the study 
commenced, all participants provided written informed consent. 
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A preliminary laboratory session was used to determine the VO2PEAK of the athletes and 
to allow familiarization with the treadmill and all other equipment. In two subsequent 
laboratory sessions, participants completed identical 90 min runs (at 65% VO2PEAK) in the 
heat (32.4 ± 0.9oC and 46.8 ± 6.4% RH) preceded by either a seated control (CON) or a 
pre-cooling (P-C) condition for 60 minutes in a randomised, counterbalanced crossover 
design. Trial 1 and 2 were separated by at least one week to avoid heat acclimation 
(Barnett and Maughan, 1993).  
 
Baseline assessment occurred 1 h prior to each seated condition (PRE), with post-
condition assessments being taken immediately following the completion of the condition 
(0 min). Post-trial assessments were then carried out immediately after run completion 
(POST) and then 1 (1 h POST), 2 h (2 h POST), 4 h (4 h POST) and 24 h (24 h POST) 
into recovery. During PRE and post-trial testing measurements included; BM, HR, BP, 
echocardiographic imaging, venous and fingertip blood sampling. Tc, Tsk and HR were 
monitored throughout the protocol. At 15 min intervals throughout the exercise protocol, 
participants provided thermal and exertional ratings. Fingertip blood samples for BLa 
were obtained PRE and at 30 min intervals throughout the exercise protocol. 
 
6.2.2 Protocols 
VO2PEAK protocol and measurements: 
The VO2PEAK test and both 90 min trials were completed upon a HP-Cosmos treadmill 
(Nussdorf-Traunstein, Germany), as described in Section 5.2.2.  
 
Experimental Procedures: 
Prior to the initial experimental trial, participants arrived at the laboratory at least 3 h 
postprandial having refrained from alcohol and caffeine for 12 h and strenuous activity 
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during the previous 24 h. All participants recorded dietary intake for 48 h prior, 
replicating this diet before the subsequent experimental trial. A volume of 5 ml of water 
per kg BM (363 ± 63 ml) was consumed 2 h before arriving at the laboratory to achieve 
euhydration (Montain and Coyle, 1992). An additional 7 ml of water per kg BM (508 ± 
89 ml) was ingested during exercise to ensure similar hydration between trials. All trials 
were performed at the same time of day in order to avoid the circadian variation in internal 
body temperature (Reilly and Brooks, 1986). During both trials participants were required 
to run at 65% of their measured VO2PEAK at a gradient of 0%. To provide an environment 
replicable to outdoor conditions whereby the movement of air aids evaporative and 
convective heat loss (Jones and Doust, 1996; Saunders et al., 2005), for both trials a fan 
was placed 2 m in front of participants, with a wind speed relative to the participants 
running speed, measured at 1.3 m above the treadmill belt (Figure 6.1). 
 
 
Figure 6.1 Experimental setup 
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On arrival at the laboratory, nude BM was recorded to the nearest 0.1 kg (model 875, 
Seca, Hamburg, Germany) and a flexible translucent PVC rectal probe was inserted 
(Grant Instruments, UK). Following 5 min rest in a supine position, SBP (a surrogate of 
afterload) and DBP was measured using a Dinamap automated BP monitor (Critikon 
Corporation, Tampa, USA). Each participant then underwent a resting echocardiographic 
examination, as described in Section 3.2.2.  
 
Whole blood samples were collected by venepuncture without venostasis from an 
antecubital vein using a 21G butterfly syringe into a serum gel tube and the blood was 
left to clot. After being centrifuged at 1500 g for 10 min, serum was aliquoted and stored 
(– 80°C) for subsequent analysis of cTnI and NT-proBNP (See Section 3.2.1). PV 
changes were estimated from changes in haemoglobin (Hb) and haematocrit (Hct; Dill & 
Costill, 1974; Maughan et al., 2001) from fingertip blood samples. Fingertip samples 
were collected into heparinized microhematocrit tubes (Hawksley and Sons, Sussex, UK) 
and microcuvettes (HemoCue AB, Angelholm, Sweden) for the determination of Hct 
(Hawksley 1560 Microhematocrit reader) and Hb (HemoCue hemoglobin meter; 
HemoCue Inc, Lake Forest, California, USA), respectively. Results of cTnI and NT-
proBNP were corrected for percentage change in PV. 
 
Tc and mean weighted Tsk was measured, as described in Section 5.2.2. Heat storage was 
calculated from the equation employed by Havenith et al. (1995) whereby values were 
calculated from changes in Tc (∆Tc) and Tsk (∆Tsk) from PRE compared to values at 15 
min intervals during exercise (See Equation 5.2). A HR monitor (Polar A1, Polar Electro, 
Finland) was fitted and worn throughout the exercise protocol. Participants also rated 
their thermal sensation (ASHRAE, 2004), thermal comfort (ASHRAE, 2004) and 
perceived exertion (RPE; Borg, 1970). A capillary sample was drawn for determination 
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of BLa concentration (Biosen HbA1c, EKF-diagnostic GmbH, Germany) in order to 
assess physiological stress, whereby participants straddled the treadmill for BLa measures 
to be taken. The difference in nude BM between PRE and POST-exercise, corrected for 
the volume of fluid ingested and urine output was used to calculate exercise-induced BM 
loss. 
 
Pre-cooling and control seated conditions 
During the P-C condition, participants underwent a pre-cooling manoeuvre by means of 
water immersion for 60 min prior to the exercise trial. Pre-cooling involved each 
participant being seated and submerged in water at the height of the participant’s sternal 
notch (Figure 6.2). A water temperature of 20.3 ± 0.3oC was used in order to avoid some 
of the comfort issues associated with cold water immersion (Quod et al., 2006). Every 10 
mins, participants were required to make a slight movement of the arms and legs to avoid 
a ‘warm pocket’ of water developing close to the skin. Upon leaving the water, 
participant’s towel dried and dressed. The seated control condition (CON) involved the 
participants remaining seated for 60 min in a laboratory (ambient temperature 20.2 ± 
1.7oC and RH 60.2 ± 2.5%). For consistency, the exercise protocol commenced 10 min 
following the end of both seated conditions. 
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Figure 6.2 Participant undergoing the pre-cooling procedure 
 
6.2.3 Data Analysis 
Data are reported as the mean ± SD and were supported by assessing the mean difference 
(mean diff) and 95% confidence interval [95% CI]. The Shapiro-Wilk test was applied to 
the data in order to assess for normal distribution. All variables except BM loss, PV loss 
and cTnI were assessed using a Two-way (Condition x Time) repeated-measures 
ANOVA. Sphericity was analysed by Mauchly’s test of sphericity followed by 
Greenhouse-Geisser or Huynh-Feldt adjustment where appropriate. Where any 
differences were identified, pairwise post-hoc comparisons with a Bonferroni correction 
were used in order to show where they lay. The change in PRE to POST BM and PV was 
analysed using a Student’s paired t-test. cTnI were analysed descriptively because of the 
likelihood of undetectable PRE-exercise values. All statistical analyses were conducted 
using IBM SPSS Statistics 24 (IBM Corp., Armonk, NY, USA). An alpha level of p < 
0.05 was considered statistically significant. Furthermore, effect size using Cohen’s d and 
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partial eta squared ( 2P ) were calculated, as described in Section 4.2.3. Cardiac biomarkers 
were also compared to the upper reference limits of an apparently healthy population. 
 
6.3 Results 
Eight participants (mean ± SD; age 28 ± 6 years, height 1.76 ± 0.08 m, BM 72.6 ± 12.5 
kg and VO2PEAK 53 ± 6 mL.kg
-1.min-1) completed both trials, with two participants being 
withdrawn due to Tc reaching the safety cut-off criteria. BM loss was similar between 
conditions (CON: 2.2 ± 0.6 kg, P-C: 2.1 ± 0.4 kg), with relative BM loss being similar 
between CON (3.2 ± 1.1%) compared to P-C (2.9 ± 0.6%). PV loss was also similar 
between conditions (CON: 8 ± 8, P-C: 6 ± 10). A small insignificant interaction between 
condition and time for exercise HR was observed. There was an insignificant small effect 
between conditions, whilst a large significant effect was seen across time (F(1.955,13.688) = 
251.210, p < 0.001; 2P  = 0.97). Post-hoc analysis revealed 0 min to be lower than all 
exercise time points (p < 0.001; Figure 6.3a). A progressive increase in HR was apparent 
with 15 min being significantly lower than the subsequent time points (p < 0.01), with a 
number of time points being significantly lower than the final 90 min time point (Figure 
6.3a). A large significant interaction between condition and time for Tc was observed 
(F(1.962,13.737) = 11.723, p = 0.001; 
2
P
  = 0.63) whereby Tc was significantly higher between 
0 and 45 min in the CON condition compared to P-C (Figure 6.3b). Tc was significantly 
higher following CON compared to P-C to a large extent (mean diff = 0.40; F(1.000,7.000) = 
7.375, p = 0.030; 95% CI [0.05, 0.75]; 2P  = 0.51). A large significant effect was seen 
across time for Tc (F(1.348,9.437) = 83.661, p < 0.001; 
2
P
  = 0.92) with post-hoc analysis 
showing significant differences between all comparisons apart from PRE to 15 min and 
75 min to 90 min (Figure 6.3b). A reduction in Tc following the P-C condition was 
apparent, with an increase in Tc in both conditions to a similar point at exercise cessation. 
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A large significant interaction between condition and time was observed for Tsk 
(F(2.461,17.224) = 5.651, p = 0.010; 
2
P
  = 0.45), whereby Tsk was significantly higher at 0 and 
15 min following CON compared to P-C (Figure 6.3c). A large significant effect for 
condition (mean diff = 0.96; F(1.000,7.000) = 33.887, p = 0.001; 95% CI [0.57, 1.35]; 
2
P
  = 
0.83), whereby CON was higher than P-C was seen for Tsk, as well as a large significant 
effect for time (F(7,49) = 43.509, p < 0.001; 
2
P
  = 0.86; Figure 6.3c). Heat storage 
demonstrated a large significant interaction between condition and time (F(1.490,10.430) = 
13.196, p = 0.002; 2P  = 0.65), whereby heat storage was significantly different at 0 min 
(Figure 6.3d). An insignificant moderate effect was seen for condition, however, a large 
effect for time was observed (F(1.900,13.302) = 129.432, p < 0.001; 
2
P
  = 0.95) with post-hoc 
analysis showing significant heat gain between 0 and 60 min, with all possible 
interactions being below p = 0.017, after which there was a plateau in heat gain. A large 
insignificant interaction between condition and time was apparent for BLa, with a large 
insignificant effect between conditions. A moderate significant effect was observed for 
time (F(4,28) = 12.127, p < 0.001; 
2
P
  = 0.63; Figure 6.3e), with post-hoc analysis showing 
increases from PRE at 30 min (mean diff = 0.6; p = 0.032; 95% CI [0.1, 1.2]) and 60 min 
(mean diff = 1.2; p = 0.001; 95% CI [0.6, 1.8]). BLa at 30 min was also lower than 60 
min (mean diff = 0.6; p = 0.044; 95% CI [0, 1.1]). 
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a) 
 
d) 
 
b) 
 
e) 
 
c) 
 
 
 
Figure 6.3 The mean ± SD of a) HR, b) Tc, c) Tsk, d) Heat Storage and e) BLa across 
assessment time points in both trials (n = 8). * Significantly different to PRE, p < 0.05. # 
Significantly different to 0, p < 0.05. $ Significantly different to 15, p < 0.05. § 
Significantly different to 30, p < 0.05. ¥ Significantly different to 45, p < 0.05. ¢ 
Significantly different to 60. € Significantly different between CON and P-C, p < 0.05. 
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RPE demonstrated a large insignificant interaction between condition and time, with a 
large effect for condition shown. A large significant effect for time was seen for RPE 
(F(1.662,11.636) = 34.434, p < 0.001; 
2
P
  = 0.83), with post-hoc analysis revealing a 
progressive increase in RPE (Figure 6.4a). A large significant interaction between 
condition and time was observed for thermal sensation (F(7,49) = 6.407, p < 0.001; 
2
P
  = 
0.48; Figure 6.4b), with CON being significantly higher than P-C at 0 and 15 min. 
Thermal sensation was found to be higher within the CON trial compared to the P-C as a 
large significant effect for condition was found (mean diff = 1; F(1.000,7.000) = 7.936, p = 
0.026; 95% CI [0, 1]; 2P  = 0.53). A large significant effect for time has also been found 
(F(2.339,16.373) = 65.259, p < 0.001; 
2
P
  = 0.90), with post-hoc analysis revealing a 
progressive increase in thermal sensation. A large significant interaction was found 
between condition and time for thermal comfort (F(3.011,21.079) = 3.994, p = 0.021; 
2
P
  = 
0.36), with a significant difference at 0 and 15 min (Figure 6.4c). An small insignificant 
effect was seen for condition, whilst a large significant effect for time was found 
(F(1.810,12.669) = 8.021, p = 0.007; 
2
P
  = 0.36), with post-hoc analysis revealing a progressive 
decline in thermal comfort. 
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a) 
 
c) 
 
b) 
 
 
 
Figure 6.4 The mean ± SD of a) RPE, b) Thermal Sensation and c) Thermal comfort 
across assessment time points in both trials (n = 8). * Significantly different to PRE, p < 
0.05. # Significantly different to 0, p < 0.05. $ Significantly different to 15, p < 0.05. § 
Significantly different to 30, p < 0.05. ¥ Significantly different to 45, p < 0.05. ¢ 
Significantly different to 60, p < 0.05. 
 
6.3.1 Echocardiographic Data 
6.3.1.1 Loading 
LVEDV demonstrated an insignificant moderate interaction between condition and time 
as well as an insignificant moderate effect for condition. A large significant effect for 
time was shown (F(5,35) = 6.018, p < 0.001; 
2
P
  = 0.46), with post-hoc analysis revealing 
POST to be lower than PRE (mean diff = -15; p = 0.005; 95% CI [-25, -5]) and 2 h POST 
(mean diff = -18; p = 0.041; 95% CI [-35, -1]), and 1 h POST lower than 2 h POST (mean 
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diff = -10; p = 0.043; 95% CI [-20, 0]; Table 6.1). HR showed an insignificant moderate 
interaction between condition and time, with an insignificant small effect for condition 
also seen. A large significant effect for time was observed (F(5,35) = 8.610, p < 0.01; 
2
P
  = 
0.55), with post-hoc analysis revealing POST to be higher than PRE (mean diff = 29; p = 
0.015; 95% CI [6, 52]), 2 h POST (mean diff = 22; p = 0.036; 95% CI [1, 42]), 4 h POST 
(mean diff = 22; p = 0.015; 95% CI [4, 39]) and 24 h POST (mean diff = 25; p = 0.002; 
95% CI [10, 40]; Table 6.1). A large insignificant interaction for SBP was observed 
between condition and time, whilst a moderate effect for condition was seen. A large 
effect for time was demonstrated (F(5,35) = 6.791, p < 0.001; 
2
P
  = 0.49), with post-hoc 
analysis revealing 1 h POST to be lower than 4 h POST (mean diff = -10; p = 0.004; 95% 
CI [-17, -4]) and 24 h POST (mean diff = -10; p = 0.048; 95% CI [-19, 0]; Table 6.1). 
DBP demonstrated a large insignificant interaction between condition and time, with a 
large insignificant effect for condition as well as time (Table 6.1). A moderate 
insignificant interaction between condition and time was observed for E:E’, with a small 
insignificant effect for condition and moderate insignificant effect for time (Table 6.1). 
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Table 6.1 LV loading across assessment points in both conditions (n = 8, mean ± SD). 
 CON P-C 
Variable PRE POST 1 h 
POST 
2 h 
POST 
4 h 
POST 
24 h 
POST 
PRE POST 1 h 
POST 
2 h 
POST 
4 h 
POST 
24 h 
POST 
LVEDV (ml) 155±24 146±35 150±26 164±22 155±28 148±22 157±24 136±18 146±19 154±16 150±21 153±24 
HR 
(beats.min-1) 
59±15 89±17 83±28 65±14 65±13 66±20 62±15 90±16 71±15 70±9 70±5 63±13 
SBP (mmHg) 130±8 124±11 122±11 129±13 132±13 130±9 132±10 125±7 120±12 121±12 132±11 131±13 
DBP 
(mmHg) 
70±8 74±15 66±11 72±13 70±11 70±13 71±10 65±11 64±11 65±10 71±11 69±10 
E:E’ 7±1 7±3 6±1 6±1 6±1 7±1 7±1 6±2 6±2 6±1 7±1 6±1 
 
LVEDV: left ventricular end diastolic volume, HR: heart rate, SBP: systolic blood pressure, DBP: diastolic blood pressure, E:E’: peak early trans-mitral flow/peak early myocardial 
tissue velocity. PRE, POST, 1 h POST, 2 h POST, 4 h POST and 24 h POST: before, immediately after, and 1 hour, 2 hours, 4 hours and 24 hours after each trial, respectively. 
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6.3.1.2 LV Systolic Function 
EF demonstrated a large insignificant interaction between condition and time, with a post-
hoc power analysis of 0.7. A small insignificant effect for condition and a large significant 
effect for time was observed (F(2.166,15.161) = 7.413, p = 0.005; 
2
P
  = 0.51), with post-hoc 
analysis revealing PRE to be higher than 2 h POST (mean diff = 5; p = 0.038; 95% CI [0, 
9]; Table 6.2). Some individual variation was apparent, with some individuals 
demonstrating elevated levels POST, whilst others showed reduced values (Figure 6.5a). 
A large interaction between condition and time for SV was observed (F(5,35) = 2.771, p = 
0.033; 2P  = 0.28), with 24 h POST being lower in the CON trial compared to P-C (mean 
diff = -10; p = 0.024; 95% CI [-19, -2]). A small insignificant effect for condition was 
shown, whilst a large significant effect for time was found (F(5,35) = 9.637, p < 0.001; 
2
P
  
= 0.58), with post-hoc analysis revealing PRE to be higher than POST (mean diff = 17; p 
= 0.034; 95% CI [1, 33]), 1 h POST (mean diff = 14; p = 0.031; 95% CI [1, 28]) and 4 h 
POST (mean diff = 6; p = 0.008; 95% CI [2, 10]; Table 6.2). The majority of participants 
demonstrated a similar post-exercise response (Figure 6.5b). A moderate insignificant 
interaction between condition and time, with a small insignificant effect for condition was 
found for SBP/LVESV. A large significant effect for time was observed (F(5,35) = 6.511, 
p < 0.001; 2P  = 0.48), with post-hoc analysis revealing PRE to be higher than 2 h POST 
(mean diff = 0.28; p = 0.045; 95% CI [0.01, 0.55]; Table 6.2), with a varied response 
between participants (Figure 6.5c). S’ demonstrated a moderate insignificant interaction 
between condition and time, whilst a large insignificant effect for condition was seen. A 
large significant effect for time was found (F(5,35) = 2.615, p = 0.041; 
2
P
  = 0.27; Table 
6.2), however, post-hoc analysis revealed no significant differences with individual 
variation apparent in response to exercise and condition (Figure 6.5d). 
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Table 6.2 LV systolic function across assessment points in both conditions (n = 8, mean ± SD). 
 CON P-C 
Variable PRE POST 1 h 
POST 
2 h 
POST 
4 h 
POST 
24 h 
POST 
PRE POST 1 h 
POST 
2 h 
POST 
4 h 
POST 
24 h 
POST 
EF (%) 55±5 48±7 48±7 52±7 52±4 49±4 55±5 49±6 47±5 49±4 52±5 54±6 
SV (ml) 85±19 72±27 74±22 85±22 81±20 73±16 86±16 66±13 69±14 75±9 79±18 83±20 
SBP/LVESV 
(mmHg.ml-1) 
1.89± 
0.21 
1.68± 
0.16 
1.59± 
0.21 
1.67± 
0.29 
1.80± 
0.23 
1.75± 
0.18 
1.89± 
0.36 
1.72± 
0.20 
1.56± 
0.14 
1.55± 
0.21 
1.88± 
0.29 
1.89± 
0.31 
S’ (cm.s-1)  8±1 9±1 9±1 9±1 9±1 8±1 8±1 9±2 9±1 10±1 9±1 9±1 
 
EF: ejection fraction, SV: stroke volume, SBP/LVESV: systolic blood pressure/left ventricular end systolic volume, S’: peak systolic myocardial tissue velocity. PRE, POST, 1 h 
POST, 2 h POST, 4 h POST and 24 h POST: before, immediately after, and 1 hour, 2 hours, 4 hours and 24 hours after each trial, respectively. 
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a) 
 
c) 
 
b) 
 
d) 
 
Figure 6.5 Individual heterogeneity for LV systolic function across assessment points in 
both conditions where a) EF, b) SV, c) SBP/LVESV and d) S’ (n = 8). PRE, POST, 1 h 
POST, 2 h POST, 4 h POST and 24 h POST: before, immediately after, and 1 hour, 2 
hours, 4 hours and 24 hours after each trial, respectively. * Significantly different to PRE. 
€ Significantly different between CON and P-C, p < 0.05. 
 
6.3.1.3 LV Diastolic Function 
A large insignificant interaction between condition and time for E was observed, with a 
small insignificant effect for condition. A large significant effect for time was seen (F(5,35) 
= 12.145, p < 0.001; 2P  = 0.63; Table 6.3), however, post-hoc analysis revealed no 
significant differences. The majority of participants demonstrated a decrease in response 
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to both conditions post-exercise (Figure 6.6a). A large interaction between condition and 
time was seen for A (F(5,35) = 2.802, p = 0.031; 
2
P
  = 0.29), however, post-hoc analysis 
revealed no differences between conditions at any time points. A large insignificant effect 
for condition was shown, with a large significant effect for time (F(5,35) = 3.535, p = 0.011; 
2
P
  = 0.34; Table 6.3), whilst again post-hoc analysis showed no significant differences. 
Some individual variation was apparent, with some individuals demonstrating elevated 
levels POST, whilst others showed reduced values (Figure 6.6b). As a consequence, E:A 
demonstrated a large insignificant interaction between condition and time, with a post-
hoc power analysis of 0.3. A moderate insignificant effect for condition was also shown. 
A large significant effect for time was found (F(5,35) = 14.638, p < 0.001; 
2
P
  = 0.68; Table 
6.3), with post-hoc analysis revealing PRE to be higher than POST (mean diff = 0.82; p 
= 0.047; 95% CI [0.01, 1.62), 1 h POST (mean diff = 0.66; p = 0.008; 95% CI [0.18, 
1.14]) and 2 h POST (mean diff = 0.60; p = 0.012; 95% CI [0.13, 1.07]). POST was 
significantly lower than 24 h POST (mean diff = -0.7; p = 0.017; 95% CI [-1.32, -0.13]), 
as was 1 h POST (mean diff = -0.57; p = 0.009; 95% CI [-1.00, -0.15]) and 2 h POST 
(mean diff = -0.51; p = 0.017; 95% CI [-0.93, 0.09]). The majority of participants 
demonstrated a decrease to both conditions post-exercise (Figure 6.6c). E’ demonstrated 
an insignificant moderate interaction between condition and time and a small effect for 
condition. A large significant effect for time was observed (F(5,35) = 15.378, p < 0.001; 
2
P
  
= 0.69; Table 6.3) with post-hoc analysis showing POST was significantly lower than 
PRE (mean diff = -3; p = 0.012; 95% CI [-5, -1]), 1 h POST (mean diff = -2; p = 0.019; 
95% CI [-3, 0]), 2 h POST (mean diff = -2; p = 0.006; 95% CI [-3, -1]), 4 h POST (mean 
diff = -3; p = 0.001; 95% CI [-4, -1]) and 24 h POST (mean diff = -3; p = 0.003; 95% CI 
[-5, -1]). 1 h POST was also significantly lower than 24 h POST (mean diff = -1; p = 
0.026; 95% CI [-3, 0]). The majority of participants again demonstrated a decrease to both 
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conditions post-exercise (Figure 6.6d). An insignificant small interaction between 
condition and time was observed for A’. Large but insignificant effects for both condition 
and time were also seen (Table 6.3). However, post-hoc analysis showed a significant 
increase in A’ at 1 h POST compared to PRE (mean diff = 2; p = 0.026; 95% CI [0, 3]) 
and 24 h POST (mean diff = 1; p = 0.047; 95% CI [0, 3]). A’ showed an apparent 
individual variation post-exercise (Figure 6.6e). As a result, E’:A’ showed an 
insignificant moderate interaction between condition and time. A moderate insignificant 
effect for condition was seen, whilst a large significant effect for time was observed (F(5,35) 
= 13.911, p < 0.001; 2P  = 0.67). Post-hoc analysis revealed PRE to be significantly higher 
than POST (mean diff = 0.69; p = 0.014; 95% CI [0.14, 1.23]), 1 h POST (mean diff = 
0.60; p = 0.001; 95% CI [0.30, 0.90]) and 2 h POST (mean diff = 0.49; p = 0.022; 95% 
CI [0.07, 0.90]). POST was significantly lower than 24 h POST (mean diff = -0.60; p = 
0.015; 95% CI [-1.08, -0.12]), whilst 1 h POST was significantly lower than 4 h POST 
(mean diff = -0.24; p = 0.024; 95% CI [-0.45, -0.03]) and 24 h POST (mean diff = -0.51; 
p = 0.007; 95% CI [-0.88, -0.15]). Similar to other variables, the majority of participants 
again demonstrated a decrease in response to both conditions post-exercise (Figure 6.6f). 
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Table 6.3 LV diastolic function across assessment points in both conditions (n = 8, mean ± SD). 
 CON P-C 
Variable PRE POST 1 h 
POST 
2 h 
POST 
4 h 
POST 
24 h 
POST 
PRE POST 1 h 
POST 
2 h 
POST 
4 h 
POST 
24 h 
POST 
E (cm.s-1)  84±11 60±19 67±15 69±15 74±12 77±15 85±12 57±18 63±17 71±14 78±12 82±11 
A (cm.s-1) 43±11 45±7 48±16 48±12 49±14 38±9 42±7 55±15 47±11 49±11 46±12 45±11 
E:A 2.11±0. 
67 
1.42± 
0.60 
1.48± 
0.47 
1.51± 
0.48 
1.65± 
0.58 
2.12± 
0.67 
2.11± 
0.55 
1.16± 
0.53 
1.40± 
0.48 
1.50± 
0.40 
1.81± 
0.54 
1.91± 
0.52 
E’ (cm.s-1) 12±1 9±2 11±2 11±2 12±2 12±2 13±2 10±1 11±2 11±2 11±2 13±1 
A’ (cm.s-1) 7±1 8±3 8±2 8±2 8±2 7±1 7±1 9±2 9±2 8±2 8±1 7±2 
E’:A’ 1.97± 
0.46 
1.40± 
0.66 
1.42± 
0.30 
1.52± 
0.55 
1.66± 
0.49 
1.83± 
0.48 
1.96± 
0.55 
1.17± 
0.36 
1.32± 
0.29 
1.44± 
0.33 
1.57± 
0.40 
1.94± 
0.61 
 
E: peak early trans-mitral flow velocity, A: peak atrial filling velocity, E:A: early to late diastolic filling ratio, E’: peak early diastolic myocardial velocity, A’: peak late diastolic 
myocardial velocity, E’/A’: peak early to late myocardial tissue velocity ratio. PRE, POST, 1 h POST, 2 h POST, 4 h POST and 24 h POST: before, immediately after, and 1 hour, 2 
hours, 4 hours and 24 hours after each trial, respectively. 
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a) 
 
d) 
 
b) 
 
e) 
 
c) 
 
f) 
 
Figure 6.6 Individual heterogeneity for LV diastolic function across assessment points in 
both conditions where a) E, b) A, c) E:A, d) E’, e) A’ and f) E’:A’ (n = 6). PRE, POST, 
1 h POST, 2 h POST, 4 h POST and 24 h POST: before, immediately after, and 1 hour, 2 
hours, 4 hours and 24 hours after each trial, respectively. * Significantly different to PRE, 
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p < 0.05. # Significantly different to POST, p < 0.05. $ Significantly different to 1 h 
POST, p < 0.05. § Significantly different to 2 hr POST, p < 0.05. 
 
6.3.2 Cardiac Biomarkers 
cTnI was not detectable in serum samples taken PRE-exercise in both conditions (Figure 
6.8). However, by the 2 h POST assessment, all participants demonstrated detectable 
values, with all but one participant (participant 1 CON) demonstrating values above the 
upper reference limit by the 4 h POST assessment. Whilst this time point displayed a 
number of peak values, some participants demonstrated a peak in cTnI at the 24 h POST 
assessment. Within and between participants, there was no consistency between peak 
cTnI values and the time points they occurred at. Data for NT-proBNP was below the 
upper reference limit for a healthy population for all participants PRE-exercise (Figure 
6.9) and remained below this limit for 6 out of 8 participants across all time points. 
Participant 5 demonstrated elevations above the upper reference limit within the P-C 
condition, whilst participant 6 demonstrated elevations above this limit within both 
conditions. A small insignificant interaction between condition and time was observed 
for NT-proBNP. A small insignificant effect for condition as well as an insignificant large 
effect for time was also found. 
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Figure 6.8 Individual data for cTnI across assessment points in both conditions. The 
dotted line represents the 99th percentile of an apparently healthy population (≤ 0.04 µg.L-
1; Uettwiller-Geiger et al., 2002; n = 8). PRE, POST, 1 h POST, 2 h POST, 4 h POST and 
24 h POST: before, immediately after, and 1 hour, 2 hours, 4 hours and 24 hours after 
each trial, respectively. 
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Figure 6.9 Individual data for NT-proBNP across assessment points in both conditions. 
The dotted line represents the upper reference limit of an apparently healthy population 
(125 ng.L-1; Silver et al., 2004; n = 8). PRE, POST, 1 h POST, 2 h POST, 4 h POST and 
24 h POST: before, immediately after, and 1 hour, 2 hours, 4 hours and 24 hours after 
each trial, respectively. 
 
6.4 Discussion 
The present study represents the first attempt to manipulate Tc through pre-cooling, prior 
to exercise in a controlled hyperthermic environment, and then assess the impact upon 
LV cardiac function and markers of cardiac damage. The findings indicate that some 
measures of systolic function were reduced POST-exercise compared to PRE, whilst 
consistent evidence of diastolic dysfunction was apparent. Similar changes in cardiac 
function between conditions were observed, with a marked heterogeneity between 
participants in response to both conditions and exercise time points. cTnI was elevated 
above detection levels in all participants in both conditions, demonstrating heterogeneity 
between participants and conditions. There was no significant change in NT-proBNP 
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across time points, nor was there a difference between conditions. Therefore, overall there 
was no effect of pre-cooling upon measures of cardiac function and damage. 
 
The key focus of this study was to compare the thermal and cardiovascular stress of 
exercise in a hyperthermic environment and any potential effect of pre-cooling on LV 
cardiac function and biomarker appearance during recovery. Therefore, initial 
consideration as to whether the two exercise bouts presented differing thermal and 
cardiovascular stresses must be considered. The pre-cooling intervention significantly 
reduced Tc and Tsk at the start of the P-C trial compared to CON and delayed the rise in 
Tc and Tsk during the first 30 min of exercise, with most differences disappearing before 
the end of the protocol. The P-C trial also demonstrated a greater heat storage compared 
to CON trial during first 30 min. It was apparent in the P-C trial that the lowering of Tsk 
prior to exercise had increased the temperature gradient between the skin and the 
environment in comparison to the CON trial. As the environmental temperature was 
greater than Tsk, it is therefore possible that the use of pre-cooling increased the potential 
for heat gain through convection, aided by the airflow produced by the fan. Whilst airflow 
was similar between conditions, it has been shown to aid heat exchange through 
convection and evaporation (Saunders et al., 2005). Therefore, it may well explain the 
greater increase in Tsk and heat gain in the first 15 min of the P-C trial in comparison to 
the CON. Overall it is likely that whilst there was a significant difference in thermal stress 
between trials, this was of a limited duration, evidenced by a similar Tc and Tsk at the end 
of both trials. 
 
BM and PV loss between conditions was similar, however, this can be attributed to 
metabolic factors such as substrate loss and muscle breakdown (Hoffman et al., 2018; 
Maughan et al., 2007) and may be a result of the amount of heat lost through the 
188 
 
evaporation of sweat. Heat loss through sweat is largely determined by metabolic heat 
production and environmental heat load (Neilsen, 1996), both of which were the same for 
both trials within this study.  
 
The present study also found no HR difference between conditions, despite the difference 
in Tc up to 45 mins, with a similar magnitude of cardiovascular drift as exercise continued. 
The increase in Tsk across both trials demonstrates a decrease in evaporative cooling 
efficiency and likely an increase in peripheral vasodilation and cutaneous blood volume 
(González-Alonso et al., 1999), resulting in a decrease in central blood volume during 
exercise (Coyle and Gonzalez-Alonso, 2001). It is also likely that the similar rate of 
intravascular fluid loss through sweat production was also a confounding factor to the 
observed similarity in cardiovascular drift between trials. A combination of blood volume 
redistribution and intravascular fluid loss may have resulted in a reduction in venous 
return (Rowell et al., 1966, 1969), therefore, leading to an elevated HR in order to 
maintain cardiac output in both trials. It is likely that the total myocardial work performed 
was similar between trials. This is also reflected by a progressive increase in RPE as 
exercise duration increases, with no significant difference in RPE between trials. Thermal 
comfort and sensation also only differed between trials immediately following the cooling 
or controlled procedure. Similar BLa concentrations were observed between conditions, 
suggestive of a maintained muscle blood flow during both trials. The similar BLa, HR 
and RPE would, therefore, suggest similar physiological stressors between trials and 
likely explains the lack of difference in LV function and cardiac biomarkers. 
 
6.4.1 LV Systolic Function 
Systolic function was significantly reduced at POST-exercise time points compared to 
PRE in both trials, with no difference in function between conditions apart from a 
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reduction in SV 24 h POST in the CON trial. It is possible that the reduction in PV seen 
in both trials may partially explain some of the change in systolic function. The average 
change in EF was similar between trials (12% reduction in CON, 11% reduction in P-C), 
likely due to the similarity in cardiovascular load between conditions. The change in EF 
is within a range expected from participant and technical variability and may partially be 
due to an increase in peripheral vasodilation and cutaneous blood volume (González-
Alonso et al., 1999). Therefore, it is probable that the rate of fluid loss through sweat 
production, along with peripheral vasodilation may have partly led to a reduction in 
venous return and therefore reduced LV preload. A significant decrease in SBP/LVESV 
was apparent 2 hr POST exercise. Whilst a small amount of change could be attributed to 
measurement variability, a change of up to 16% is unlikely due to measurement error 
alone. Research by Charkoudian et al., (2003) has suggested 90 min of cycling can result 
in an decreased post-exercise SBP through exercise induced dehydration of 1.6% BM 
compared to a saline infused maintenance of hydration. Therefore, the decrease in 
SBP/LVESV in the present study may be due to a decreased SBP post-exercise through 
changes in hydration status or alternately post-exertional hypotension (MacDonald, 
2002). This is further supported by an increase in S’ suggesting an increased inotrophy, 
however, S’ is localized in nature by only being representative of the septal wall. 
 
6.4.2 LV Diastolic Function 
Changes in diastolic filling parameters can be affected by changes in loading and HR 
(Burns et al., 2007; Dawson et al., 2003; Oxborough et al., 2010) which may have an 
impact on the current findings due to the speculated changes in blood volume distribution, 
particularly immediately POST-exercise. Myocardial tissue velocities did not appear to 
follow the same pattern of change as measures of HR or loading, suggesting the alteration 
in LV filling pattern may only be partially related to blood pool redistribution induced by 
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exercise and heat stress, supported by a lack of change in left atrial driving pressure 
(E:E’). The decrease in E, with little or no compensation in A, reflects an intrinsic 
alteration in LV pressure decay due to impaired relaxation/myocardial stiffening during 
diastole, compliance and atrial contractility (Middleton et al., 2006a).  
 
There were no differences in diastolic variables between trials, however, given the limited 
difference in thermal burden and cardiovascular stress as previously discussed 
(determined post hoc), this is to be expected. The insignificant reduction in diastolic 
function found in Chapter 5 and by Scharhag et al. (2006) following 60 minutes exercise, 
compared to an increased duration and apparent diastolic dysfunction in the present study 
and that by Tian et al. (2014) suggest a minimum duration dependant threshold for 
diastolic functional changes. The E:A ratio decreases did not exceed what would be 
expected due to measurement variability but were significantly reduced in some 
participants below the clinical cut-off for diastolic dysfunction (less than 1.0; Lang et al., 
2015), however, changes appeared to be transient in nature as a recovery in diastolic 
measures before 24 hr POST was observed. No participants reported any clinical signs 
and symptoms and changes did not appear to impact upon exercise performance, 
suggestive of limited clinical significance. 
 
6.4.3 Cardiac Biomarkers 
cTnI was undetectable in all serum samples taken PRE-exercise and is likely explained 
by the training status and control of exercise prior to each trial in this laboratory based 
study. Detectable cTnI values were observed in all participants by the 2 h POST 
assessment point, with all but one participant (participant 1 CON) demonstrating values 
above the upper reference limit for a healthy population by the 4 h POST assessment 
point. It is pertinent to note here that across both trials only 3 participants demonstrated 
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elevated cTnI levels immediately after exercise cessation, highlighting the importance of 
repeated measures for cTn post-exercise. The current study also revealed a peak in cTnI 
in some participants at 24hr POST-exercise, whilst others showed a normalization in cTnI 
at the same time point. Typically a normalization in cTn is expected after 24 (Middleton 
et al., 2006b; Shave et al., 2004c) to 48 hours (Melanson et al., 2006) post-exercise. 
Therefore, it may be speculated that a true peak value may have occurred between the 4 
h POST and 24 h POST exercise data collection points, however, it was not possible to 
evaluate the normalization of elevated values in all participants due to the absence of 
blood sample collection at 48 hours post-exercise. There was no clear evidence of an 
effect of pre-cooling on cTnI with participant peak values varying across trials. The lack 
of difference between cardiovascular stress i.e. exercise intensity and thermal stress 
between trials may explain the current findings. A study by Tian et al. (2014) suggested 
a blunting effect of cTn increase in the second exercise trial compared to the first. This 
was not apparent in the present study given there was no order effect of the trials on cTnI. 
The findings from the current and previous studies suggests the likely mechanisms for 
cTn release to be a physiological response due to the high percentage of participants with 
increased cTn post-exercise, low absolute levels and a rapid normalization of values, 
representing cTn release from the “unbound” cytosolic reservoir rather than necrosis 
(Gresslien and Agewall, 2016; Shave et al. 2010). The individual variation demonstrated 
within the current study, however, warrants further investigation. 
 
Data for NT-proBNP was below the upper reference limit for a healthy population for all 
participants PRE-exercise and remained below this limit for 6 out of 8 participants across 
all time points, with no significant increase across time. Any small changes in NT-
proBNP likely reflect the limited hemodynamic stress of a 90 min exercise bout at a 
relatively moderate intensity. Serrano-Ostáriz et al, (2011) suggest that once an 
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exercising HR exceeds 100-120 beats.min-1, exercise duration exerts a bigger influence 
on NT-proBNP release (Legaz-Arrese et al. 2011). This is supported by the higher NT-
proBNP concentrations in the present study compared to smaller concentrations following 
60 min running in Chapter 5. The findings from Chapter 5, however, suggested a more 
complex interaction between exercise intensity and duration given a greater NT-proBNP 
concentration was found within a hyperthermic environment compared to a normothermic 
environment. As NT-proBNP is elevated in response to volume overload and myocyte 
stretch (Shave et al., 2007b), this finding was attributed to a greater total of myocardial 
work within the heat. Within the present study there was no difference in NT-proBNP 
concentration between trials, supporting the earlier statement that there was a limited 
difference in cardiovascular stress between trials. It is unclear why 2 participants 
demonstrated elevated concentrations at the 4 hr POST or 24 h POST assessment points. 
NT-proBNP demonstrates a half-life of around 120 minutes (Hall, 2004), therefore, any 
peak values were likely to have been detected within the earlier sampling points of the 
present study.  
 
6.4.4 Limitations 
Within the present study, a controlled laboratory-based design was chosen to allow the 
appropriate control and comparison of a hyperthermic environment with the manipulation 
of Tc in a repeated measures design. The volume of exercise, whilst controlled for 
duration and intensity, was greater than that in Chapter 5, however, was lower than the 
stimulus reported in previous field-based studies which have evidenced cardiac 
dysfunction and elevated cardiac biomarkers (Chapter 3 and 4; George et al. 2005; Whyte 
et al. 2005). The exercise duration was selected to ensure the majority of participants 
completed both trials before an unethical Tc was reached and exercise was terminated. 
Whilst this may have limited the exercise dose performed, 2 of the initial 10 participants 
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were unable to complete the exercise duration due to an elevated Tc, leading to an 
underpowered EF and E:A. Therefore, whilst the duration of exercise may have limited 
the expression of any systolic functional changes, it allowed the evaluation between trials 
of the same running speed and exercise duration. Another consequence of a controlled 
laboratory-based design is the use of a fixed intensity and duration exercise protocol. 
Whilst such protocols lack the ecological validity for the application to athletic 
environments, it has been previously noted that systolic and diastolic functional changes 
as well as elevations in markers of cardiac damage are influenced by exercise intensity 
and/or duration (Gresslien and Agewall, 2016; Middleton et al., 2006a; Oxborough et al., 
2010). The completion of a fixed distance would enable a comparison between the 
effectiveness of pre-cooling given that the intensity and duration would differ between 
trials, but also typically pre-cooling allows for participants to exercise at a higher intensity 
to elicit a similar HR (Ross et al, 2013). Within the present study, a fan was used to allow 
for adequate airflow which aids evaporative and convective heat loss (Jones and Doust, 
1996; Saunders et al., 2005) to replicate outdoor conditions. It has more recently been 
suggested that an adequate airflow can provide the same benefits as pre-cooling, with no 
extra benefit when the strategies are combined, demonstrated by no difference between 
Tc and Tsk after 15 min of fixed intensity cycling (Morrison et al., 2014). It may be 
possible that the use of a fan dampened the thermal and cardiovascular benefits that have 
been observed in other pre-cooling studies. Whilst cold water immersion is suggested to 
be the most effective method of individual pre-cooling (Bongers et al., 2015; Jones et al., 
2012) and is a popular strategy employed by some athletes prior to competition (Périard 
et al., 2017), it may not be the most practical method due to issues such as time, cost, 
access and transportation (Ross et al, 2013). The present study also found a limited benefit 
of pre-cooling, particularly with regards to reducing cardiovascular stress. Future studies 
may wish to consider other methods of manipulating cardiovascular strain to evaluate the 
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impact upon cardiovascular function and markers of cardiac damage i.e. per-cooling 
(during exercise) and post-exercise cooling. 
 
6.5 Conclusion 
Diastolic, but not systolic function was significantly reduced following 90 min of running 
in a hyperthermic environment, with no difference apparent between pre-cooling and 
control conditions. The release of cTnI was evident in all participants following both 
trials, with a small release of NT-proBNP, again with a limited effect of pre-cooling. The 
results also presented a high degree of individual variation between participant’s 
responses to the exercise stimulus in both trials of the study. Pre-cooling appeared to have 
no beneficial or adverse effect on the cardiovascular parameters measured in this study, 
therefore pre-cooling may be more useful as a perceived comfort/performance benefit. 
The findings from the present study extend the limited previous work evaluating the effect 
of environmental temperature on cardiovascular function and markers of cardiac damage.  
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CHAPTER 7 
General Discussion 
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7.1 Introduction 
Participation in single, or multi-day, prolonged bouts of endurance exercise has proved 
increasingly popular over recent years (Knoth et al., 2012) and provides a substantial 
cardiovascular challenge. A growing evidence-base suggests that the physiological 
demands of maintaining a high cardiac workload for a prolonged period may result in a 
transient impairment in cardiac function, evidenced by a reduction in LV contractile 
function and/or relaxation during recovery (Douglas et al., 1990b; George et al., 2004, 
2005; Middleton et al., 2007a; Shave et al., 2004a, 2004c; Vanoverschelde et al., 1991). 
An elevation in cardiac biomarkers such as cTn, a biomarker of cardiomyocyte cell insult, 
immediately following acute bouts of prolonged exercise in apparently healthy 
individuals has also been widely documented (Shave et al., 2007a). There is no consensus 
regarding the prevalence, mechanisms and clinical management of exercise-induced cTn 
release (Shave et al., 2010). A combination of factors such as exercise duration, intensity 
and volume, participants training experience, as well as environmental factors have been 
suggested to precipitate changes in ventricular function and biomarker appearance 
(Gresslien and Agewall, 2016; Oxborough et al., 2010; Sedaghat-Hamedani et al., 2015). 
 
The main purpose of this thesis was to examine the effect of single and repeat bouts of 
prolonged exercise and environmental temperature upon LV function and cardiac 
biomarker release. In all four studies presented in this thesis, healthy individuals were 
examined over a variety of different exercise challenges. This chapter first summarises 
the findings of each study, followed by an overarching discussion of developing issues. 
A consideration on limitations related to the studies and potential future directions are 
presented, before the significance of the findings and a reflection on potential mechanisms 
involved. 
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7.2 Synopsis of Findings 
All four studies focused on LV function and cardiac biomarker release in response to 
prolonged exercise, with the findings summarised in Table 7.1. The first two empirical 
studies concentrated on the design of repeated exercise bouts, an area that has received 
little attention in the extant literature but represents greater accumulated cardiovascular 
work. The findings from these studies suggested that the CV system of amateur cyclists 
and well trained runners coped well with the accumulated exercise stress imposed by 
repeated day exercise. Studies two-four focused on the effect of a hyperthemic 
environment, another novel area of study which may also represent a greater 
cardiovascular work. Within a field based environment, study two demonstrated clear 
evidence of cardiac dysfunction and an increase in cardiac biomarkers. We also combined 
the use of controlled laboratory studies, of which there are few in the literature with an 
environmental challenge. The participants in study three coped well with the exercise 
stress, however the exercise dose in the laboratory likely negated any meaningful impact 
upon cardiac function and biomarker release. The final study was the first to use an 
intervention within this area of study, however, pre-cooling appeared to have no 
beneficial or adverse effect on the cardiovascular parameters measured. 
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Table 7.1 Summary of study findings 
 Participants Intensity 
of 
Exercise 
Environmental 
Conditions 
LV cardiac function Cardiac biomarkers Hypothesis 
Study 1: 
Repetitive road 
cycling over 10 
days (1666 km 
Recreationally 
trained cyclists 
Self-
paced 
 
8.2–18.8oC 
39-82% RH 
Systolic and diastolic dysfunction 
was present and remained 22 h 
into recovery. Limited support for 
a cumulative change in both 
systolic and diastolic function. 
Highly individual pattern of cTnI and 
NT-proBNP appearance 
REJECTED 
Study 2: 
1) Single day 37 
km 
2) Multi-stage 
ultramarathon, 
250 km over 5 
days 
Well trained 
long distance 
runners 
Self-
paced 
 
30–40oC 
31-40% RH 
Decrease in systolic and diastolic 
function 
 
Depression in systolic and 
diastolic function, with limited 
support for an accumulative 
effect. 
Elevation in cardiac biomarkers cTnI 
and NT-proBNP 
 
Sporadic changes in cTnI and NT-
proBNP, with limited support for an 
accumulation 
1 - ACCEPTED 
 
2 - REJECTED 
 
3 - REJECTED 
Study 3:  
60 min 
normothermic 
trial 
60 min 
hyperthermic 
trial 
Recreationally 
trained athletes 
65% 
VO2peak 
 
 
65% 
VO2peak 
13oC 
 
 
 
30oC 
Systolic and diastolic function 
were not significantly altered in 
either condition. 
Limited release of in cTnI and NT-
proBNP, with a tendency for markers 
to be higher in the hyperthemic 
condition 
REJECTED 
Study 4: 
Control + 90 
min running 
trial 
Pre-cooling + 
90 min running 
trial 
Recreationally 
trained athletes 
65% 
VO2peak 
 
 
65% 
VO2peak 
32.4 ± 0.9oC, 
46.8 ± 6.4% 
RH 
Diastolic, but not systolic function 
was significantly reduced 
following 90 minutes of running, 
with no difference between pre-
cooling and control conditions. 
cTnI was evident in all participants 
following both trials, with a limited 
release of NT-proBNP that was not 
mediated by pre-cooling. High 
degree of individual variation 
between participant’s responses to 
the exercise stimulus in both trials. 
REJECTED 
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7.3 Overarching Themes 
Reflection on the thesis as a whole allowed for the development of items of discussion 
that were beyond the scope of single studies. Consequently we have highlighted four 
overarching themes to explore. 
 
7.3.1 Accumulation of Changes in Cardiac Function and Markers of Cardiac Damage 
over Repeated Bouts of Exercise 
A major focus of this thesis was to extend our understanding of the impact of exercise on 
cardiac function and biomarker release from a single exercise exposure model to multi-
day exercise model(s). Alterations in cardiac function and biomarker release have been 
well documented following a single bout of exercise (Appleman et al. 2014; Douglas et 
al., 1990b; Eijsvogels et al., 2014a, 2015; George et al., 2004, 2005; Middleton et al., 
2007a; Shave et al., 2004a, 2004c; Vanoverschelde et al., 1991). Many athletes, however, 
engage in repeated bouts of exercise either during competition, through the repetitive 
element of training, or a combination of the two. Therefore, the evaluation of single bouts 
of prolonged exercise provides limited information into the practical understanding of 
cardiac dysfunction and biomarker release in different exercise settings. Despite the 
common occurrence of repeated bouts of activity, there are only a small number of studies 
that have focused upon the cardiovascular consequences of engaging in repeated bouts of 
endurance exercise (Appleman et al., 2015; Bonetti et al., 1996; Corsetti et al., 2012; 
Denissen et al., 2012; Middleton et al., 2007b; Oosthuyse et al., 2012; Shave et al., 2002b; 
Williams et al., 2009, 2011). A number of these studies have minimal assessment points 
during the events (Appleman et al., 2015; Bonetti et al., 1996; Corsetti et al., 2012; 
Denissen et al., 2012; Shave et al., 2002b; Williams et al., 2009), restricting the 
evaluation of an accumulative effect.  
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The current thesis (Chapters 3 and 4) demonstrated no strong evidence for a cumulative 
impact of repeated exercise exposures on cardiac function and biomarker release in 
recreational cyclists in a normothermic environment nor in well-trained runners in a 
hyperthermic environment. As highlighted previously, Chapter 3 demonstrated the 
presence of systolic and diastolic dysfunction 22 hours into recovery; similar to findings 
by Williams et al. (2009) who noted evidence of diastolic dysfunction 2 days post 
exercise. Chapter 4 suggested that whilst parameters of systolic and diastolic function 
were reduced, they recovered partially, between exercise bouts suggesting limited clinical 
implication. Previous research into single day exercise has suggested that training status 
may mediate cardiac functional responses (Middleton et al., 2006a), therefore, it may be 
speculated that the prolonged dysfunction evidenced in Chapter 3 may well be a related 
to training status and required further investigation. Low concentrations of cardiac 
biomarkers in Chapter 3 were likely due to the low exercise intensity (Stewart et al., 
2016). Transient elevations in cTnI were evident in Chapter 4 with elevated samples after 
one stage followed by an undetectable level at the next sample point. Therefore, it is more 
likely that elevated cTnI levels are representative of a physiological rather than a 
pathological response (Eijsvogels et al., 2011, 2015). The participants in Chapters 3 and 
4 appeared to cope well with the volume of exercise required to complete the events and 
appeared to have sufficient recovery opportunities, thereby minimising any accumulation 
occurring. 
 
7.3.2 Field Based versus Laboratory Based Studies of Cardiac Function and Cardiac 
Biomarker Release 
Previous research within this area has employed a broad range of research designs, 
however, these can largely be categorized into either 1) a field-based competitive 
endurance event (typically a single post-exercise assessment) or 2) a controlled 
201 
 
laboratory-based bout of steady-state endurance exercise. The choice of the research 
setting is highly dependent upon the research question proposed, and can impact upon the 
internal and external validity of the experiment. A laboratory setting usually allows for 
the tighter control of extraneous variables, thus increasing the likelihood that the observed 
results are due to the experimental manipulation, increasing the internal validity of the 
study (Thomas et al., 2015). The limitation(s) of a controlled laboratory setting can, 
however, impact on the external validity (ability to generalize results to other participants, 
settings, measures etc.) of the results, which a field-based study can offer. Whilst the 
results of a laboratory-based study can be generalized to a larger population if the sample 
is representative, this generalization may only apply to the specific laboratory situation 
and cannot be applied to a real-world setting, reducing the ecological validity and 
practical significance of the study (Thomas et al., 2015). Within the present thesis, we 
adopted both laboratory and field based research designs to answer the specific research 
aims and hypotheses of individual studies. 
 
Studies one and two (Chapters 3 and 4) were field based investigations, designed to 
develop the theme of repeated exposures to exercise. Study one indicated that LV systolic 
and diastolic function were depressed in some cyclists, although this was highly variable 
both between and within cyclists as were elevations in cardiac biomarkers, with a general 
lack of a cumulative effect. The lack of data collection prior to each cycling day in study 
one limited data interpretation, which was addressed in the design of study two.  
 
Study two highlighted the need to investigate the effect of environmental temperature 
(See Section 7.3.3) and thus we also adopted controlled laboratory based studies in studies 
three and four in the present thesis. Environmental conditions during field-based studies 
are often not reported or can be highly variable across an event and therefore, do not allow 
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the effect of environmental temperature to be investigated. The direct comparison in a 
repeated measures design required a laboratory setting to control the environmental 
exposure as well as other confounding variables such as exercise intensity. It is likely that 
the reduced exercise dose in study 3 limited any meaningful impact of cardiac function 
and biomarker release compared to study two. The extended duration of the exercise dose 
in study four not only supports the theory that diastolic functional changes precede 
systolic changes (Middleton et al., 2006a), but the apparent diastolic dysfunction also 
highlighted a minimum duration dependant threshold for diastolic functional changes 
exists. 
 
Whilst exercise in a laboratory provides a controlled environment, exercise typically 
occurs in near still wind conditions unless equipment is used to produce an adequate wind 
speed. The presence of wind speed can influence the capacity of heat loss through both 
convection and evaporation (Nielsen 1996; Saunders et al., 2005). Saunders et al., (2005) 
demonstrated that wind still conditions or very low winds speeds during exercise, can 
lead to excessive heat storage through a reduced capacity of the environment to absorb 
the heat produced, demonstrated by higher Tc, Tsk, HR and RPE. Within the present thesis, 
the use of fans to replicate outdoor conditions (Jones and Doust, 1996) was made in a bid 
to increase the ecological validity of the laboratory studies. The use of a set pace of 
exercise increases the internal validity of the laboratory studies, however does limit the 
relevance to competitive situations and the exercise dose. 
 
7.3.3 The Impact of Environmental Temperature 
Many athletes engage in bouts of exercise in hot, cold, humid and high altitude 
environments, however limited information upon the effect of environmental temperature 
upon changes in LV function and biomarker appearance exists (Bonetti et al., 1996; 
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Dávila-Román et al., 1997; Douglas et al., 1987; Gaudreault et al., 2013; Neumayr et al., 
2001, 2002; Rifai et al., 1999). The limitations of a number of these studies are associated 
with the field-based nature of the studies, whereby a lack of control exists, particularly 
with no ability to manipulate environmental conditions during ultra-endurance events 
making it difficult to draw conclusions. With only one lab-based study focusing on the 
effect of environmental strain upon cardiac function and damage in a normothermic and 
hypothermic environment (Shave et al., 2004c), the current thesis provides novel insights 
into the impact of exercise within a hyperthermic environment. Chapter 5 demonstrated 
only a tendency for greater cardiac functional or biomarker changes in a hyperthermic 
compared to a normothermic environment, with Chapter 6 showing no differences 
between conditions when Tc was manipulated through pre-cooling prior to exercise in a 
hyperthermic environment. A clear finding from both Chapters 5 and 6 was that systolic 
function was not altered independently of a reduction in preload. It is probable that the 
rate of fluid loss through sweat production, along with peripheral vasodilation may have 
led to a reduction in venous return and therefore, reduced LV preload. It is also apparent 
that the duration of the exercise was too small of a stimulus to induce changes in systolic 
function. The short duration of the exercise and timing of assessments in Chapter 5 may 
also confounded data interpretation with regards to diastolic function and cardiac 
biomarkers as again the exercise stimulus was found to be too short to induce significant 
changes, making it difficult to evaluate the impact of environmental temperature. Overall 
the participants in Chapters 5 and 6 appeared to cope well with the volume of exercise 
and environmental conditions required to complete the exercise trials. Future studies 
should attempt to utilise greater durations of exercise when evaluating the effect of the 
environment upon cardiac function and biomarkers. 
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7.3.4 Individual Variation 
Throughout this thesis it is apparent significant intra and inter-individual variation existed 
in response to the exercise demands placed upon the participants which is concurrent with 
other previous single (Eijsvogels et al., 2015; Scott et al., 2009) and multi-day studies 
(Williams et al., 2011). Whilst some participants appeared to cope well with the exercise 
demands, others demonstrated a greater level of cardiac dysfunction and/or changes in 
cardiac biomarkers. A number of personal and exercise related factors have previously 
been implicated with both phenomena which will be discussed below, however, within 
the present thesis the importance of these factors is a matter of speculation. 
 
A novel finding from Chapter 4 was a reduction in global systolic function (EF and SV) 
following exercise of a near marathon distance in a hyperthermic environment. Previous 
literature typically suggests no changes in systolic function, as measured by EF, observed 
following marathon distances (George et al., 2006; Middleton et al., 2006b; Whyte et al., 
2005), however, the duration of the exercise was much greater in Chapter 4, which has 
previously been implicated in the aetiology of systolic dysfunction (Middleton et al., 
2006a; Oxborough et al., 2010). A meta-analysis found exercise duration and fitness 
status had a significant impact upon changes in EF. Untrained individuals completing 
moderate duration exercise (> 3 hours) and trained individuals completing ultra-long 
duration exercise (> 10 hours) demonstrated a reduction in EF of 4.5% and 6% 
respectively (Middleton et al., 2006a), whereas more recently Serrano Ostariz et al. 
(2013) found no association between race duration or training status and systolic 
dysfunction following 206 km cycling. Within the present thesis it was clear that an 
exercise duration threshold existed for systolic function, although at present it is unclear 
what this is, given that no changes were observed which were unrelated to loading 
following short duration exercise (Chapters 5 and 6). Similarly, the insignificant 
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reduction in diastolic function found in Chapter 5 and by Scharhag et al. (2006) following 
60 minutes exercise, compared to an increased duration and apparent diastolic 
dysfunction in Chapter 6 and that by Tian et al. (2014) suggest a minimum duration 
dependant threshold for diastolic functional changes (> 60 min; Middleton et al., 2006a). 
Furthermore, training status could not explain any variations in post-exercise response 
(Middleton et al., 2006a). Decreases in systolic and diastolic function have also been 
found to be unrelated to age, weight loss or exercise intensity (Serrano Ostariz et al., 
2013; Stewart et al., 2016). Future research should consider factors which may explain 
individual variation in changes in LV function following prolonged exercise. 
 
The high inter-individual variation of cTn release in a field-based environment has been 
previously reported (Shave et al., 2007a), which has been partially attributed to the large 
variation in exercise parameters such as intensity and duration, given that most 
competitive environments are based on the completion of set distances. Serrano-Ostáriz 
et al. (2009) reported that cTnI was mediated by exercise duration and intensity with 
lower concentrations reported following shorter duration or lower intensity exercise. It is 
pertinent to note that the exercise durations used within the study were particularly short 
(45 min to 180 min) in comparison to previous research and intensities of 85% and 95% 
of individual anaerobic threshold may underestimate the typical competitive running 
speeds. More recently, Eijsvogels et al. (2015) noted that a longer exercise duration was 
significantly related to higher cTnI levels but could only explain a small proportion of the 
individual variance in post-race levels. Within the present thesis, there was no association 
between exercise duration or running speed with cTnI release in Chapter 4, similar to 
findings from Fortescue et al. (2007), however, pacing strategies within Chapters 3 and 
4 may have impacted upon the present findings. Whilst Chapters 5 and 6 in the present 
thesis used a controlled exercise intensity and duration, high inter-individual variation 
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was still apparent, implicating factors other than exercise characteristics. A lower 
participant age has also been associated with higher post-exercise cTnI concentrations 
(Eijsvogels et al., 2015; Fortescue et al., 2007; Mingles et al., 2009), a finding often 
concomitant with a lower training experience (Fortescue et al., 2007; Mingles et al., 
2009), however, other studies have found no link between age (Mehta et al., 2012; Shave 
et al., 2004a) or training experience with cTn release (Scheer et al., 2011). Future research 
should consider possible exercise, personal and environmental factors associated with 
cTn release. 
 
Previous research has suggested those participants who covered less training distance per 
week demonstrated a greater elevation in NT-proBNP (Neilan et al., 2006a). A large 
difference in participant weekly training distance in the present thesis was apparent i.e. 
Chapter 4, and could partially explain the inter-individual variation. It has been previously 
suggested the increase in NT-proBNP is associated with exercise duration (Serrano-
Ostáriz et al., 2011), supported in the present thesis by greater concentrations of NT-
proBNP in Chapters 3 and 4 in comparison to the shorter durations of Chapters 5 and 6. 
The similarity of concentrations of NT-proBNP in Chapters 5 and 6 between participants 
when exercise duration and intensity were controlled may also provide evidence for the 
influence of exercise duration on NT-proBNP release. NT-proBNP release was not 
associated with exercise duration in Chapter 4 phase 1, suggesting other factors are also 
implicated. A complex interaction of baseline (age, gender, volume overload, HR, blood 
pressure; Chen et al., 2008), prior exercise (training history; Neilan et al., 2006a) and 
exercise-related factors (exercise duration; Serrano-Ostáriz et al., 2011) are suggested to 
explain the variability in levels of biomarkers (Legaz-Arrese et al., 2011). 
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Training history and fitness has been implicated with both cardiac dysfunction and 
biomarker elevation, however, it may also interlink with a participants response to 
exercise in differing environmental temperatures. The rate of body heat storage is 
dependent upon the rate of metabolic heat production and the rate of heat dissipation 
(Mora-Rodriguez, 2012). An improvement in VO2max through training results in an 
enhanced heat dissipation by lowering the Tc threshold for skin vasodilation and sweating 
(Nadel et al., 1974). When participants are working at the same relative intensity (i.e. 
65%VO2peak), those with a greater experience in endurance training will be working at 
a higher absolute workload than less trained individuals, thereby generating more 
metabolic heat. The higher exercise workload will also result in an increased cutaneous 
blood flow and sweat rate in the trained participants (Nadel et al., 1974). Within in a 
normothermic environment, the higher metabolic heat production is compensated by the 
higher heat dissipation resulting in heat balance (Mora-Rodriguez, 2012). Within a 
hyperthermic environment, the metabolic heat production can exceed the capacity of the 
environment to accept heat, resulting in a greater heat accumulation in well trained 
participants. Therefore, within the present thesis, training status of the participants in 
Chapters 4 to 6 may impact upon the CV compromise between maintaining thermal 
equilibrium and the exercise intensity, which could explain some of the individual 
variation apparent. 
 
7.4 Limitations and Future Research 
7.4.1 Experimental Design 
The experimental design of a study is largely dependent upon the aim of the research 
question in focus. As previously discussed, the setting of the research environment 
(laboratory versus field based) can also impact upon the study design. In Chapter 3, the 
reluctance of participants and time constraints did not allow for daily pre-exercise data 
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collection points, which confounded data interpretation when evaluating if an 
accumulation of across the cycle challenge was apparent. The research design was 
improved in Chapter 4 to include pre and post-exercise assessment points each day which 
provided more support for the pattern of changes in cardiac function and biomarkers. A 
limitation of both Chapters 3 and 4 was that it was not possible to determine the time 
point in which LV systolic and diastolic function or cardiac biomarkers peaked or 
returned to pre stage 1 values. Whilst cTn has been detected in individuals in as little as 
30 minutes exercise (Middleton et al., 2006; Shave et al., 2010), it is suggested an 
elevation in cTn in response to exercise is evident in all individuals, but may not always 
be detected due to the time of sampling (Gresslien and Agewall, 2016). A peak in cTnI 
has previously been reported after 3-6 hours (Lippi et al., 2012; Scharhag et al., 2006; 
Shave et al., 2010) with a normalization after 24 (Middleton et al., 2007a; Shave et al., 
2004c) to 48 hours (Melanson et al., 2006). Therefore, it may well be that the 
concentrations of cTn may have been underestimated in Chapters 3 and 4. In Chapters 5 
and 6 we included multiple sample points in an attempt to monitor the kinetics of cTnI 
release. Chapter 6 provided a greater number of post-exercise assessment points 
compared to the majority of research within this area and this approach should be adopted 
moving forward to help fully understand biomarker kinetics and the association with other 
variables (person, exercise and environment). 
 
The volume of exercise was controlled (for duration and intensity) in Chapters 5 and 6 
but was lower than the stimulus reported in previous field-based studies, which have 
provided the more robust and consistent evidence of cardiac dysfunction and elevated 
cardiac biomarkers (George et al. 2005; Whyte et al. 2005). The exercise duration in 
Chapter 5 limited the expression of both systolic and diastolic functional changes. The 
exercise duration of both Chapters was selected to ensure participants completed both 
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trials before an unethical Tc was reached and exercise was terminated prematurely, 
allowing the evaluation between trials of the same running speed and exercise duration. 
Whilst the duration of the exercise limited the exercise stimulus, it did highlight a 
minimum duration dependant threshold for diastolic functional changes. 
 
7.4.2 Sample Size 
The sample sizes in some Chapters within the present thesis were small, which may have 
led to a reduced statistical power. The measurement variance in flow and tissue velocities, 
coupled with participant heterogeneity may explain the lack of statistical significance, 
particularly within Chapter 5. Increasing the sample size would increase the statistical 
power. Chapter 3 may also be considered as a series of case studies (n = 3), however the 
nature of ultraendurance exercise often means recruitment is difficult, particularly when 
coupled with invasive techniques such as venous blood sampling. 
 
7.4.3 In-event Data 
Through the completion of this thesis it is apparent that alterations in cardiac function and 
elevations in cardiac biomarkers are highly variable: person to person, measurement to 
measurement and to the posed exercise stimulus itself. In Chapter 4, the reluctance of 
participants did not allow for a measurement of exercise intensity making it difficult to 
draw conclusions in relation to the acute cardiovascular stress of the exercise bouts. The 
varied terrain and different pacing strategies of runners (i.e. walking uphill sections and 
running downhill) may have placed variable hemodynamic loading and stress on the 
cardiac muscle at irregular intervals, permitting periods of recovery in some runners 
(Denissen et al., 2012). The recording of exercise intensity may, therefore, provide 
valuable insight into the variable cardiovascular load involved in field-based events. 
Whilst Chapter 3, and data from Williams et al. (2011), demonstrated a heterogeneous 
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response between participants, this cannot be solely be attributed to exercise intensity. 
Data from Chapters 5 and 6 support this notion in that whilst relative exercise intensities 
were consistent across participants and trials, factors other than total myocardial work 
and thermal strain are implicated. Further research should focus on elucidating the factors 
that precipitate changes in ventricular function and biomarker appearance. 
 
In Chapter 5 we collected blood samples during the exercise bouts in an attempt to 
monitor the kinetics of cTnI and NT-proBNP release. Whilst cTn has been detected in 
individuals in as little as 30 minutes exercise (Middleton et al., 2006; Shave et al., 2010), 
it is possible that the pause during the exercise in Chapter 5 in order to obtain a blood 
sample may have led to a short recovery period from the exercise stimulus.  
 
7.4.4 Future Research 
A number of areas for future research have been highlighted within the individual 
chapters as well as within this general discussion. It is clear from the current thesis that a 
number of recommendations when designing research studies within this area should be 
considered i.e. including multiple assessment points post-exercise (section 7.4.1), the use 
of greater participant numbers (section 7.4.2) and collection of in exercise data (section 
7.4.3). As mentioned in section 7.3.3, this thesis provided novel insights into the effect of 
a hyperthermic environment upon cardiac function and biomarkers, however, due to the 
limited exercise dose utilised in the present thesis, this remains an area for future research. 
Future studies should firstly attempt to utilise greater durations of exercise when 
evaluating the effect of the environment upon cardiac function and biomarkers. Whilst 
Chapter 6 used the method of pre-cooling to manipulate Tc, the cardiovascular benefits 
were found to be attenuated after 20-25 mins of exercise (Bolster et al., 1999), highlighted 
by similar exercise HR, Tc and Tsk. Future studies may wish to consider other methods of 
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manipulating cardiovascular strain to evaluate the impact upon cardiovascular function 
and markers of cardiac damage i.e. per-cooling (during exercise) and post-exercise 
cooling. Per-cooling methods such as cold water/slurry ingestion, water spray cooling or 
cooling packs (Bongers et al., 2017) may have larger potential benefit on 
thermoregulation, particularly during exercise in a hyperthermic environment compared 
to pre-cooling methods. An attenuation of Tc through per-cooling would allow serve to 
maintain central blood volume, limiting the magnitude of cardiovascular drift and 
therefore reducing the cardiovascular strain of the exercise bout. The method of post-
cooling allows the reduction of Tc, Tsk and/or muscle temperature directly post-exercise 
(Bongers et al., 2017), which would also directly impact upon the cardiovascular load 
post-exercise. Whole body cryotherapy has been shown to have no negative impact upon 
cardiac function after a weekly course of daily cryotherapy sessions (Banfi et al., 2009), 
however its effect upon cardiac function immediately post-exercise has yet to be 
evaluated. Whilst a number of methods of pre-cooling and post-cooling are available, 
future research should also take into account methods which are practical for use in a 
field-based competitive setting. 
 
7.5 Clinical Implications 
Part of the rationale for research within this area is based upon the concern that prolonged 
exercise may have a deleterious effect upon the health of the heart. The findings of this 
thesis contribute towards highlighting possible clinical implications of the exercise 
demands but also provoke some discussion of the possible mechanisms behind changes 
in cardiac function and elevations in markers of damage. 
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7.5.1 Cardiac Function 
Within the present thesis, changes in systolic function were apparent following multi-day 
exercise (Chapters 3 and 4) and longer (Chapter 4) but not shorter duration single-day 
exercise (Chapters 5 and 6). A number of participants in Chapters 3 to 6 demonstrated 
post-exercise EF below the lower limit for normal LV systolic function (52%; Lang et 
al., 2015). Within Chapter 3, similar exercise HR’s across each day, suggest alterations 
in EF from the previous day did not seem to impact upon exercise performance. Chapter 
4 demonstrated the change in EF appeared to be transient as EF typically recovered 
partially, if not fully by the PRE-exercise measurement point each day suggesting a 
limited impact in the short term, however the long term effects of prolonged exercise 
deserves future research. 
 
Similarly, changes in diastolic function were also apparent following multi-day exercise 
(Chapters 3 and 4) and longer (Chapters 4 and 6) but not shorter duration single-day 
exercise (Chapter 5). The E:A ratio was significantly reduced in some participants below 
the clinical cut-off for diastolic dysfunction (less than 1.0; Lang et al., 2015) in Chapters 
3 to 6. This appeared to be transient in nature as a recovery in diastolic measures before 
24-hr POST was observed in Chapter 6 and is consistent with other studies (Shave et al., 
2004a) alongside a recovery between stages in Chapter 4. Overall, no participants 
reported any clinical signs and symptoms and changes did not appear to impact upon 
exercise performance either during or on subsequent exercise days, suggestive of limited 
clinical significance. 
 
The mechanisms responsible for exercise induced changes in cardiac function are not 
fully understood. Whilst echocardiography is a useful tool in identifying changes in 
cardiac function, it provides a limited insight in identifying any mechanisms involved. 
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The use of statistical analysis can identify some of the relationships between changes in 
loading which may account for some of the alterations in functional parameters (i.e. 
Chapters 5 and 6). Two potential mechanisms have been proposed as intrinsic, non-load 
related mechanisms behind changes in cardiac function: 1) Myocyte damage (Neilan et 
al., 2006b) and 2) β-andrenergic receptor downregulation (Hart et al., 2006). Previous 
single day studies have suggested an association between cTn release and cardiac function 
(Neilan et al., 2006b; Rifai et al., 1999) but this cannot be confirmed within the present 
thesis as the relatively consistent changes in systolic and diastolic function occurred 
alongside marked individual variability in cTnI release. This would support two separate 
phenomena between changes in cardiac function and elevations in cardiac biomarkers 
with potential different mechanisms. During exercise, an increase in sympathetic activity 
via the neurotransmitters adrenaline and noradrenaline stimulate the β-andrenergic 
receptors in the myocardium, resulting in an increased chronotropic, inotropic and 
lusitropic effect on the LV (Opie, 2004). A tolerable sympathetic load/threshold has been 
suggested (Stewart et al., 2016), which if exceeded for prolonged periods of time could 
induce a desensitization or down regulation of cardiac β-andrenergic receptors (Banks et 
al., 2010; Oxborough et al., 2010) and autonomic responsiveness (Seiler et al., 2007) 
leading to a reduced force of contraction and impaired rate of LV relaxation. This is 
thought to be a result of the sustained exposure/accumulation of circulating 
catecholamines during prolonged exercise (Seals et al., 1988) and may, therefore, explain 
the minimum duration dependant thresholds for both systolic and diastolic dysfunction 
observed in the current thesis. 
 
7.5.2 Cardiac Biomarkers 
As previously discussed a highly individual variation in cTnI release was apparent in the 
present thesis linked to a number of personal and exercise related factors. It has been 
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proposed there are 6 potentially interlinked mechanisms to explain elevated cTn levels: 
1) an increased membrane permeability allowing unbound cTn in the cytosolic pool to 
enter the circulation; 2) cellular release of proteolytic troponin degradation products 
whilst membrane integrity remains; 3) formation and release of membranous blebs during 
temporary ischaemia of cardiac cells; 4) stimulation of myocyte turnover; 5) myocyte 
necrosis; and 6) increased rate of apoptosis (Eijsvogels et al., 2015; Gresslien and 
Agewall, 2016). The combination of results within the present thesis highlight a number 
of findings: transient elevations in cTnI evident in phase 2 of Chapter 4 with elevated 
concentrations after one stage followed by a rapid normalization of undetectable 
concentrations at the next sample point, a high percentage of participants with increased 
cTn post-exercise (Chapter 6) and low absolute levels of cTn (Chapter 3 and 4). With the 
absence of any clinical signs and symptoms of an adverse cardiovascular event, the 
elevations in cTnI are more likely to represent an acute physiologic perturbation, most 
likely representing cTn release from the cytosolic reservoir (Gresslien and Agewall, 2016; 
Shave et al. 2010) as opposed to underlying cardiac damage or pathology (Eijsvogels et 
al., 2011, 2015; Shave et al., 2010). The present thesis along with a number of other 
studies did not report an association between cTnI and NT-proBNP values (Herrmann et 
al., 2003; Scheer et al., 2011), suggesting the release of these biomarkers represents 
different phenomena. 
 
It is suggested an increased NT-proBNP during and after exercise is related to a growth-
regulating property of BNP, leading to myocardial adaptation in healthy athletes 
(Scharhag et al., 2006), rather than a sign of heart damage. Concentrations of NT-proBNP 
were increased above clinical cut-off values in Chapter 3 and phases 1 and 2 of Chapter 
4, which would be suggestive of LV dysfunction in a clinical setting (Shave et al., 2007). 
Given that NT-proBNP concentrations were below the clinical cut-off value following 22 
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hours of recovery in Chapter 3, the changes in NT-proBNP are more likely to represent 
the elevated cardiovascular work within both Chapters 3 and 4 as NT-proBNP is elevated 
in response to volume overload and myocyte stretch (Shave et al., 2007b). This is further 
supported by the fact NT-proBNP concentrations were near to or below the upper 
reference limit of a healthy population following the shorter exercise durations of 
Chapters 5 and 6. 
 
7.6 Conclusions 
The present thesis contributes to the existing knowledge related to LV cardiac function 
and markers of cardiac damage following prolonged exercise. The first aim of this thesis 
was to identify whether repeated day exercise would mediate a cumulative decrease in 
LV function as well as a cumulative increase in cardiac biomarker concentrations. The 
findings from Chapters 3 and 4 indicate that whilst evidence of cardiac dysfunction and 
an elevation in cardiac biomarkers exists, there was limited support for a cumulative 
change in both systolic and diastolic function and markers of damage. The second aim of 
this thesis was to examine the impact of prolonged exercise in a hyperthermic 
environment upon cardiac function and levels of cardiac biomarkers. Whilst Chapter 4 
provided the additional stress of a hyperthemic environment, the field-based setting did 
not allow for the control of other exercise-related parameters. Chapters 5 and 6 showed a 
limited effect of environmental temperature or manipulating Tc and Tsk (via pre-cooling) 
prior to exercise in a hyperthermic environment, however, further research with exercise 
of a longer duration in this area is warranted. Overall, the impact of acute endurance 
exercise upon cardiac function and biomarker appearance is transient in nature and more 
likely represent an acute physiologic perturbation as opposed to underlying cardiac 
damage or pathology. Throughout this thesis it is apparent inter-individual variation exists 
in response to the exercise demands placed upon the participants, however further 
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investigation into the related factors are required. Furthermore, no participants reported 
any clinical signs and symptoms and the observed changes did not appear to impact upon 
exercise performance either during or on subsequent exercise days, suggesting a limited 
clinical significance. As the number of individuals participating in endurance exercise 
continues to increase, medical personnel should be aware of the exercise factors which 
may lead to alterations in cardiac function and elevations in cardiac biomarkers following 
prolonged exercise and should check for other symptoms to avoid misdiagnosis of 
myocardial injury. 
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